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ABSTRACT 
 
 
The innate immune system has a variety of ways of recognizing infection from pathogens such 
as viruses and bacteria. One of its first lines of defence is to detect Pattern Associated Molecular 
Patterns (PAMPs) using Pattern Recognition Receptors (PRRs) such as the Toll-Like Receptors 
(TLRs), the RIG-Like Helicases (RLHs) and the Nod-Like Receptors (NLRs). These receptors 
recognize certain molecular structures from the pathogens and lead to first line of defence 
which includes increased cytokines and IFNs. 
 
This study delineate the human body’s innate immune responses to human respiratory viruses 
such as HRV (Human Rhinovirus), RSV (Respiratory Syncytial Virus) and IAV (Influenza A virus). 
In Vitro experiments carried out on various kinds of lung tissues suggest that respiratory disease 
pathogenesis is related to inflammatory mediators including interleukins and cytokines 
produced by the host’s innate immune system. 
 
Virus induced respiratory tract infection are known to trigger bronchiolitis, wheezing and acute 
asthma exacerbations, as a result of inflammation of lung tissues and excessive release of pro- 
inflammatory cytokines such as IL-1β. This study identifies that intracellular macromolecular 
complexes called inflammasomes assemble as a result of viral trigger. Inflammasomes convert 
the inactive forms of the pro-inflammatory cytokines to their active forms. Although the exact 
mechanism of activations of these complexes was unknown. This study identified that Virus 
encoded proteins such as the 2B protein of HRV, the SH protein from RSV and the Influenza 
M2 which are also termed viroporins can activate the inflammasome by causing ion imbalance 
(across cells membranes and organelles). Thus providing a trigger for inflammasome 
assemblage.
 v 
 
 
 
Drugs which act as Ion channel blockers have been shown to block viroporin activity and hence 
reduce IL-1β production. Therefore in the future the use of ion inhibitors could be a possible 
therapeutic intervention in order to reduce lung inflammation and prevent associated 
respiratory disease such as COPD and Asthma.
 vi 
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CHAPTER 1 
 INTRODUCTION 
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1.1 Respiratory Viruses and Disease 
Viral infection of the lower respiratory tract causes severe illness and disease in people 
from infants to the elderly. Prevention of lower respiratory tract infection (LRTI) is not 
yet available for most viral infections, apart from the readily available influenza vaccine. 
Hence understanding the basis of pathological mechanisms of such viral infections 
causing LRTI, is needed to develop novel and effective therapeutic approaches. In this 
study we attempt to gain an insight into the human body’s anti-viral innate immune 
response. After viral recognition, airway epithelial cells and other immune cells produce 
a vast range of mediators that include innate interferons and proinflammatory cytokines. 
These play a crucial role in controlling the effects of the viral invasion and controlling 
inflammation and disease pathogenesis.  
LRTI most commonly leads to different kinds of disease including bronchiolitis and 
pneumonia. Asthma exacerbations and Chronic Obstructive Pulmonary Disease (COPD) 
are other debilitating effects of respiratory viral infections.  Respiratory viruses 
commonly infect the airway epithelial cells (AECs) and also resident mucosal immune 
cells like the macrophages and dendritic cells (DCs) (Schwarze and Mackenzie 2013). 
The majority of the viruses causing such maladies are ssRNA viruses; major examples 
are Influenza virus, Respiratory Syncytial virus (RSV), Rhinoviruses, Parainfluenza 
viruses and Human Metapneumovirus. During the virus’s replication cycle, double 
stranded RNA intermediates get recognised by a plethora of Pattern Recognition 
Receptors (PRRs). Some of them are the Toll Like Receptors (TLRs) and the RIG-like 
helicases (RLRs). For instance TLR3 is endosomal and recognises viral invasion, so does 
RIG-I and MDA-5 which are present in the cytoplasm of the cell. All these PRRs that are 
upregulated in the airway epithelial cells (AECs) promote a downstream signalling 
cascade that activates the NFκB transcription complex and eventual production of 
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interferons. A type-I interferon called the IFN-β is secreted in an autocrine fashion 
enhancing its own production. It also promotes the production of IFN-α and (type-III) 
IFN-λ in AECs and innate immune cells (Vareille et al. 2011). The function of these 
interferons (IFNs) is to induce antiviral genes in AECs causing programmed cell death in 
infected cells. It also causes the activation of natural killer cells to combat infection. 
Recent studies show that the lack of IFN response in virus infected AECs in patients 
suffering from pre-existing lung disease (COPD and Cystic Fibrosis) results in an 
increased viral load. This causes an increase in proinflammatory stimuli and potential 
lung and airway inflammation (Contoli et al. 2006). Therapies that enhance type I/III 
responses will prove beneficial for patients suffering from pulmonary disease caused by 
viruses, such an effect is observed in in vitro studies using macrolide azithromycin 
(Gielen et al. 2010, Vareille et al. 2011).  
The airway epithelium acts as a physical barrier to pathogens entering the body through 
air-borne routes, acting as a defensive interface between the environment and the body. 
Each cells are attached to each other through cell-cell junctions including tight junctions 
(TJs), adherens junctions (AJs) and gap junctions (Roche et al. 1993). This forms an 
impermeable and defensive structure to invading pathogens at the same time allowing 
maintenance of ionic gradients. On top of this epithelium that acts as a physical barrier, 
sits a layer of mucous that allows the exchange of gasses, water and soluble nutrients. 
This is the second layer of barrier and is not hostile or permeable to most pathogens. 
About 90% of inhaled pathogens and viruses are cleared by the mucociliary escalator. 
These pathogens and particles are trapped in the mucous in the bronchioles and 
transported to the trachea, and most of the time is expelled. This transportation is feasible 
due to the beating action of the cilia that are present on the surface of the lung epithelium 
(Voynow and Rubin 2009). The mucus contains antimicrobial substances such as 
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lysozymes and defensins. It also contains cytokines and antioxidant proteins, to name just 
a few of the 200 different kinds of proteins present taking part in preventing pathogen 
entry (Voynow and Rubin 2009).  
In spite of all the defence mechanism the body provides, occasionally pathogens gain 
entry into bronchial and alveolar cells and establish themselves, continuing viral 
replication and causing an infection. In such cases the body’s own immune system (the 
innate immunity) responds in several ways to eliminate the virus, which is the scope of 
this study.  
 
1.1.1 ssRNA viruses  
Single stranded RNA viruses can be generally categorised under: positive stranded RNA 
viruses and negative stranded RNA viruses and they do not have a DNA phase. Examples 
of plus stranded RNA viruses are poliovirus, rhinovirus (picornaviridae), togaviruses, 
flaviviruses etc. Examples of negative-stranded RNA viruses include influenza virus 
(orthomyxoviridae), measles virus, mumps virus etc.   
In order to replicate viruses have clever strategies. RNA viruses replicate via an RNA 
intermediate. This requires an enzyme called the RNA-dependent RNA-polymerase in 
order to successfully replicate their viral genome, which is the strand of RNA. Due to the 
absence of suitable enzymes in the eukaryotic cells, the RNA viruses code for RNA-
dependent RNA polymerase. In plus stranded RNA viruses, the virion (genomic) RNA 
functions as an mRNA because of their similarity in structure and function. Immediately 
after infection of a eukaryotic cell, the mRNA is translated. However on the other hand, 
negative stranded RNA genome is negative sense (hence the name), which means that the 
RNA is complimentary to the mRNA. Before translation occurs the formation of a plus-
sense mRNA is needed. Apart from needing to code RNA-dependent RNA polymerase, 
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these RNA viruses need to package it in the virion so that mRNAs can be made after host 
cell infection (Hunt, April 26, 2010 ). 
 
1.1.1.1 Human Rhinoviruses (HRV) 
Human Rhinoviruses (HRV) belongs to the family of viruses called Picornaviridae and 
the genus Enterovirus, and are the major causative agents of common cold.  They also 
play a major role in asthmatic exacerbations, cystic fibrosis and chronic obstructive 
pulmonary disease (COPD) (Gern 2010). Like other Picornaviruses they also contain 60 
copies each of four capsid proteins, VP1, VP2, VP3, and the small myristoylated VP4. 
These are arranged on an icosahedral lattice.  
 
Figure 1.1 Picornavirus Genome. Schematic representation showing the coding regions 
for structural and non-structural proteins, the 5’ and 3’ untranslated regions (5’UTR; 
3’UTR) and the genome-linked protein Vpg  (Modified from (Andino et al. 1999) ).  
 
The particle is 30nm across. The genome of the virus consists of a positive sense single 
stranded RNA molecule which is 7100 bases long.  In its 3’ end the RNA has a poly-(A) 
tail which is 70-150 bases long and the 5’ end carries a covalently linked peptide (VPg) 
(Ahlquist and Kaesberg 1979, Nair and Panicali 1976). The 5’ region is non-translational 
and is approximately 650 bases long and is involved in cap-independent translation 
initiation and RNA replication (Rohll et al. 1994) (Harutyunyan et al. 2013). 
The life cycle of Picornaviruses share a common pathway. After entering the cell, the 
genomic RNA acts as an mRNA which acts as a template for the synthesis of a very large 
peptide molecule. This molecule is proteolytically cleaved and mature viral proteins are 
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formed. The viral RNA molecule is amplified in a two-step process. Firstly a 
complementary negative strand of the RNA is synthesised and secondly new molecules 
of positive strand RNA is made using this negative template as a reference  (Gamarnik et 
al. 2000).  A RNA-dependent RNA polymerase catalyses the synthesis of both the 
negative and positive stranded RNA (Dasgupta et al. 1979, Flanegan and Baltimore 
1977). Viral proteins are essential for RNA replication such as cis-acting elements 
(present in the viral genome), proteins (Andino et al. 1999, Barton et al. 1995, Blyn et al. 
1997, Gamarnik and Andino 1996, Jackson and Kaminski 1995) from the host cell and 
cell membrane structures. Paul et al have discovered that a primer dependent enzyme (3D 
pol) directly urydinylated the viral protein Vpg, and the resultant protein acts as a primer 
for the initiation process  (Harutyunyan et al. 2013).  It is however not clear how 
amplification of a single RNA molecule into thousands of copies are made.  
Initiation of picornavirus translation begins in a cap-independent manner and is promoted 
by an internal ribosome entry mechanism. A RNA segment of the 5’ UTR is needed for 
this process.  There is a vast amount of knowledge that has been gathered over the years 
about translation mechanism (Andino et al. 1999, Belsham and Sonenberg 1996), but the 
molecular details of the mechanism is still unclear.  
1.1.1.2 Influenza A Virus (IAV) 
 Influenza A virus belongs to the Orthomyxoviridae family of viruses. It is an enveloped 
virus that contains a negative strand RNA genome which is segmented. The viral genome 
encodes for 11 different viral genes which it utilises to infect cells and create more viral 
progeny and eventually subvert the host cell machinery.  Influenza virus come in a 
number of shapes but the most abundant ones are spherical. The viral proteins HA,NA 
and M2 (a viroporin) are abundantly found in the viral envelope which is found in the 
lipid bilayer (lipid bilayer is obtained from the host cell membrane) (Fields, B.N. 
2007)(Samji 2009).  
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The following four stages will briefly describe the influenza life cycle. It starts with the 
entry of the virus into the host cell. Then the vRNPs enter the nucleus of the host cell. 
Following this the viral genome goes through transcription and replication, and the export 
of the vRNPs occur from the nucleus. Assembly and budding occurs at the host cell 
plasma membrane. The following diagram provides a schematic representation of the 
Influenza A life cycle.  
  
Figure 1.2. Schematic diagram showing the influenza life cycle. Influenza A surface 
protein consists of M2 ion channel protein, lectin haemagglutinin and sialidase an 
enzyme. The virus uses haemagglutinin to adhere itself to the target host cell. Following 
this, endocytosis and fusion occurs. Host cell machinery starts producing viral 
components. Subsequent viral protein synthesis and particle assembly in the host cell 
prepares the virion progeny for the budding process to exit the host cell. (von Itzstein 
2007).  Diagram obtained from: (von Itzstein 2007).  
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1.1.1.3 Respiratory Syncytial Virus (RSV)  
Human Respiratory Syncytial Virus (RSV) causes respiratory tract infections in infants 
which most of the time results in complicacies like bronchiolitis and pneumonia and even 
death. The virus is classified under the genus pneumovirus (also includes bovine RSV 
and mouse pneumonia virus). The family of this virus is Paramyxoviridae. RSV consists 
of 10 genes and studies have identified the conserved mRNA termini, intergenic 
sequences, and coding regions for each of these genes (Barik 1992, Stec et al. 1991)  The 
RSV genome consists of a non-segmented negative stranded RNA; the RNA being about 
15,221 nucleotides (nt) long. The gene order is 3'(leader)-lC-1B-N-P-MSH- G-F-22K-L-
(trailer)5'; alternative names of some genes are NS1 (1C), NS2 (1B), 1A (SH), and M2 
(22K)(Barik 1992).  The 10 RSV proteins have all been identified and most of them are 
virion components. The most abundant among these are the 1C and the 1B which appear 
to be non-structural (Fernie and Gerin 1982, Peeples and Levine 1979, Pringle et al. 1981, 
Wunner and Pringle 1976). The viral RNA is contained in the nucleocapsid core. The N,P 
and L proteins are also found in the nucleocapsid core (Mittmann et al. 2002). Although 
still debatable, it is vastly believed that  the nucleocapsid of the RSV is the transcription 
complex of the virus and this encodes for an RNA-dependent RNA polymerase activity 
(Barik 1992). Proteins are present in the functional Ribonucleoprotein Complex (RNP) 
the functions of which are not characterised yet. Figure 1.3 represents a schematic 
diagram of the RSV genome.  
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Figure 1.3 RSV Genome. The negative-sense RNA genome (strain A2) is depicted 3’ to 
5’ showing the extragenic 3’ leader (le) and 5’ trailer (tr) regions and the intervening 10 
viral genes (rectangles) that are each expressed as a separate mRNA . M2-1 and M2-2 are 
overlapping open reading frames of the M2 mRNA. The M2 and L genes overlap slightly, 
and L is expressed by polymerase backtracking. Diagram and legend obtained from 
(Collins and Graham 2008).  
         
1.2 Innate Immunity and Toll-like Receptors   
The innate immune system is essential in recognising microbial pathogens that invade the 
body. This recognition is possible due to the presence of germline-encoded pattern-
recognition receptors (PRRs) which identifies molecular patterns present on the pathogen 
itself; these are called pathogen-associated molecular pattern (PAMPs) (Janeway 1989). 
A series of signalling cascade is generated after PRR recognises PAMPs and this forms 
the basis of the first line of host defence that is necessary for killing the invading 
microbes. Additionally the adaptive immune response is also triggered off by PRR 
signalling as a result of dendritic cell (DC) maturation.  
The first PRR to be identified was the Toll Like Receptors (TLRs) which are also the 
most characterised and recognise a wide scale of PAMPs (Akira 2003, Beutler 2009, 
Hoffmann 2003, Medzhitov 2007). To date there has been 10 and 12 TLRs identified in 
human and mouse respectively. 
1.2.1 Toll-like Receptors   
Each TLR detects different PAMPs derived from bacteria, viruses, mycobacteria, fungi 
and parasites. PAMPs derived from these pathogens include lipoproteins (identified by 
TLR1, TLR2 and TLR6), double stranded RNA (dsRNA) which is recognised by TLR3. 
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Bacterial lipopolysaccharide (LPS) by TLR4, flagellin by TLR5, single-stranded (ss) 
RNA by TLR7 and TLR8; DNA by TLR9 are few other common examples (Akira et al. 
2006). The following table gives a brief overview of TLRs recognising PAMPs.  
 
Table 1. Detection of PAMPs by TLRs and other PRRs.  
     
1.2.2 Toll-like Receptor Structure   
TLRs fall under the category of type I transmembrane proteins. The extracellular domain 
contains a leucine rich repeat (LRR), composed of 19-25 tandem copies of the 
“xLxxLxLxx” motif, 24-29 amino acids in length, in a horseshoe-like structure (Akira et 
al. 2006, Jin and Lee 2008). This mediate PAMP recognition. TLRs also contain a 
transmembrane region and cytosolic Toll-IL-1 receptor (TIR) domains that activate 
downstream signalling pathways.  
 TLRs can be found both on the cell surface and intracellular compartments. All TLRs 
have the capability to form either homodimers or heterodimers through their TIR domains 
which triggers downstream signalling. Often an additional protein might be required by 
a TLR to be bound to them for activation. For example MD2 is a protein that binds TLR4 
strongly on the cell surface. TLR4 is responsible for recognising LPS and triggering a 
downstream signalling cascade (Shimazu et al. 1999) involved in the LPS recognition by 
TLR4 are CD14 and LPS binding protein (LBP) (Kitchens 2000). Examples of TLR 
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heterodimerization can be seen in the case of TLR2 when it binds to TLR1 and TLR6 
including non-TLR receptors like CD36 and Dectin-1. These bindings to various proteins 
help recognise TLR2 ligand (Gantner et al. 2003, Hoebe et al. 2005). Crystal structures 
of a few TLRs have been elucidated, such as TLR1,TLR2 (Jin and Lee 2008),TLR3 , 
TLR4(Kim et al. 2007) and TLR6 (Kang J. Y. et al. 2009). Vastly TLRs can be 
categorised under intracellular and extracellular members as shown in the following 
figure.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4  TLR localisation. TLR1, TLR2, TLR4, TLR5, TLR6, and TLR11 recognise 
their ligands on the cell surface, whilst TLR3, TLR7, TLR8, and TLR9 are located 
intracellularly, in endosomes and lysosomes (Yamamoto and Takeda 2010).   
 
 
1.2.3 Toll-like Receptor Signalling Pathways  
TLR signalling can be broadly classified into two categories depending on the adaptor 
molecule each TLR utilises. Most of TLR signalling is MyD88 dependent (except TLR3) 
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and in some cases it is Trif dependent (TLR3 and TLR4). MyD88 (Myeloid 
differentiation primary response gene 88) is a member of the family of adapter molecules 
containing a cytoplasmic TIR domain. Other similar adaptor molecules include TIRAP 
(TIR-containing adaptor protein, also known as Mal; MyD88-adaptor like), TRIF (TIR-
domain-containing adapter-inducing IFN-β), and TRAM (TRIF-related adaptor 
molecule). TLRs contain a TIR domain which recruits specific adaptors (containing TIR-
domain) which results in the signalling specificity for the TLRs (Yamamoto and Takeda 
2010).  
 
 
 
 
 
 
 
 
 
 
 
Figure 1.5 Innate Immune response to TLRs. Different TLRs represented along with 
their respective PAMPs. Apart from TLR3 all other TLRs utilize the adapter molecule 
MyD88. TLR3 uses only Trif whereas TLR4 uses Trif, TRAM, TRAP and MyD88. 
Eventual release of inflammatory cytokines is observed in all cases and Type I IFN in 
some cases.  
 
The activation of NF-κB and AP-1 is a primary outcome of TLR activation which results 
in the induction of inflammatory pathways and production of Interferons. TLRs utilise 
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their extracellular leucine-rich repeats for recognising pathogens whereas the 
transmembrane and cytoplasmic Toll/interleukin-1 receptor (TIR) domains is needed for 
downstream signal transduction. Activation of all TLRs results in an eventual triggering 
of inflammatory pathway and activation of the nuclear factor (NF)-κB which is a dimeric 
transcription factor and activating protein-1 (AP-1). NF-κB contains two subunits, p65 
and p50 and is a heterodimer in most cell types. The inactive form of this protein complex 
is found in the cytoplasm of unstimulated cells interacting with inhibitor of NF-κB (IκB) 
proteins. Phosphorylation of IκB occurs (at serine residues) as a result of TLR stimulation 
by its ligands. Phosphorylation is sequestered by the IKK complex which consists of IKK 
alpha and IKK β protein kinases and a regulatory molecule, IKK gamma/Nemo. As a 
result of this Iκ B is targeted for degradation and ubiquitination by the 26s proteasome. 
NF-κB is then released in the nucleus and acts as a transcription factor (Akira et al. 2006, 
Kawai and Akira 2010, Takeda and Akira 2004, Yamamoto and Akira 2004, Yamamoto 
and Takeda 2010) 
 
 All TLRs apart from TLR3 utilises MyD88 whish is a master adaptor molecule. It is also 
used by by all IL-1R family members (Akira et al. 2006). The TIR domain is essential for 
the binding of MyD88 and Mal/TIRAP and causes selective participation of TLR2 and 
TLR4 mediated MyD88 signalling (Yamamoto and Takeda 2010). The adaptor molecule 
interacts with IL-1R-associated kinase (IRAK) 4, through homophilic interactions of its 
death domains. IRAK4, via IRAK1, regulates the activity of tumour necrosis factor (TNF) 
receptor-associated factor (TRAF) 6, a RING finger-containing E3 ligase, which is 
involved in lysine 63 (K63)-linked ubiquitination-mediated signalling. TRAF6, catalysed 
by the E2 ubiquitin conjugating enzyme complex Ubc13 and UEV1A, activates the TAK1 
– TABs complex (Akira 2009, Akira et al. 2006). This complex activates the IKK (IκB 
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kinase) complex of NEMO (NF-κB essential modulator), IKK-α, and IKK-β, which in 
turn phosphorylates IκB, tabbing it for ubiquitination and targeting it to the proteosome 
for degradation, thereby releasing NF-κB and allowing it to translocate to the nucleus 
(Karin and Ben-Neriah 2000). 
 
 
 
 
 
 
 
 
 
Figure 1.6 Visualization of the MyD88 dependent and TRIF dependent TLR 
signalling pathway. TIR containing adaptor molecule MyD88 is essential for 
downstream signalling for the secretion of inflammatory cytokines through TLR 
signalling. Also shown is the MyD88 independent pathway leading to IRF3 activation via 
IKKε/IKKί. Another TIR containing adaptor molecule TRIF mediates the MyD88-
independent pathway (Takeda and Akira 2004). 
 
The other TLR activated downstream pathway is MyD88-independent, which means the 
adaptor molecule Trif is utilised by TLRs instead of MyD88. This also activates NF-κB 
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and AP-1. The only TLRs participating in such a signalling cascade is TLR3 and TLR4. 
TLR3 uses the TIR domain to bind itself to TRIF however TRAM is required for TL4 
downstream TRIF-dependent signalling (Yamamoto and Takeda 2010). TRIF signals to 
TRAF3, which activates the IKK complex of TRAF-associated NF-κB activator 
(TANK)-binding kinase 1 (TBK1) and IKKε. This complex activates the signal-
dependent phosphorylation of IRF3 and IRF7, causing homo- or heterodimerization, 
nuclear translocation, and assembly onto the IFN-β enhancer, assisted by CBP/p300 
(CREB binding protein) (Fitzgerald et al. 2003, Sharma et al. 2003).  
Depending on the pathway used the transcription factors NF-κB, ATF2-c-Jun, MAPKs, 
IRF3, or IRF7 are activated, resulting in the upregulation of Type I IFNs. This causes 
inflammation and other physiological defence mechanisms are triggered (Yamamoto and 
Takeda 2010).  
 
1.2.4 Virus Recognition by Toll-like Receptors  
    
Different kinds of Pathogen Associated Molecular Patters (PAMPs) are recognised by 
TLRs which are a type-I integral membrane glycoprotein (Akira 2009, Akira et al. 2006). 
Primary human airway epithelial cell lines express 10 different kinds of TLRs (TLR1-
TLR10) (Muir et al. 2004, Sha et al. 2004). TLRs play a crucial role in the initiation of 
immune responses in the respiratory epithelium, producing mitogen activated protein 
(MAP) kinases, and many other transcription factors such as interferon regulatory factor 
3 (IRF3), and IRF7 causing the release of numerous proinflammatory cytokines such as 
type I  (α and β) and type III (γ) IFNs (Iwamura and Nakayama 2008).  
A TLR subfamily which is found in the endosomes of the airway epitheliums consisting 
of TLR3, TLR7, TLR8, and TLR9 recognise viral nucleic acids which causes the 
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induction of type I IFNs. For instance TLR3 recognises infections by Human 
Rhinoviruses, RSV (Groskreutz et al. 2006) and Influenza virus (Guillot et al. 2005). 
TLR7, TLR8, and TLR9 recognize double- stranded RNA (dsRNA), single-stranded 
RNA (ssRNA), and CpG DNA, respectively (Kawai and Akira 2008). MyD88 is an 
essential adapter molecule utilised by TLR7 and TLR9 for the activation of NF-κ B and 
IRF7 which in turn leads to the release of proinflammatory cytokines and  (Kawai and 
Akira 2007) type I interferons (Greene and McElvaney 2005), however only a very few 
studies have investigated the role of TLR7,8 or 9 in respiratory virus infections. 
Adenoviral vectors interact with TLR9 and TLR7 is known to interact with Influenza 
virus, in dendritic cells (DCs) (Lund et al. 2004, Reibman et al. 2003) however it is still 
unknown whether these observations are relevant in airway epithelial cells.  Intracellular 
TLRs and TLR3 are known to recognise viruses whereas the extracellular TLRs (such as 
TLRs 2,4 and 6) recognise bacterial products. These bacteria recognising TLRs may also 
be involved in virus recognition and innate immune sensing by the airway epitheliums. 
We learn that RSV fusion protein and TLR4 interactions which results in a MyD88 
dependent signalling cascade and inducing immune response in airway epithelium 
(Boukhvalova et al. 2006, Haeberle et al. 2002) A newer study describes the interactions 
of TLR2 and TLR6 with RSV  (Vareille et al. 2011).  
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1.3 Innate Immunity and RIG-I-like Receptors    
Apart from the very well-known PRRs such as the Toll Like Receptors, there are other 
PRRs that has been recently discovered which are TLR independent. These include the 
retinoic acid inducible gene-I (RIG-I)-like receptor (RLR) family. This family has three 
known member and they are: RIG-I (also known as DDX58) (Yoneyama et al. 2005), 
melanoma differentiation-associated gene 5 (MDA5, also known as IFIH1 or 
Helicard)(Kang D. C. et al. 2002) and laboratory of genetics and physiology 2 (LGP2, 
also known as DHX58) (Rothenfusser et al. 2005). 
1.3.1 RIG-I, MDA5, and LGP2 Structures 
RIG-I and MDA-5 are proteins that are homologous in nature. They are 925 aa and 1025 
aa long respectively and are known to be upregulated after they are able to detect 
cytoplasmic viral RNA during viral replication (Wilkins and Gale 2010). They belong to 
the family of helicases, superfamily 2 (SF2). Both the proteins have seven conserved 
‘helicase motifs’ that helps to mediate binding of ATP and nucleic acid (Gorbalenya et 
al. 1988). RIG-I is associated with F-actin and is hence found to localize at the 
cytoskeleton of the cell whereas MDA-5 is found to be distributed throughout the cytosol 
(Mukherjee et al. 2009).  
A N-terminal region and a caspase activation and recruitment domain (CARDs) is a 
common feature in both RIG-I and MDA-5. They also contain  a central SF2 type 
DExD/H-box RNA helicase domain, and a C-terminal repressor domain (RD) (Takeuchi 
and Akira 2007). LGP2,  which is the third RLR as mentioned before is 678 amino acids 
long and contains a DExD/H-box RNA helicase domain (which shows 31% and 41% 
amino acid identities to the RNA helicase domains of RIG-I and MDA5, respectively) 
and a C-terminal RD, but lacks any CARDs (Yoneyama et al. 2005).  
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 Fig 1.7 Structural Diagrams of RLR showing their functional domains (Wilkins and 
Gale 2010).  
 
 
 
 
 
 
 
 
 
Figure 1.8 Representation of RIG-I activation through a 3-step model. Left: 
monomer in resting form. Centre: Dimer when bound to RNA ligand. Right: Final 
activated form. Shown above are the positions of CARDs, Repressor Domain (RD) and 
helicase domain. RIG-I -ligand interaction cause a conformational change resulting in 
downstream signalling of innate antiviral immunity (Wilkins and Gale 2010). 
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 1.3.2 CARDs and RLR Dimerisation  
CARDs belong to the pro-apoptotic death domain family and contains death domains, 
death effector domains and pyrin domains. They also have six antiparallel alpha helices. 
They are known to have homophilic interactions (CARD-CARD interactions) that 
promotes cell death pathway and eventually triggering off a downstream signalling that 
activates IRF3/7 and NFκB. ATPase activity is a valiant feature of the internal DExD/H-
box RNA helicase domain, activated upon ligand binding. This feature is of no use for 
RNA binding however plays a role in downstream signalling (Takahasi et al. 2008, 
Yoneyama et al. 2005).  
RIG-I in its C-terminal Repressor Domain (RD) contains a zinc binding site that plays an 
important role in controlling IFN mediated IFN responses (Saito et al. 2007). It has been 
proven that RIG-I uses its C-terminal RD to bind itself to uncapped 5’-triphosphate 
single-stranded RNA (5’-pppRNA). This is feasible due to the presence of an invariant 
lysine residue that helps with interacting with phosphate. RIG-I has an active (open) and 
an inactive (closed) state. The RD represses the CARD and the helicase domain in its 
inactive state. Upon viral RNA binding to the RD, RIG-I is converted to its active state 
following a conformational change. The active state of RIG-I is a dimerised state that 
promotes a downstream signalling via CARDs. RIG-I only constitutively activates 
downstream signalling without the presence of the RD. Overexpression of RD causes 
inhibition of antiviral response (Cui et al. 2008). The following model (figure 1.10) 
represents the activation of RIG-I by 5’-pppRNA resulting in ligand induced dimer 
formation of RD.  
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Figure 1.9 Proposed model for activation of RIG-I and dimer formation after 5’-
triphosphate RNA binding (grey with red phosphates). CARDs and the helicase 
domains are repressed by the RD in the active state of RIG-I. Binding of 5’-triphosphate 
RNA induces a conformational change, resulting in the dimerization of RIG-I and 
activation of downstream signalling (Cui et al. 2008). 
 
 
1.3.2.1 IPS-1 
Post viral-ligand binding both RIG-I and MDA-5 takes part in a downstream signalling 
using their CARDs that eventually directly activates IRF3/7 and indirectly NF-κB. An 
intermediate protein is involved in the signal transduction called IFN-β Promoter 
Stimulator 1(IPS-1) (find Kawai 2005). It is also known as MAVS (Mitochondrial 
Antiviral Signalling Protein) (Seth et al. 2005), VISA (Virus Induced Signalling 
Adaptor)(Xu et al. 2005) and Cardif (CARD adaptor inducing IFN-β) (Meylan et al. 
2005). IPS-1 plays as an adapter protein for both RIG-I and MDA-5 signalling eventually 
resulting in effective anti-viral response against a variety of RNA viruses (Kumar et al. 
2006, Sun et al. 2006). The length of IPS-1 is 540 amino acids which is found on the outer 
membrane of the mitochondria. It is anchored there with a short hydrophobic C-terminal 
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region (Seth et al. 2005). Although fixed there, during viral infection it moves into a 
detergent-resistant mitochondrial fraction. We get a link between mitochondrial function 
and viral infection from the location of IPS-1 (Hiscott et al. 2006). Structural elucidation 
of IPS-1 led us to discover the following: a N-terminal CARD-like domain (CLD), 
homologous to the CARDs of RIG-I and MDA5, a proline-rich region, and a C-terminal 
effector domain. Crystal structure of N-terminal CLD of IPS-1 has been determined to 
2.1 Angstrom resolution. The structure is very typical of the death domain superfamily 
consisting of a six-helix bundle.  
 
 
 
 
Figure 1.10  Schematic diagram of IPS-1. The position of each significant area is 
shown. TRAF3 not shown. Abbreviations: T2, TRAF2 binding motif; T6, TRAF6 
binding motif; PRR, proline-rich region; TM, mitochondrial transmembrane domain. 
Amino acid positions are indicated (Johnson and Gale 2006).  
 
 
1.3.3Host Response to Viral Infection    
 
RNA acts as a ligand to RIG-I and MDA-5 leading to their activation involving 
interactions with IPS-1 via CARD-CARD binding. In the process it recruits downstream 
signalling molecule as seen in figure 1.11. Molecules involved in such signal transduction 
often belong to the TRAF family. For example; IPS-1 contains a TRAF-interacting motif 
to which TRAF3 binds directly. TRAF2 and TRAF6 binds to IPS-1 in the same manner 
(Oganesyan et al. 2006,Saha et al. 2006, Xu et al. 2005). The TRAF proteins signals 
downstream that eventually activates transcription factors IRF3/7 and NF-κB.  
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The first signalling pathway occurs through the canonical IKK complex composed of 
IKK-α and IKK-β along with its regulatory subunit NEMO. IκB is phosphorylated by this 
complex. Phospho-I κB then acts as a inhibitor of NF-κB on serines 32 and 36; following 
this ubiquitination of Phospho-IκB occurs and results in its targeted degeneration in the 
proteasome. NFκB is released as a result and translocates to the nucleus (Karin and Ben-
Neriah 2000).  The second pathway is non-canonical and involves the complex IKK 
which consists of TBK1 and IKKε. IRF3 and IRF7 are phosphorylated by this complex 
and causes homo-dimerisations or heterodimerisation. The IRFs then translocate to the 
nucleus and acts as transcription factors and assemble to the IFN-β enhancer, assisted by 
CBP/p300 (Fitzgerald et al. 2003). IRFs are also known to be activated by NEMO (Zhao 
et al. 2007).  
TRAF3 is important in recruiting both the IKK complexes through its IPS-1 interactions 
whilst TRAF2 and 6 essentially activates NF-κB.  
Transcriptional upregulation of type I IFNs is the most significant outcome of 
transcription factors IRF3/7 and NF-κB after reaching the nucleus. IFNs then signal 
through the IFN-α/β receptor and the Jak-STAT pathway. This causes interferon 
stimulated gene expression (ISG) which triggers off apoptosis of infected cells. ISG 
expressions results in innate immune response by inhibiting viral infection. They are also 
known to trigger adaptive immune response (Lei et al. 2009, Yoneyama and Fujita 2009). 
The RLR signalling pathway described is pasteurised in the following diagram (Figure 
1.11). 
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Figure 1.11 The RLR signalling pathway. Viral RNA binds to RIG-I followed by 
downstream signalling IRF3 and NF-κB that induces the production of IFN-α/β from a 
virus infected cell. IFN-α/β binds to the IFN-α/β receptors and signals through the Jak-
STAT pathway driving interferon stimulated gene (ISG). This results in antiviral innate 
immune response (Wilkins and Gale 2010).  
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RLR Ligands 
The innate immune response to different viral pathogens vary greatly by different RLRs; 
RIG-I and MDA-5 being no different. Although they are very similar structurally their 
preference for viral recognition is different. The cause for this is thought to be due to 
amino acid sequences of the DExD/H-box RNA helicase domains of RIG-I and MDA5 
which are 35% identical which is very little. This genetic diversity allows them to prefer 
different specifications for distinct RNA conformations (Kato et al. 2006, Loo et al. 
2008). 
RIG-I Ligands 
Both positive and negative stranded viruses are detected by RIG-I. These viruses include 
HCV, RSV and some related paramyxoviruses. RIG-I also detects VSV and Influenza A 
viruses (Kato et al. 2008, Loo et al. 2008). Reoviruses, WNV and Dengue viruses are all 
detected by both RIG-I and MDA-5 (Fredericksen and Gale 2006) as well as measles 
virus (Ikegame et al. 2010). RIG-I detects the uncapped 5’-ppp RNA (Hornung et al. 
2006). This is how RIG-I distinguishes from self and non-self (viral) RNA. Host RNA is 
always capped or post-translationally modified removing the 5’triphosphate. This is why 
RIG-I is not activated by the host RNA.  RIG-I  detects both dsRNA  (Yoneyama et al. 
2004) and 5’-ppp ssRNA (Pichlmair et al. 2006). Although this is the case, some form of 
double-strandedness may be required (Schmidt et al. 2009). RIG-I can also recognise 
particular sequences or motifs within viral RNA, such as uridine and adenosine-rich 3’-
sequences in 5’-ppp ssRNA (found within HCV and other viruses (Saito et al. 2008, Uzri 
and Gehrke 2009) or short double-stranded blunt-end 5’-pppRNA (Schlee and Hartmann 
2010).  
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Table 2. Table showing putative RIG-I ligands which are generated by enzymatic 
polymerization or cleavage. The RNA molecules shown in the table are not molecularly 
defined (Schlee and Hartmann 2010).  
The host endonuclease RNAase L produces cleavage products during a viral infection, 
these are known to be recognised by RIG-I and hence RLR mediated antiviral response 
is amplified (Malathi et al. 2007). Short dsRNA  products/ viral transcripts (less than 1kb 
length) are also recognised by RIG-I (Kato et al. 2008). It is still a matter of debate as to 
what exactly the RIG-I ligand is. Suggestions include negative stranded viral RNA 
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genome which are generated during the viral replication cycle; this being the major actor 
for RIG-I upregulation and antiviral response. Other types of RNA  products are not 
responsible for RIG-I activation and an eventual IFN induction (Rehwinkel 2010, 
Rehwinkel and Reis e Sousa 2010). 
 
 
 
 
 
 
 
Fig 1.12  Diagram showing putative RIG-I ligands. Variety of RNA agonists trigger 
RIG-I expression. Green arrows show 5’PPP-bearing RNAs. RNAs without 5’PPP are 
shown in blue. Orange arrows show RNA which may have different 5’end characteristics. 
Antagonists shown in black arrow. Activated RIG-I promotes the induction of interferons 
and other pro-inflammatory cytokines via MAV (red bold arrow). Eventual release of IL-
1β after inflammasome activation (Rehwinkel and Reis e Sousa 2010).  
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MDA5 Ligands 
MDA5 mostly is known to detect Picornaviridae. Most common ones are Human 
Rhinovirus (HRV), encephalomyocarditis virus (EMCV) and Theiler’s virus. The viral 
genome contains a VPg region at its 5’ end which is detected by MDA5. As we have 
discussed before that the 5’ triphosphate is essential for RIG-I recognition; the VPg region 
blocks this and doesn’t allow RIG-I recognition and allows MDA5 binding (Kato et al. 
2006, Pichlmair et al. 2006). Upregulation of MDA5 is also noticed in infections by 
reoviruses (Loo et al. 2008), flaviviruses (Fredericksen and Gale 2006), paramixoviruses 
and norovirus (McCartney et al. 2008). It has been observed that mice in the absence of 
MDA5-IPS1 pathway have increased mortality post CBV3 infection; it is believed that 
this is due to the importance of MDA5 and IPS1 pathway mediating Type 1 IFN responses 
(Huhn et al. 2010, Wang Q. et al. 2009). MDA5 is required for Poly I:C-induced IFN 
production (Kato et al. 2006, Loo et al. 2008). MDA5 prefers binding to long dsRNA 
products (greater than 1-2kb in length) whilst RIG-I detects short dsRNA (Kato et al. 
2008).  
 
LGP2 Ligands 
In Vitro studies show that, LGP2 negatively regulates RIG-I and MDA5  and also MDA5 
mediated antiviral response. LGP2 when produced in excess causes inhibition of IRF3 
and NF-κB production, post viral infection (Rothenfusser et al. 2005).  A plausible 
explanation of how it happens is that LGP2 isolates away dsRNA from RIG-I and MDA5 
and hence prevents the activation of an antiviral signal (Saito et al. 2007). Other studies 
say that using its RD, LGP2 is able to prevent RIG-I dimerisation and its interaction with 
IPS-1 (Komuro and Horvath 2006). Other possibilities include; that LGP2 competes with 
IKKε for recruitment to IPS-1. The RD of LGP2 binds to dsRNA in a more stronger 
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manner than does MDA5; structural analyses has revealed (Li et al. 2009, Pippig et al. 
2009, Takahasi et al. 2009). However, in vivo analyses on the contrary shows us that 
LGP-2 acts as positive regulator of antiviral response mediated through RIG-I and 
MDA5. This functions through its ATPase domain (Satoh et al. 2010, Venkataraman et 
al. 2007). 
 
1.4 NALPs in Innate Immunity 
NALPS- These are cytoplasmic proteins that have been implicated in the activation of 
Caspase-1 by TLRs as a response to pathogenic invasion into a cell. They are similar in 
structure to APAF-1 (apoptotic protease-activating factor-1) that is known to activate 
Caspase-9. NALP1 forms a large multiprotein complex that has the ability to activate 
Caspase-1, and is referred to as the inflammasome (Tschopp et al. 2003).  
The successful completion of the human genome sequence has shown us that TLRs are 
not the only PRRs that contain LRRs (Leucine Rich Repeats). This family of proteins was 
named CATERPILLER. They have no TIR domain unlike the TLRs, but contain three 
distinct domain. Some of these domains are called NACHT domain, Caspase recruitment 
domain (CARD) or the pyrin domain (PYD) (Tschopp et al. 2003)  
In this study we focus on only one of the sub-families called the NALPs, details of its 
structure and function of a few member are discussed in the following chapter (1.5 
Inflammasomes). Below in a diagram showing the typical domains of the NLR 
subfamilies (NLRPs, NAIPs, NLRCs and CIITA). 
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Diagram 1.13 The typical domains of the NLR subfamilies (NLRPs, NAIPs, NLRCs 
and CIITA) are shown. Diagram obtained from (Yao and Qian 2013) 
 
 
1.5 Inflammasomes 
Cellular infection and stress are causative agents for activating molecular platforms called 
the Inflammasome which are responsible for the production and maturation of 
proinflammatory cytokines such as Interleukin 1-β and IL-18 which when released from 
the cell causes potential inflammation. Inflammasomes form large multimeric structures 
which come together when each of the component are overexpressed in the cytosol 
(Martinon et al. 2002). An activated inflammasome in turn activates Caspase-1 which 
cleaves pro IL-1β into IL-1β which is then secreted from the cells. It is believed that this 
process is analogous to the formation of an apoptosome as a response to apoptotic stimuli. 
Strikingly nuclear magnetic resonance spectroscopy (NMR) reveals structural similarities 
between an inflammasome and an apoptosome. (Faustin et al. 2007). In vitro studies tell 
us that a sufficient subset of NLRs can activate the inflammasome. NLRP1,2,3,6,12, 
NLRC4 and NOD2  when overexpressed with caspase-1 and ASC ectopically, facilitates 
the activation of caspase-1 and IL-1β processing (Davis et al. 2011, Martinon et al. 2002). 
The physiological role of most inflammasomes are still unclear, only a minority of these 
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protein have known characteristics and function, such as the NLRP3, NLRC4 and NAIP5. 
It is not very clear if at all the other NLRs have a role in inflammasome assembly. A 
structurally unrelated inflammasome known as the AIM2 (absent in Melanoma 2) sheds 
some light on inflammasome assemblage (Davis et al. 2011).  
 
1.5.1 Structure and function 
The NLR and PYHIN family proteins can form inflammasomes. The NLR protein has 
three domains, a C-terminal leucine-rich repeat (LRR) domain, an intermediate 
nucleotide binding and oligomerization domain (NOD, also called NACHT domain), and 
a N terminal pyrin (PYD), caspase activation and recruitment domain (CARD) or a 
baculovirus inhibitor of apoptosis repeat domain (BIR). The LRR domains of these 
proteins are hypothesized to interact with putative ligands and play a role in 
autoregulation of these proteins. The NACHT domain can bind to ribonucleotides, which 
regulates the self-oligomerization and inflammasome assembly (Latz 2010, Martinon et 
al. 2002).  
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Fig 1.14 Schematic Diagram of an Inflammasome and its activators. The NLRs, ASC 
and Caspase-1 assembles to form the penta- or heptameric structure called the 
inflammasome resulting in the maturation of IL-1βand IL-18 as well as inflammatory cell 
death, by either pyroptosis or pyronecrosis. The two categories of inflammasome 
activators are sterile activators (host and environmental derived products) and pathogen-
associated activators (PAMPs from bacteria, virus, fungus and protozoa) (Davis et al. 
2011).  
 
 
1.5.2 Mechanism of Activation  
As a result of infection or injuries a multi-protein complex called the inflammasome is 
activated by Caspase-1, in the cytoplasm of the cell. Caspase-1 cleaves the pro-forms of 
interleukin-1 cytokine family members making them active and to be secreted from the 
cells. The IL-1 family is heavily involved in many pro-inflammatory activities and plays 
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a role in inflammatory disease pathogenesis. Although there are a few ligands discovered 
for NLRP1, IPAF, and AIM2 inflammasomes, not much is known about mechanisms of 
NLRP3 inflammasome activation. Various different molecular entities have been held 
responsible for the activation of NLRP3 inflammasome, such as extracellular ATP, pore 
forming toxins or viroporins, crystals and many others. New research suggest that NLRP3 
activation  is made possible indirectly by host factors that are generated in response to 
NLRP3 triggers (Latz 2010).  
How the inflammasome is actually activated is still unclear, however there are different 
proposed models of activation. In these models the whole picture of a signal transduction 
pathways is not yet deciphered. Because of the presence of various different kinds of 
PAMPs, DAMPs and pathogens that activate the inflammasome, it is possible that 
multiple pathways exist.  
“In addition, the transcriptional upregulation of limiting factors such as pro-IL1β and -
IL18, which constitute signal 1, is a prerequisite for inflammasome activation. In addition 
to induced transcription of genes encoding procytokines, activation of NLRP3 
transcription is also induced by NF-κB activators such as TLR ligands. Three models 
have been put forth to explain mechanisms of inflammasome activation.” (Davis et al. 
2011) 
Model 1 proposes the idea that NLRP3 inflammasome is activated by ROS (Reactive 
Oxygen Species) which is generated by PAMPs and DAMPs. It has been observed that 
many NLRP3-specific agonists induce the formation of ROS and when reactive oxygen 
compounds like Hydrogen Peroxide were added, it resulted in the formation and 
activation of NLRP3 inflammasome. Although there are different biological pathway that 
can activate ROS but not all of them has the ability to activate inflammasome. 
Additionally is ROS is inhibited it can cause NLRP3 inflammasome activation to be 
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suppressed (Meissner et al. 2008). It is still not clear where ROS is generated. A recent 
paper published tells us that, a protein called thioredoxin-interacting protein (TXNIP 
which is a redox sensitive protein) is involved in the pathway where ROS activates the 
inflammasome (Zhou et al. 2010). This is still highly controversial. So, in general the 
detailed mechanism by which ROS activates inflammasome need further clarification. 
The second model of inflammasome activation involves formation of pores on the plasma 
membrane that is initiated either by P2X7 receptors or by pore forming toxins. These pore 
forming toxins also facilitate K+ efflux and possibly the influx of small DAMPs or 
PAMPs. One of the definite causes for the initiation of inflammasome activation is K+ 
efflux. All the three NLR inflammasome seems to be inhibited by hyperosmotic K+ levels 
during lysis.  
The lysosomal rupture model serves as our third model of inflammasome activation. 
Inflammasomes are believed to be activated due to the lysosomal damage, specifically 
due to Cathespin B leakage. Pharmacologically if cathespin B is inhibited, a drastic 
inhibition of inflammasome activation is noticed even in response to DAMP stimulation. 
Partial impairment of inflammasome activation is observed in mice deficient in cathespin 
B; when they are treated with NLRP3 agonists. In vivo studies suggest that deficiency of 
either cathespin B or L is a cause for decrease in inflammasome activation in response to 
cholesterol crystals. It is yet to be understood whether or not these pathways work 
independently or in concert in stimulation-dependent contexts (Davis et al. 2011). 
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Fig 1.15 NLRP3  inflammasome activation. A suggested three way model of NLRP3 
inflammasome activation detailed above.1) ATP acts as a NLRP3 agonist triggering the 
formation of pores by the Ppannexin-1 hemichannel which allows NLRP3 agonists to 
enter the cytosol and directly engage NLRP3. 2) Lysosomal rupture initiated by 
crystalline particles that are engulfed. Cytoplasmic  lysosomal contents are sensed by 
NLRP3 by via cathepsin- B-dependent processing of a direct NLRP3 ligand. 3)Production 
of  Reactive Oxygen Species (ROS) is triggered by PAMPs and DAMPs (including ATP, 
crystals). ROS in turn activates the NLRP3 inflammasome complex formation. 
Eventually clustering of Caspase-1 induces autoactivation results in secretion of pro-
inflammatory cytokines (Schroder and Tschopp 2010).  
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Fig 1.16  Model of Inflammasome Activation. Combination of a series of signals results 
in inflammasome activation. The models put forth above suggests that a wide variety of 
biological molecule which indirectly activates inflammasomes rather than a direct 
receptor-ligand pairing.  
As we have explained before, the inflammasome needs 2 signals for its activation (namely 
signal 1 and 2). Studies by Shimada et al refers to the signal 1 as the primary cause of 
NFKB production and signal 2 being mitochondrial apoptosis, culmination of both of 
which causes the NLRP3 inflammasome to be activated. This results in the secretion of 
IL 1 β. In this case the secondary signal activator is claimed to be oxidised  mitochondrial 
DNA (mtDNA) released into the cytosol due to ATP induced mitochondrial dysfunction 
and apoptosis. MtDNA binds to NLRP3 in the cytosol causing its activation. An 
antiapoptotic protein called Bcl2 inversely regulates mitochondrial dysfunction and 
preventing NLRP3 inflammasome activation. MtDNA is believed to directly interact and 
 [36] 
 
activate NLRP3 inflammasome. We know this from experiments showing that 
macrophages that lack mtDNA had very little production of IL-1β, although it went 
through apoptosis. Oxidized nucleoside 8-OH-dG has a drastic inhibiting effect on the 
inflammasome-oxidiesed mtDNA binding. Shimada and group infers that oxidized 
mtDNA which is released during programmed cell death causes the NLRP3 
inflammasome to be activated. This provides us with a clue in deducing the apoptosis-
inflammasome activation signal. (Shimada eta l). 
 
1.5.3 Types of Inflammasome 
1.5.3.1 NLRP 1 
Expression levels of NALP1 are comparatively lot less in a cell than NLRP3 or NLRC4, 
and is generally found in adaptive immune cell and non-hematopoietic tissues. Human 
NLRP1 gene encodes an N-terminal CARD domain, a central NACHT, LRR, FIIND, and 
a C-terminal CARD. This structural layout is unique to NLRP1 (Davis et al. 2011). 
NLRP1 forms a macromolecular complex after interacting with Caspase-1 and -5 and 
also possible with ASC, in cell free lysates (Martinon et al. 2002). This complex promotes 
the processing of IL-1β/IL-18 and also pyroptosis. NLRP1 also interacts with caspase-2 
and 9 triggering the formation of an apoptosome eventually resulting in cell death (Hlaing 
et al. 2001). Because it hasn’t been possible yet to obtain Nlrp1 -/- mouse model much of 
its physiological relevance and mechanism of interaction is still unknown (Davis et al. 
2011). 
 Experiments on murine models suggests that NLRP1 may be involved in the sensing of 
the bacterial toxin LT which is one of the major virulence factor from the bacteria Bacillus 
anthracis.  
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Fig 1.17 Minimal model for NLRP1 inflammasome. Depicted above in an 
unoligomerized inflammasome complex. Domains: CARD, caspase recruitment domain; 
LRR, leucin rich repeats; NACHT, nucleotide-binding and oligomerization domain; 
PYD, pyrin domain, FIIND, domain with function to find; HIN, HIN-200/IF120x domain 
(Schroder and Tschopp 2010). 
 
1.5.3.2 NLRP 3 
Also known as cryopyrin or NALP3, has been shown to be expressed in myeloid cells 
and its upregulation is observed when macrophages are stimulated with PAMPs. 
(O'Connor et al. 2003). The NLRP3 gene encodes for proteins that has an N-terminal 
pyrin domain, a central NBD domain and C-terminal LRR domain (Hoffman et al. 2001). 
NALP 3 does not contain a caspase recruitment domain (CARD) and cannot recruit 
procaspase-1 unless the adaptor molecule ASC is present. A pyrin domain is responsible 
for NLRP3s interaction with ASC.  NLRP3 although interacts with CARD8 the role of 
which is not understood yet (Allen et al. 2009). NLRP3 also activates caspase-1 in the 
presence of ASC (Agostini et al. 2004). Programmed inflammatory cell death and 
secretion of IL-1β/IL-18 are some of the obvious consequences of NLRP3 inflammasome 
activation. 
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Fig 1.18. Minimal model for NLRP3 inflammasome. Depicted above in an 
unoligomerized inflammasome complex. Domains: CARD, caspase recruitment domain; 
LRR, leucin rich repeats; NACHT, nucleotide-binding and oligomerization domain; 
PYD, pyrin domain (Schroder and Tschopp 2010).  
 
 
 
 
1.5.3.3 NLRC 5 
The NOD like receptors (NLRs) are receptors found intracellularly, and NLRC5 is the 
largest among them and is widely expressed. It has been recently identified to regulate 
immune responses. NLRC5 is induced by interferons during a pathogenic invasion and is 
also known to be a master regulator of major histocompatibility complex (MHC) class I 
genes (Yao and Qian 2013).  
 
Figure 1.19 Structural Domain of NLRC5. NLRC5 has typical tripartite domains 
including the N-terminal atypical caspase activation and recruitment domain (CARD), 
the centrally located NACHT (named after NAIP, CIITA, HET-E, and TP-1 proteins) and 
multiple leucine rich repeats (LRRs) at the C-terminal.  Obtained from (Yao and Qian 
2013).  
A subgroup of NLRs can form an inflammasome complexes and NLRC5 is one of them 
facilitating conversion of pro-caspase 1 into caspase-1 and a production of  IL-1β and IL-
18 (Tschopp et al. 2003). Although the exact mechanism of how the NLRC5 
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inflammasome works is not understood, it is associated with the NLRP3 inflammasomes 
and the activators of both are similar. NLRC5 is predominantly found in hematopoetic 
cells and inflammasome study has not been conducted. However RNAi experiments 
suggests that  knocking down NLRC5 abrogates the production of pro-inflammatory 
cytokines such as IL-1β and IL-18 and also Caspase-1, in response to bacterial infections, 
PAMPs, DAMPs and also viruses.  Colocalization of NLRP3 and NLRC5 is also 
observed in a few studies (Triantafilou et al. 2013a). Together they are known to activate 
inflammasome in Bronchial cells in response to HRV infection (Triantafilou et al. 2013a) 
1.5.3.4 AIM 2 
AIM2 [also known as PYHIN4], belong to the HIN-200  family member which is a double 
stranded DNA (ds DNA) sensors that induces IL-1β maturation through activating 
Caspase-1, which is a common characteristics of inflammasomal activity (Tschopp et al. 
2003). AIM2 is the first  member which does not belong to the NLR family but forms an 
inflammasome scaffold. “oligomerization of the complex is suggested to be mediated not 
by a central oligomerization domain within the inflammasome scaffold protein (as for the 
NLR NACHT domain) but by clustering upon multiple binding sites in the ligand, 
dsDNA, to which AIM2 binds via its C-terminal HIN domain (Tschopp2011) (Bu¨ rckstu¨ 
mmer et al., 2009; Fernandes- Alnemri et al., 2009; Hornung et al., 2009).” 
 
Fig 1.20 Minimal model for AIM2 inflammasome. Depicted above in an 
unoligomerized inflammasome complex. Domains: CARD, caspase recruitment domain; 
PYD, pyrin domain.  
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The AIM2 inflammasome consists of AIM2, Caspase-1, ASC aswell as a PYD domain 
which interacts with the ASC homotypically; PYD-PYD interaction. The ASC CARD 
domain recruits procaspase-1 to the complex. In other inflammasomes, once its 
autoactivated, caspase-1 directs the maturation of proinflammatory cytokines and their 
secretion (IL-1β and IL-18). The AIM2 inflammasome is activated by dsDNA from 
viruses, bacteria or the host itself (Hornung et al., 2009; Muruve et al., 2008) 
(tschopp2011). The physiological relevance of AIM2 needs further study and 
investigation, currently its known to predominantly act as a cytosolic DNA virus sensor.  
1.5.4 Virus recognition by Inflammasomes 
Three distinct inflammasome complexes are known at present to be involved in antiviral 
immunity. They are the NLRP3 inflammasome  (Allen et al. 2009, Kanneganti 2010),the 
RIG-I inflammasome (Poeck et al. 2010) and the AIM2 (Burckstummer et al. 2009, 
Hornung et al. 2009) inflammasome.  The link between these three inflammasome and 
the pro –form of caspase-1 is the 22kDa adaptor protein called the apoptosis-associated 
speck-like protein that contains a CARD (ASC). As mentioned before the activated 
caspase-1 cleaves pro-IL-1β and pro-IL-I8 into biologically active IL-1β and IL-18. After 
secretion of these active cytokines from the cells a series of biological effects take place 
that includes inflammation and infection associated autoimmune processes. The 
following table shows a list of viruses that activates Caspase-1 and induces IL-1β and IL-
18 production.  
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Table 3  Inflammasomes and their corresponding NLRs that are involved in 
recognising viral infection (Kanneganti 2010). AIM2. Absent in melanoma 2; MAVS, 
mitochondrial antiviral signalling protein; MDA5, melanoma differentiation-associated 
antigen 5; NLRP3, NLR family PYD containing protein 3; NLRX1, NLR family member 
X1 protein; OAS2, 2ʹ‑5ʹ-oligoadenylate synthetase type 2; poly(I:C), polyinosinic–
polycytidylic acid; RIG-I, retinoic acid inducible gene-I.  
The following is a short summary of how the intracellular sensors of the innate immune 
system works when it comes to viral recognition and an eventual activation of 
inflammasomes causing the release of pro-inflammatory cytokines. PAMPs, also known 
as pathogen associated molecular patters after recognising the presence of pathogens 
(virus in this case) activates the NOD-like receptors (NLRs). This in most cases mean 
that the inflammasome complex is formed and its assemblage, which has an eventual 
outcome of pro-inflammatory cytokine production, thereby amplifying antiviral response.  
NLRP3 and AIM2 in the presence of PAMPs oligomerize and recruit the adapter protein 
ASC which has a caspase recruitment domain (CARD). The CARD of both ASC and pro-
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caspase-1 binds to each other activating caspase-1 and results in the cleavage of pro-IL1β 
and pro-IL-18 into IL-1β and IL-18  respectively (Kanneganti 2010).  
The RNA helicase domain of RIG-I senses single stranded RNA (ssRNA) through the 
5’triphosphate moiety of the RNA strand of the viral genome. Signalling occurs through 
the N-terminal CARD domain of RIG-I which interacts with the CARD domain of the 
adapter molecule mitochondrial antiviral signalling protein (MAVS). This is followed by 
interferon (IFN) response factor 3 (IRF3) and IRF7 to be phosphorylated and activated. 
These in turn,  turns on the transcription of type I IFN (IFNα/β) genes (Kanneganti 2010).  
 
RIG‑I also regulates IL‑1β production transcriptionally and post-translationally following 
recognition of 5ʹ-triphosphate double-stranded (ds) RNA. Whereas RIG‑I-triggered 
transcription of pro-IL‑1β depends on nuclear factor-κB (NF-κB) activation and is 
mediated by MAVS, inflammasome formation, caspase‑1 activation, and IL‑1β and IL‑18 
production in response to RIG‑I activation involve ASC. The NLRs NOD2, NLR family 
member X1 (NLRX1) and NLR family CARD-containing protein 5 (NLRC5) associate 
with MAVS. Whereas NOD2 mediates the induction of type I IFNs, NLRX1 and NLRC5 
inhibit RIG‑I–MAVS interactions and thereby negatively regulate type I IFN production. 
LRR, leucine-rich repeat; MAPK, mitogen-activated protein kinase; MYD88, myeloid 
differentiation primary-response protein 88; RIPK2, receptor-interacting serine-threonine 
protein kinase 2; ROS, reactive oxygen species; TLR, Toll-like receptor; TNF, tumour 
necrosis factor; TRIF, TIR-domain-containing adaptor protein inducing IFNβ 
(Kanneganti 2010). 
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Figure 1.21 Innate immune response to viruses by intracellular sensors.  
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1.6 Viroporins 
Viral Ion channels also generally known as Viroporins are short peptide chains containing 
50-120 amino acids and play a very important role in the regulation of cellular processes 
and also viral entry into the cell as well as assembly of the virions. These small proteins 
also modulate and change the electrochemical balance in cell compartments of the host 
cell (Wang K. et al. 2011). There are several features of viroporins that they have in 
common including their small size and their hydrophobic nature, membrane 
permeabilization being a very typical trait which occurs when they oligomerize. Their 
main role is to participate in virus assembly and release of viruses from infected cells. If 
a viroporin encoding gene is deleted from the viral genome, there is a drastic reduction 
of viral pathogenicity and the formation of viral progeny. This gives a clear idea of its 
functions (Gonzalez and Carrasco 2003).  
General features of viroporins include a highly hydrophobic domain able to form an 
amphipathic alpha-helix. The component proteins are inserted into the membrane and 
they oligomerize to form a hydrophilic pore. The hydrophobic 'aa’ residues face the lipid 
bilayer and the hydrophilic residues form a part of the pore. There are many other 
additional features of viroporins which make them unique, such as an additional 
hydrophobic region interacting with the membrane. Potentially this can cause the 
membrane to be disorganised. Sometimes the viroporin may have a stretch of ‘detergent 
like acting’ basic aa. These factors may cause membranes to destabilize (Gonzalez and 
Carrasco 2003).  
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 1.6.1 Viroporins as Channel Proteins 
The virus encoded ion channel, viroporins represent only one factor taking part in the 
cascade of interactions between virus and cells, which leads to the virus entering the cell, 
replication and make profound changes in membrane permeability (Ciampor 2003). As 
the name suggests, viroporins forms pores in cell membranes and internal organelles 
enhancing membrane permeability which is noted in several virus-cell system. There are 
a couple of different modes of membrane ‘leakiness’ observed which have been 
distinguished according to the time of infection. During viral entry, early membrane 
modification occurs independent of gene expression since these alterations are caused by 
the virion’s components (Gonzalez and Carrasco 2003). During the course of the infection 
many different viral products have the capacity to affect the cell membrane. Viroporins 
are one of them which are responsible, at least to some extent for causing membrane 
leakiness that happens late in infection (Gonzalez and Carrasco 2003).  
 
 
 
Table 4 List of viroporins along with the length of their amino acid residues 
(Gonzalez and Carrasco 2003).  
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Narrowly speaking, the fact that different kinds of viral proteins are able to modify 
membrane permeablity, defines the activity of a viroporin. Some viral glycoproteins have 
an architectural advantage in the formation of a physical pore when they oligomerize. In 
theory, peptides may fuse together to form a physical viral glycoprotein pore that acts in 
conjugate with transmembrane domains. When inserted, the fusion peptide would create 
a pore in the virion membrane. More so, domains adjacent to the transmembrane region 
could be replaced by the pore forming glycoproteins, while other viruses may have no 
viroporin activity. 
 
Fig 1.22 Schematic presentation of the pore formation by viroporins (Gonzalez and 
Carrasco 2003) 
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Fig 1.23 Viroporin classification depending on the number of transmembrane domains 
they contain and the membrane topology of the monomers. a) Class I viroporins are 
characterised by its single membrane-spanning domain. There are proteins inserted inside 
the membranes that differentiates between the A and B subclasses. Class IA has proteins 
with lumenal amino terminus and cytosolic carboxyl terminus whereas class IB has an 
opposite orientation. b) Class II viroporins have transmembrane helix-turn-helix hairpin 
motifs. In subclass A both the N and C terminals of the proteins are lumenal whereas in 
subclass B the N and C terminals are facing the cytosol. (Nieva et al. 2012).  
 
1.6.2 Viroporin 2B 
It has been demonstrated by (Ito et al. 2012) that the Encephalomyocarditis virus (EMCV) 
which is a positive strand RNA virus of the Picornaviridae family activates the NLRP3 
inflammasome in mouse dendritic cells and macrophages. When macrophages were 
infected with live EMCV or they were transfected with EMCV virions, a robust 
expression of Type I interferons was noticed. But this failed to produce any IL-1β. 
However, when the EMCV viroporin 2B was transfected into lipopolysachharide primed 
macrophages, NLRP3 inflammasome activation is prominent. In un-transfected cell or 
transfected cells (with protein 2A and 2C, which are non-structural), NLRP3 is found to 
be uniformly distributed throughout the cytoplasm. In transfected cells however with the 
viroporin 2B, NLRP3 is observed to co-localize in the perinuclear space (Ito et al. 2012). 
A similar observation is made with the Influenza M2 viroporin (Pinto et al. 1992). 
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Elevation of the intracellular Ca2+ level is a very typical characteristic effect caused by 
the picornaviridae 2B, but not mitochondrial reactive oxygen species and lysosomal 
cathepsin B, was important in EMCV-induced NLRP3 inflammasome activation (Ito et 
al. 2012). Virus induced IL-1β secretions were not reduced even after chelation of 
extracellular Calcium. These results indicate and confirm that, like many other viroporins 
and specially Picornaviridae 2B has the capacity to independently activate the NLRP3 
inflammasome resulting in the production of IL-1β subtraction and potential 
inflammation (Gonzalez and Carrasco 2003, Ito et al. 2012, Madan et al. 2010). 
Triantafilou and group (2013) demonstrates that the Rhinovirus 2B viroporin acts in a 
very similar way. NLRP3 in untransfected bronchial epithelial cells (BES) is found 
generously scattered around the cytosol but co-colacalizes to the Golgi and ER upon 2B 
transfection. The same happens for NLRC5. Subsequently the NLRP3 and NLRC5 
inflammasomes are activated resulting in the production of IL-1β. Rhinovirus 2B also 
causes Ca2+ reduction in these organelles thus disturbing the intracellular calcium 
homeostasis. The NLRP3 and NLRC5 act in a cooperative manner during the 
inflammasome assembly by sensing intracellular Ca2+ fluxes and trigger IL1β secretion. 
These results reveal for the first time that human rhinovirus infection in primary bronchial 
cells triggers inflammasome activation (Triantafilou et al. 2013a). This study has been 
described in details in later chapters which is also the mail scope this research.  
 
1.6.3 Viroporin M2 
The M2 protein is encoded from a small part of the Influenza virus RNA genome (Lamb 
and Pinto 1997). Another protein called the M1 is encoded by this RNA fragment 
although the synthesis of these proteins occur in different mRNAs, generated by 
differential splicing. The M2 protein is 96 amino acid long and is classed under a type III 
integral membrane phosphoprotein. It’s structurally divided into three regions: a 23 
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residue fragment which is extracellular, a transmembrane domain which is 19 amino acid 
long. The cytoplasmic tail is composed of 54 residues (Lamb and Pinto 1997). The M2 
protein homo-oligomerises and is active in its tetrameric form. Studies in the Xenopus 
laevis oocyte led us to elucidate the functionality of the M2 protein (Pinto et al. 1992).  
 
1.6.4 Viroporin SH 
The RSV genome contains a negative stranded RNA of about the size of ~15kb 
transcribing 11 proteins and three membrane proteins. One of these membrane proteins 
is the SH which is categorised as a viroporin.  The other two membrane proteins are the 
F and G which are essential for viral entry, attachment and fusion. However it is less clear 
as to what part the SH protein plays, since RSV that lacks SH (RSVΔSH) is still viable 
(Krusat and Streckert 1997) and also forms syncytia (Collins and Mottet 1993). The SH 
protein is 64 aa long in RSV subgroup A and is 65 aa long in RSV subgroup B. It is a 
type II integral membrane protein with an extracellular facing C terminus and an α-helical 
trans-membrane domain (TM), with a very highly conserved sequence (Gan et al. 2012). 
The RSV SH protein co-localises at the membranes of the Golgi complex and the ER in 
an infected cell. It is also found in the plasma membrane (Rixon et al. 2004). There are 
several forms of the SH viroporin that it exists in, e.g. full length truncated form (4.5kDa), 
and a post translationally modified form. The most prevalent form is the full length un-
modified form (Collins and Mottet 1993).  The RSV small hydrophobic protein has been 
classified as a viroporin which alters membrane permeability displaying properties of a 
cation-selective ion channel.  
Studies have shown that SH plays an essential role in triggering signal 2 leading to 
caspase 1 production and inflammasome activation (Triantafilou et al. 2013b) 
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1.6.5 Other Viroporins 
Apart from the viroporins that are described above, there are many other examples of 
such which have received very less attention. The typical viroporin structure matches or 
have very high resemblance to a lot of other animal virus proteins. Sometimes they have 
been even found to have the membrane permealization property that a classical viroporin 
structure suggests. Such an example is of the p7 (small hydrophobic protein) resembling 
the alphavirus 6K, encoded by a species of Flaviviridae family. P7 from the Human 
hepatitis C virus (HCV) associates with intracellular compartments of the secretory 
pathways. Some has been also found to localize in the plasma membrane {Harada, 2000}. 
P7 forms a hexamer functioning as a Calcium channel in black lipid membranes.  
Algae virus encodes a potassium channel protein corresponds to Kcv protein from 
Paramecium bursaria chlorella virus (PBCV-1). Kcv localizes more at the ER and less in 
the Golgi and forms a two membrane spanning domains linked by 44 amino acids.  
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1.7 Aims and Hypothesis 
Viruses and bacteria elicit a very strong innate immune response once they are detected 
by the plethora of germ line encoded proteins which are a part of the innate immune 
system. One of its first lines of defence is to detect Pathogen Associated Molecular 
Patterns (PAMPs) using Pattern Recognition Receptors (PRRs) such as the Toll-Like 
Receptors (TLRs), the RIG-Like Helicases (RLHs) and the Nod-Like Receptors (NLRs). 
These receptors recognize certain molecular structures from the pathogens and lead to 
first line of defence which induces increased cytokines and IFNs.  
The aim of this study is to delineate how the innate immune system responds to viral 
invasion such as HRV (Human Rhinovirus), RSV (Respiratory Syncytial Virus) and IAV 
(Influenza A virus). Inflammatory mediators such as interleukins and cytokines which are 
secreted as a result of these invading viral pathogens are responsible for disease 
pathogenesis and lung injury. In vivo experiments carried on various kinds of lung tissue 
for this study suggests the same and sheds light on cellular mechanisms that cause lung 
inflammation.  This study aims to understand and identify intracellular macromolecular 
complexes called inflammasomes that is known to assemble as a result of viral trigger. 
Inflammasomes convert the inactive forms of the pro-inflammatory cytokines to their 
active forms. Although the exact mechanism of activations of these complexes was 
unknown and finding the trigger is one of the scopes of this study. Here, we aim to identify 
that virus encoded proteins such as the 2B protein of HRV, the SH protein from RSV and 
the Influenza M2 which are also termed viroporins can activate the inflammasome by 
causing ion imbalance (across cells membranes and organelles) thus providing a trigger 
for inflammasome assembly and an eventual release of inflammatory cytokines.   
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There is emerging evidence that points towards the fact that ion flux can act as trigger to 
the activation of inflammasomes and a subsequent release of IL-1β. When this happens 
in the lungs due to respiratory viral infections, disease pathogenesis progresses to 
developing lung disease such as COPD, Asthma and wheezing etc. This study 
hypothesises that viroporins such as the HRV- 2B, RSV- SH protein and the M2 protein 
of the Influenza virus are responsible for the changes in the intracellular ion homeostasis 
(such as Na+ and K+ and also Ca2+) that modulates inflammasome activation and cell 
death in the lung.  We propose therapeutic interventions; that by blocking these ion 
channels using drugs, we inhibit inflammasome assemblage that proves beneficial in 
terms of drastic reduction in lung inflammation. By inhibiting the activity of electrogenic 
pumps (for example the Na+/K+/ATPase and Ca2+ transport pumps) using drugs such as 
Adamantyls and Verapamil etc. respectively (in vitro) we demonstrate the potential of 
using these drugs to combat lung disease in the near future.  
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CHAPTER 2 
MATERIALS AND METHODS 
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2.1 Materials 
2.1.1 Chemicals 
All fine chemicals were obtained from Sigma (UK).   
2.1.2 Plasmid 
pEF1alpha-Myc Vector was purchased from Clonetech. The 2B coding sequences for 
HRV14 
were amplified and cloned into p2B-myc construct using SalI and BamHI restriction sites 
as 
described in de Jong et al.  
The ER targeted construct p2B-Flag-KKAA and the Golgi targeted p2B-Flag-AAAA 
were 
constructed using a forward primer containing a BamHI restriction site ( 5’- 
ggggggggattcatcgccaccgtcagcaagggcgaggag-3’) and a reverse primer containing a stop 
codon, a NotI restriction site and a sequence encoding either the AAAAAAKKAA or the 
AAAAAAAAAA tag  5’- 
ggggggggcggccgcttacgccgctttcttagctgcggctgccgcgcccttgtacagctcgtccatgcc-3’ and 5’- 
ggggggggcggccgcttacgccgcagcagcagctgcggctgccgcgcccttgtacagctcgtccatgcc-3’, 
respectively). 
The PCR product was cloned into p2B-Flag as described in de Jong et al.   
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2.1.3 List of Antibodies  
 2B Mouse Polyclonal IgG, purchased from Santa Cruz Biotechnology  
 Caspase-1 (P-10) Rabbit Polyclonal IgG, purchased from Santa Cruz 
Biotechnology sc-515 
 IRF-3 (FL-425) Rabbit Polyclonal IgG, purchased from Santa Cruz 
Biotechnology sc-9082. 65 
 LGP2 Goat pAb to DHX58, purchased from Abcam ab82151. 
 LGP2 (H-159) Rabbit Polyclonal IgG, purchased from Santa Cruz Biotechnology 
sc-134667. 
 MDA5 (C-16) Goat Polyclonal IgG, purchased from Santa Cruz Biotechnology 
sc-48031. 
 MDA5 (H-61) Rabbit Polyclonal IgG, purchased from Santa Cruz Biotechnology 
sc-134513. 
 NALP1 Mouse Polyclonal IgG, purchased from Santa Cruz Biotechnology sc- 
 NLRP3 Rabbit Polyclonal IgG, purchased from Santa Cruz Biotechnology sc- 
 Phospho-IκBalpha (Ser32) (14D4) Rabbit mAb, purchased from Cell Signaling 
Technology #2859L. 
 Rabbit Anti-Goat Polyclonal Immunoglobulins FITC, purchased from DAKO 
F0250. 
 RIG-I (C-15) Goat Polyclonal IgG, purchased from Santa Cruz Biotechnology sc-
48929 . 
 RIG-I (H-300) Rabbit Polyclonal IgG, purchased from Santa Cruz Biotechnology 
sc-98911. 
 Streptavidin-HRP conjugate, purchased from Amersham Biosciences 1058765. 
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 Swine Anti-Rabbit Polyclonal Immunoglobulins FITC, purchased from DAKO 
F0205. 
 Swine Anti-Rabbit Polyclonal Immunoglobulins HRP, purchased from DAKO 
P0217. 
 TLR2 Goat Polyclonal IgG, purchased from Santa Cruz Biotechnology sc-8690 
 TLR3 Rabbit Polyclonal IgG, purchased from Santa Cruz Biotechnology sc-
10740 
 TLR4 Goat Polyclonal IgG, purchased from Santa Cruz Biotechnology sc-8694 
 TLR7 Goat Polyclonal IgG, purchased from Santa Cruz Biotechnology sc- 
 TLR8 Goat Polyclonal IgG, purchased from Santa Cruz Biotechnology sc- 
 
2.1.4 RNA interference 
RNA interference was used in order to silence the NLRC4, NLRC5, NLRP1, NLRP3 
genes. Different pshRNA clones were generated using the psh7SK vector from Invitrogen 
the most efficient was against the sequence: for NLRP3 
GGAAGTGGACTGCGAGAAGTT, for NLRC5, GAACCTGTGGAGCTGTCTTGT 
and GCAACAGCATCTGCGTGTCAA, for NLRC4, 
GGATGCTGCTAGAGGGATCAT and GACAACTGGGCTCCTCTGTAA for NLRP1, 
GAAGGAGGAGCTGAAGGAGTT and GGCCTGATTATGTGGAGGAGA. 
For TLR4 GCCAGGAGAACTACGTGTGAA and for TLR2 
GTCAATTCAGAACGTAAGTCA. 
Cells (1 x 105) were seeded in six well plates and transfected with 0.5 µg of pshRNA for 
either NLRC4, NLRC5, NLRP1, NLRP3, TLR2, TLR4 or scrambled shRNA as a control 
using Lipofectamine 2000® (Invitrogen). After 48h the level of silencing was determined 
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by western blotting. Transfections with the specific shRNAs resulted in an approximately 
80% decrease in receptor expression as determined by western blotting whereas 
transfection of cells with the scrambled shRNA did not show any decrease in the specific 
gene expression. 
 
2.2 Tissue Culture 
The following basic tissue culture technique was used throughout the project. All Tissue 
Culture (TC) was performed in a Microflow Class 2 laminar flow hood in a sterile 
environment. To clean work surfaces and equipments, aqueous solution of Virkon was 
used, in order to maintain and ensure sterility. Lab coat, disposable gloves and overshoes 
were worn at all times. 25 cm2 Nuclon® TM Surface flasks and Nunc Falcon tubes were 
used throughout. 
2.2.1 Cell Lines 
2.2.1.1 A549 Human Cell Line 
A549 (adenocarcinomic human alveolar basal epithelial cells) cell line (ECACC – 
European Collection of Animal Cell Cultures), maintained in 1g/L Glucose Dulbecco’s 
Modified Eagle’s Medium (DMEM), containing GlutaMAX, 10% heat-inactivated Foetal 
Calf Serum (FCS), and 1% non-essential amino acids (Invitrogen (UK)).  
 
2.2.1.2 BES Human cell line 
Bronchial Epithelial Spheroids (BES) cell line (ECACC – European Collection of Animal 
Cell Cultures), maintained in 1g/L Glucose Dulbecco’s Modified Eagle’s Medium 
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(DMEM), containing GlutaMAX, 10% heat-inactivated Foetal Calf Serum (FCS), and 
1% non-essential amino acids (Invitrogen (UK)).  
 
 
 
2.2.1.3 Human Primary cells 
Human Primary Bronchial Epithelial cells were isolated from the surface epithelium 
bronchi of three healthy donors and obtained from TCS cell works, UK. The cells were 
cryopreserved at passage 2 and were cultured and propagated for up to 14 doublings 
before senescence. The bronchial epithelial cells stained positive for cytokeratin. They 
were grown in T25 ECM-coated flasks in 5% CO2 and 37°C using the Airway epithelial 
cell medium provided by TCS. 
 
 
2.2.1.4 HEK-Blue IFN-α/β Cells 
HEK-Blue IFN-α/β cells were purchased from Invivogen USA and maintained in 
DMEM, 4.5 g/l glucose, 2-4 mM L-glutamine, 10% (v/v) fetal bovine serum, 50 μg/ml 
penicillin, 50 μg/ml streptomycin, 100 μg/ml Normocin.  
The way that these cells work to detect human type I interferon production is by 
monitoring the activation of the ISG3 pathway. This is a HEK293 cell line which has 
been transfected with human STAT2 and IRF9 genes in order to obtain fully active human 
STAT2 and IRF9 genes. These cells were again transfected with a SEAP reporter gene. 
This gene is under the control of IFN-α/β inducible ISG54 promoter. When the HEK-
Blue IFN-α/β cells are stimulated by IFN-α or IFN-β, the JAK/STAT/ISGF3 is activated. 
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This results in the subsequent production of SEAP. The amount of SEAP in the 
supernatant is measured by QUANTI-Blue™. 
QUANTI-Blue™ is a colorimetric enzyme assay developed to determine any alkaline 
phosphatase activity (AP) in a biological sample, such as supernatants of cell cultures. In 
particular, QUANTI-Blue™ provides an easy and rapid mean to detect and quantify 
secreted embryonic alkaline phosphatase (SEAP), a reporter widely used for in vitro and 
in vivo analytical studies. 
 
In the presence of alkaline phosphatase, the colour of QUANTI-Blue™ changes from 
pink to purple/blue. The intensity of the blue hue reflects the activity of AP. The levels 
of AP can be determined qualitatively with the naked eye or quantitatively using a 
spectrophotometer at 620-655 nm.  http://www.invivogen.com/quanti-blue .  
 
 
2.2.2 Thawing Cells 
Vials of cells that were stored in liquid Nitrogen were carefully removed. 10ml of their 
appropriate growth medium were added as soon as they were fully defrosted and 
transferred to a 15 ml Falcon tube. This was then centrifuged at 1200 rpm for 5 mins at 
room temperature (RT). Then the supernatant was aspirated off. 5ml of growth medium 
was added to the cells and resuspended carefully before transferring to a flask to be 
incubated at 37o C, 5% CO2.  
2.2.3 Propagating Cells 
Cells having a limited lifespan in culture. Thus they need to be propagated in order to 
ensure their survival and continual growth. Foetal Calf Serum (FCS; growth factor) and 
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fresh growth medium provides nutritional environment and viable condition for the cells 
to grow in. MEM non-essential amino acids (Sigma) is also used providing nutrition to 
the cells. Cells need propagating when they become confluent (covering 90% of the base 
of the flask). It involves splitting down their total number allowing enough space for the 
cells to grow in and eventually reach confluency. This way certain cell lines can be 
maintained indefinitely. Although after a certain number of passages the overall quality 
of the cell line decreases.  
2.2.3.1 Adherent Cell Lines 
The first step is to remove the supernatant from the flask. The cell layer was washed with 
2ml of 1X PBS to remove any dead cells or cell debris. 2mls of trypsin (A serine protease 
that hydrolyses the proteins that adhere the cells to the bottom of the flask) was added 
into the flask and incubated for 4 mins (or until the cells could be tapped off the bottom 
of the flask). Equal amounts of growth medium was added (2ml) to neutralize the trypsin. 
The cells were then split evenly into separate flasks , and fresh medium was added (to a 
total of 5 ml). Flasks containing cells were now incubated at 37oC,5% CO2. In some cases 
cell lines are required to be just maintained rather than propagating. The process is the 
same, instead of neutralizing the trypsin, 1ml of trypsin was removed and 4 ml of fresh 
medium was added and incubated at 37oC, 5% CO2. 
2.2.4 Freezing Cells 
Cells are preserved in Liquid Nitrogen (-196oC) for long time cryo-storage. A freezing 
medium is required to store the cells in order to prevent cell damage by ice formation 
around the cells. Freezing medium consists of 10% Dimethyl Sulfoxide (DMSO) in FCS. 
DMSO is a cryoprotectant but is toxic to cells in room temperature after 15 mins of 
exposure. 
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In order to freeze adherent cells, they were washed with X1 PBS, trypsinized and 
neutralised as per propagating them. They were then combined in a 15 ml falcon tube and 
centrifuged for 5 mins at 12000 rpm. Supernatant was then aspirated off and the cells 
were resuspended in 1ml of freezing medium (1ml freezing medium per flask of cells). 
In under 10 minutes they were transferred to labelled cryo-tubes (Nunc) and stored at -
80oC. This will allow the cells to cool at a rate of 103oC per minute. After 24 Hours they 
were transferred to liquid Nitrogen for long-term cryo storage. 
For transfected cell lines the freezing medium consists of 10% DMSO, 30%FCS and 60% 
selection medium.  
 
2.3 Virus Culture 
2.3.1Propagating Viruses 
Prototype strains of viruses  (Influenza Virus  (H3N2), HRVs, RSV)were propagated on 
BES cells. 100 µl of virus stock of 50 PFU (Plaque Forming Unit) was added into a Non-
treated EasyFlask 25cm2, Filter Cap (Nunc) containing BES cells with 1ml of growth 
medium (75% confluent) and incubated at 37oC,5% CO2 for about 24hrs to 36 hrs. Once 
most of the cells had been killed (the cells start to float up in suspension once killed and 
looks rounded), the flask was frozen at -20oC and was thawed. It was freeze-thawed for 
three more times to break the cells and release the virions into the medium. The contents 
of the flask was centrifuged at 12000 rpm for 2 mins. The supernatant was collected and 
stored at -80oC in cryotubes.  
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2.3.2 Purifying Viruses using a Sucrose Density Gradient 
All viruses (HRV14, HRV58,HRV5, RSV, Influenza H3N2 and Rotavirus) were purified 
using a sucrose gradient purification process. The sucrose gradients were prepared in 
40ml Beckmann SW28 ultra-centrifuge tubes. The sucrose solutions were layered into 
the tubes in the following order (with the boundary between them marked): 7ml 60% 
sucrose in PBS; 6ml 30% sucrose in PBS; and 3ml 10% sucrose in PBS. 15ml virus was 
gently loaded onto the gradient, and the tubes were centrifuged at 25,000 rpm for 90 
minutes at 4oC. The viral load bands at the interface between 30% and 60% sucrose. The 
top layers of sucrose were carefully removed, and the purified virus was transferred into 
15ml Falcon tubes and frozen at -80oC.  
 
2.3.3 Isolating Single-Stranded RNA (ssRNA) from Purified viruses 
All procedures were carried out in a sterile environment using sterile equipments and 
eppendorf tubes. 2µl vanadyl ribonuclease complex (an RNase inhibitor, which stops the 
breakdown of RNA) was added to each eppendorf, followed by 300µl ultra-pure phenol 
(the bottom layer). Phenol dissolves any proteins present. After vortexing for 5-10 
seconds, the eppendorfs were centrifuged at 13,000 rpm for 10 minutes at RT. The upper 
layer was then transferred to new eppendorfs. 300µl chloroform / isoamyl alcohol 
(chloroform dissolves lipids present, and isoamyl alcohol ensures deactivation of RNase) 
was added to each eppendorf, followed by another round of vortexing and centrifugation. 
The upper layer was again transferred into new eppendorfs. 15µl (1/20th) sodium acetate 
2M pH 6.5 and 750µl (2.5x vol) of 95% ethanol were added, mixed, and the eppendorfs 
were then frozen at -80oC for at least 60 minutes. Afterwards, the eppendorfs (straight 
from the freezer) were centrifuged at 13,000 rpm for 30 minutes at RT. The excess 
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supernatant was removed, the eppendorfs were centrifuged at 13,000 rpm for a further 
minute, and the remaining supernatant was removed, leaving just a pellet of ssRNA. 80µl 
sterile water (ddH2O), or LAL water, was added to each eppendorf, and the ssRNA was 
frozen at -80oC.  
 
2.4 Immunofluorescence  
Immunofluorescence is a technique that is used to detect and quantify an antigen that may 
be present on the cell surface or inside the cell. A specific antibody to which a fluorophore 
is attached, is used to bind to the antigen of interest on the cell surface or inside the cell.  
The amount of fluorescence represent the amount of antigen present. Fluorophores work 
by absorbing light of a specific wavelength and emitting energy at a different but specific 
wavelength; FITC (fluorescein isothiocyanate) being the most common fluorophore used. 
FITC has an excitation wavelength of 495nm (cyan) and an emission wavelength of 
519nm (green).  
TRITC (tetramethylrhodamine isothiocyanate) is another common fluorophore 
frequently used, which has an excitation wavelength of 547nm (green) and an emission 
wavelength of 572nm (yellow). There are two major types of immunofluorescence: 
primary (direct) and secondary (indirect). 
2.4.1 Direct Immunofluorescence 
A single antigen specific antibody is used in direct Immunofluorescence which directly 
conjugates to a fluorophore. The antibody with the fluorophore in turn binds to specific 
antigens and detection is made possible via microscopy or flow cytometry. (Fig. 2.1). 
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Figure 2.1: Direct immunofluorescence. An antigen-specific fluorescently-conjugated 
antibody binds directly to the antigen.  
 
2.4.2 Indirect Immunofluorescence  
 
There are two antibodies involved in Indirect Immunofluorescence: a primary antibody 
which is unlabelled and specific for the antigen of interest, the other one being a 
secondary antibody which is specific for the primary antibody. This secondary antibody 
is also fluorescently-conjugated.  
The structure of an antibody makes this possible, as it has two regions: an Fc region 
(fragment crystallisable region); and an Fab region (fragment antigen-binding region). 
The Fab region contains variable sections that determine which antigen is bound, whilst 
the Fc region is constant in a class of the same species. Antibodies can be designed in 
such a way that they contain the same Fc region but different Fab regions. In this way, 
primary antibodies with the same Fc region can be used to detect various antigens (due 
to differing Fab regions), and still be detected by a single fluorescently-conjugated 
secondary antibody specific for the Fc region of the primary antibody. Schematic diagram 
(Figure 2.2) below describes antigen-antibody binding in Indirect Immunofluorescence.  
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Figure 2.2: Indirect immunofluorescence. An antigen-specific primary antibody binds to 
the antigen, and is itself bound by a fluorescently-conjugated secondary antibody specific 
to it. 
 
 
 
2.5 Flow Cytometry 
Flow cytometry is a powerful technique used to analyse cellular characteristics of 
individual cells in a heterogeneous population. In this project, cells were fluorescently 
tagged via indirect immunofluorescence and passed through the Becton Dickinson (BD) 
Fluorescence-Activated Cell Sorting (FACSCaliburTM) system (Figure 2.3).  
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Figure 2.3 Cell populations of A549 (A) and BES (B) cell types acquired by flow 
cytometry using CellQuest (BectonDickinson, Oxford, UK). Cells were left 
unstimulated and receptor expression was determined using the appropriate primary 
antibody followed by a secondary conjugated to FITC and the Geo.Mean of Fluorescent 
intensity measured. Fluorescence was detected using a FACS Calibur (BectonDickinson) 
counting 10,000 cells not gated. The data are a representative scatter chosen from 3 
independent experiments.   
 2.5.1 Principles of Flow Cytometry  
 
A flow cytometer works by passing thousands of cells per second through one or more 
laser beams, scattering the light onto detectors. The cells must be passed through the laser 
beams in single file to get accurate readings, and this is achieved using hydrodynamic 
focusing. The sample of cells merges with a flowing stream of sheath fluid and gets 
funnelled into a smaller orifice, compressing the cells to roughly one cell in diameter. 
When the laser strikes a cell, two forms of scattered light occur: forward scatter (FSC), 
which is the amount of light that is scattered in the forward direction, quantifies a cell’s 
size; and side scatter (SCC), which is the rest of the light collected on a detector located 
90o from the laser beam, shows the granularity of a cell. Fluorescence can also be 
detected. Lasers excite the fluorophores, and the subsequent fluorescent emission travels 
along the same route as the SCC signal. The light is directed through a series of filters 
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and mirrors, so that the appropriate wavelengths are delivered to the correct detector. All 
the data is recorded and accessed using the BD CellQuest software.(8,9)  
 
 
2.6 Determining PRR Expression Levels   
   
In-direct immunofluorescence and flow cytometry were utilised in order to elucidate 
TLRs and RLRs receptor expression on A549 cells and BES cells. 
To perform the indirect immunofluorescence assay, cell samples (2x106) were either 
unstimulated, or stimulated with 20μg of RNA or 100PFU HRV5.14,58 or HRV or H3N2 
for different time points (1, 2,4,6, 12 hrs) cells  were washed in 500µl PBS  and fixed by 
adding 300µl of 4% Paraformaldehyde (PFA {Sigma}) and left to incubate at room 
temperature for 10 minutes. Cells were then washed two times. The samples were then 
re-suspended in 200µl PBS/0.02%BSA/0.02% NaN3. 0.02%BSA. To this, 2µl of primary 
antibody was added. Cells were then incubated at room temperature for 1 hour, and then 
washed twice with PBS/0.02%BSA/0.02% NaN3. The addition of the appropriate 
secondary antibody conjugated to FITC was followed. The cells were incubated with 
secondary antibody for 45 min and then washed twice and re-suspended in 500µl 
PBS/0.02%BSA/0.02% NaN3. The samples were analysed using a Becton Dickinson 
Fluorescent Activated Cell Sorter (FACS Calibur) with software supplied by Cell Quest. 
(10).  
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2.7  Phospho-IκB, IRF3 and Caspase-1 Detection     
  
2.7.1 SDS-PAGE   
SDS-PAGE (Sodium Dodecyl Sulphate Polyacrylamide Gel Electrophoresis) is a 
technique used to electrophoretically separate proteins according to their Molecular 
Weight (MW). There are two types of SDS-PAGE; continuous and discontinuous.  
    
2.7.1.1 Continuous SDS-PAGE  
 
In this method of SDS PAGE the concentration of both the buffers in both the gel and the 
tank are the same. This is considerably easier to make than the dis-continuous method, 
providing enough resolutions for electrophoresis of DNA and RNA samples. For 
observing protein samples a dis-continuous method is often used.  
     
2.7.1.2 Discontinuous SDS-PAGE    
In this method different buffers are used for the gel and the tank. The gel has two parts to 
it; the upper stacking gel and the lower resolving gel. The 4% stacking gel has larger 
pores in it (low percentage) and a low pH of 6.8 whereas the lower 10% resolving gel has 
smaller pores with a higher pH of 8.8. The protein samples are loaded at the interface 
between the two gel layers in very thin and sharp wells that are made by 1mm combs 
whilst casting the gels. The proteins whilst travelling through the resolving gel gets 
separated according to their MW. Proteins with smaller size travel faster and hence 
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traverses more distance than proteins with higher MW which travel slower and travels 
less distance. Gels contain Chloride ions which act as the mobile anion. The running 
buffer (pH 8.8) contains glycine as its anion. Both chloride and glycinate ion migrate 
through the stacking gel at the beginning of electrophoresis. Chloride ions being smaller 
and strongly charged move faster than glycinate ions. Due to the low pH in the stacking 
gel compared to the running buffer, the equilibrium favours the zero net charge 
zwitterionic form of glycine. The faster Cl- ions leave behind an area of unbalanced, 
positive counter ions in their wake, creating a steep voltage gradient (the Kohlrausch 
discontinuity) that pulls the glycinate ions along, resulting in two fronts moving at the 
same speed. The protein molecules of the sample has an intermediate mobility at this 
point and gets carried along between these two fronts through large pores of the stacking 
gel, and deposited in a focused narrow band on top of the resolving gel. When the 
Kohlrausch discontinuity enters the resolving gel, the pH increases, ionising the glycine 
and increasing its mobility. The faster running glycinate ions dissipate the discontinuity 
and run past the protein samples, allowing them to separate themselves through the 
resolving gel [National Diagnostics, URL]. (7). 
   
   
2.7.2 Western Blot    
This is a standard technique for transferring the proteins that had been electrophoretically 
separated using SDS-PAGE onto a nitrocellulose membrane. This membrane will be 
further treated with antibodies for further analysis. The transferring is done using an 
electroblotting method, where the resolving gel (stacking gel trimmed off) and the 
nitrocellulose membrane is sandwiched together in between layers of blotting paper and 
pads soaked n transfer buffer. The sandwich is put in a cassette to hold everything together 
and then set in a tank filled withtransfer buffer, which also contains an ice-pack. 
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Transferring was done at a constant current of 210 mA applied for 60 mins. This results 
in the proteins from the gel being transferred to the nitrocellulose membrane. (1,2).  
   
 
 
2.7.2.1 Probing Membranes with Antibodies  
After the proteins are transferred to the nitrocellulose membrane, the membrane is 
instantly treated with a blocking reagent. A blocking reagent solution (in this case milk 
powder dissolved in X1 PBS) contains high amounts of proteins. These prevent the 
anybodies from binding parts of the membrane which do not have protein bands. A 
nitrocellulose membrane has very high binding affinity and hence allows all proteins to 
bind strongly. Antibodies will also bind to it; however bathing the membrane in a 
blocking solution ensures that the proteins will bind to the rest of the membrane  
‘blocking’ the antibodies from binding. (1). 
 
Post-blocking, the membranes are treated (incubated for 1 hr in room tempterature) with 
primary antibody for the specific protein of interest (protein being detected). Following 
this the membranes are briefly washed in X1 PBS TWEEN and incubated in secondary 
antibodies specific to  the primary antibody and conjugated to horseradish peroxidise 
(HRP). Membranes are incubated for 1 hour and washed in X1 PBS TWEEN for 2 hours 
whilst changing the washing buffer every 20 minutes. The membranes are then treated 
with an electro-chemiluminescence (ECL) reagent,  causing the HRP to emit light only 
where the protein bands are present. This is done in a dark room, where a photographic 
film is placed onto the membranes and exposed for a short amount of time (approx 6-8 
minutes), depending on the intensity of the luminescence.    
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2.7.3 Stripping and Reprobing Membranes   
After using a nitrocellulose membranes with the bound proteins and the antibodies, it is 
possible to reprobe the membrane with different antibodies. This is done by incubating 
the membrane in a stripping buffer at 50 oC, in a shaker incubator for 5-7 minutes. This 
allows the primary and the secondary antibody to be washed off but having the proteins 
still bound strongly to the nitrocellulose  membrane. After incubation the membrane is 
washed in X1 PBS-TWEEN for 20 minutes and then blocked for 1 hour in a blocking 
solution. A complete probing procedure can be done using this membrane at this stage 
with the same or a different antibody of choice.   
   
2.8 Immunoprecipitation 
Immunoprecipitation is a standard immunological procedure that is used to isolate an 
antigen from a complex, such as a cell lysate. An antibody specific to the antigen of 
interest in incubated along with the cell lysate. An insoluble support is added to it, in this 
case is protein-A sepharose beads. This helps to immobilise the antigen-antibody 
complex. Previous to adding antibodies protein-A sepharose beads and the cell lysate was 
mixed as a preclear. Pre-clearing helps to get rid of unwanted proteins that might possibly 
bind to the immunoglobulin in a non-specific manner; allowing a reduction in the 
background and signal to noise ratio (3). The sample is vortexed thoroughly and then 
centrifuged after which the supernatant is collected in separate tubes and new lysis buffer 
is added to it. This cycle is repeated. The importance of this step is to get rid of all non-
bound proteins and leaving behind only the protein-A sepharose beads that has the 
antigen-antibody bound to it.   
The lysis buffer used has many important functions; it stabilises the native protein 
conformation. Other functions includes the inhibition of enzymatic activity of the protein. 
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The lysis buffer also minimises the possibility of the antibody binding site denaturation 
and increase protein release from the cell lysate (4). The protein of interest is eluted from 
the protein-A sepharose beads using a reducing buffer (same used in SDS-PAGE). The 
elute is left for 15 minutes at room temperature after which it can run using SDS-PAGE 
setup. 
Immunoprecipitation experiments were carried out in this study in order to determine 
whether RIG-I, MDA5 and LGP2 homo-dimerises or hetero-dimerises with each other. 
This technique exploits the possibility of isolating a particular protein of interest and also 
determine whether the protein forms a homodimer with itself or forms a heterodimer with 
any other protein. In this study, antibodies against RIG-I, MDA5 and LGP2 was used to 
precipitate out the proteins for further study. SDS-PAGE is carried out to detect different 
proteins, i.e. precipitate out MDA5 and perform SDS-PAGE to detect LGP2.  
A549 cells were stimulated with HRV5 and HRV14 on separate occasions and were 
incubated for the following time points: 1hr, 2hr, 4hr and 6hrs, or left unstimulated (0 
hours). Cells were washed at every time point and lysis buffer was subsequently added to 
them for 2 hours. The lysates were then centrifuged and supernatants were collected in 
fresh eppendorf tubes. Pre-clearing was done 2 times with protein-A sepharose beads, to 
prevent non-specific binding of the antibody to undesirable proteins that may be present. 
More PAS beads were added and incubated with an appropriate primary antibody.  
Protein A is used due to the fact that it binds specifically to the heavy chains in the Fc 
region of the antibody resulting in a favourable orientation of the antibody that allows 
anigen binding site to face outwards. This also immobilises the antibody so that it can 
bind to the antigen more effectively. (4). 
The pellets are washed in lysis buffer and the samples analysed using SDS-PAGE and 
western blotting, using X2 SDS-PAGE Non-Reducing Sample Buffer.  
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2.9 Confocal Microscopy   
Confocal microscopy is an optical imaging technique that produces images of high 
resolution and contrast. It is used to visualise the location of different proteins in a cell. 
Confocal microscopy creates sharp images of the specimen because it has the ability to 
exclude out-of-focus light reflecting from the specimen. It does it by using a spatial 
pinhole, enabling the micrograph to have high contrast and also allowing the 
reconstruction of three-dimensional images.  
This technique was first developed by Minsky in 1955. In his original experiment he 
focussed a point of light on the specimen, point by point and collected the returning rays. 
The method by which he reduced background light was by focusing light on a single point 
and then collecting the light and passing it through a second pinhole aperture that got rid 
of any unwanted light. The stage on which the specimen sat had to be moved around in 
order for the specimen to be scanned, instead of moving the light source.    
The concept of fluorescence confocal microscopy works by the following principle; a 
molecule of the specimen absorbs light of a certain frequency however emits light of a 
different frequency. The sample is treated with a suitable dye and a light of a suitable 
wavelength is shone on the specimen. The light which the specimen emits as a result is 
collected and forms an image. Lower wavelength lights are reflected using a dichroic 
mirror however light of longer wavelength is transmitted. As a result light from the source 
reflects onto the sample after its passage through the objective. Fluorescent light on the 
other hand passes through the objective and the mirror since it is of a longer wavelength. 
This phenomenon is called epifluoroscence.    
There are two lenses involved in a confocal microscope; light is focused from the focal 
point of one lens to the focal point of another. The aim is to see only the focal point of 
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one of the lenses on the specimen so a pinhole is created at the focal point of the other 
lens stopping light from any other point than the focal point from passing through. A 
single beam of light illuminates the specimen at the focal point by the use of a pinhole 
system which reduces the amount of light from out of focus parts. In fluorescent 
microscopy it is never the case that the entire section of the specimen will be illuminated. 
An image is formed at the pinhole by the focal point, thus the two points are known as 
conjugate points. The name ‘confocal’ is coined since the pinhole is conjugate to the focal 
point.  
 
Figure 2.4. Diagram demonstrating the mechanisms behing confocal microscopy.  
The blue line shows the path of the laser. The laser is reflected off the dichroic mirror and 
then the rotating (scanning) mirrors. This laser is focused on the specimen after it travels 
through the microscope lenses. The green light is the path of the emitted light from the 
specimen containing the fluorescent labels. as it passes back through the microscope and 
is descanned by the rotating mirrors. It then passes through the dichroic mirror and then 
the light from the focal plane of the lenses passes through the pinhole and can be detected. 
(5). 
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2.10 Plasmid DNA          
2.10.1 Plasmid DNA Preparation      
2.10.1.1 Transformation 
 All procedures were carried out using sterile tips near a Bunsen burner to ensure sterility. 
Agar plates previously prepared with 40μl of Ampicillin per 100μl of agar. psiRNA 
NLRP3 (Invivogen) or  psiRNA-NLRC5 (Invivogen) were transformed into a competent 
E.coli strain (E.coli GT116). 5µl of the plasmid was added to 100µl of E.coli GT116 and 
incubated on ice for 30 minutes. This was followed by heat shocking the tubes at 42 oC 
for 45 seconds, then placing them back on ice for 2 minutes. 500µl of Luria Broth (LB) 
was then added to each tube, and placed on a shaker incubator at 225 rpm at 37oC for 1 
hour. 100µl of the transformed E.coli in LB was then added to a ampicillin agar plate, 
evenly spread until absorbed, and placed in a shaker incubator at 225 rpm at 37oC 
overnight to grow. The plasmids contain a Zeocin-resistance gene, so only the E.coli that 
have taken up the plasmid will survive on the Zeocin agar plates. After growing up the 
E.coli colonies, the transformed E.coli and plasmids were expanded. 25µl Ampicillin was 
added to 25ml LB in bottles, and individual colonies were added to separate bottles, as 
well as being added to a reference plate, and incubated overnight in a shaker incubator at 
225 rpm at 37oC.  
2.10.1.2 DNA Isolation   
The luria broth containing the E Coli culture was centrifuged at 4000 rpm in 50ml tubes 
and the supernatant was swiftly discarded without agitating the pellet. After addition of 
400μl of STET buffer, the solution was vortexed to lyse the E.Coli cell walls and then 
transferred to sterile eppendorfs. 10µl lysozyme (50mg/ml) was added to each tube. 
Following this the tubes were put in a waterbath for 1 minute to boil. Samples were placed 
on ice for 5 minutes and then centriguged for 30 mins at 13,000 rpm. 5µl of RNAse A 
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(20µg/ml; degrades RNA ) was added to the solution after the pellet was removed using 
a sterile toothpick. The samples were incubated for at 37oC - 42oC for 30 minutes. 400µl 
of phenol / chloroform / isoamyl alcohol (bottom layer) was then added, the samples 
vortexed, and centrifuged for 15 minutes at 13,000 rpm.  
The supernatant was transferred to sterile eppendorfs. 400μl of chloroform / isoamyl 
alcohol was added, the samples vortexed, and centrifuged again for 15 minutes at 13,000 
rpm. Supernatants were again collected into sterile eppendorfs. The following was then 
affed to the solution; 20µl (1/20th) sodium acetate 2M pH 6.5 and 1ml (2.5x vol) of 95% 
ethanol. The solution was mixed and transferrd to the freezer (-80oC) for 1 hour/overnight. 
The samples were afterwards cetrifuged at 13,00rpm for 20 minutes from frozen. 
Supernatant was discared leaving behind very small peletes which are the purified DNA. 
Excess supernatant was removed by further centrifuging the tubes for another minute. 
Peletes were suspended in 80µl sterile water (ddH2O), or LAL water, for each tube and 
stored at -20oC.  
    
2.10.1.3 Agarose Gel Electrophoresis   
Agarose gel electrophoresis is a process that utilises a method of gel electrophoresis that 
separates a mixed population of DNA (or proteins) through a matrix made of agarose. 
DNA or RNA samples are separated according to the size of the sample fragments; 
smaller fragments translocate further than the longer fragments, through the agarose gel. 
An electrical gradient is applied on both ends of the gel, so that the negatively charged 
molecules translocate, separating the fragments. 
To check the purity of the plasmid preparations, the samples were run on an agarose gel. 
A 1%w/v agarose gel was prepared (1g agarose in 100ml of 1X ELFO), and 10µl of the 
sample (with 5µl of ELFO Loading Buffer) was run on it at 100V for 45 minutes. A 1kb 
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DNA ladder was run alongside the samples. Once run, the bands were observed using a 
Stratagene eagle eye UV imaging system. 
   
2.10.2 Silencing   
This technique is used to ‘silence’ or completely or mostly abrogate the production (or 
downregulate) of a protein in a live cell by suppressing its associated gene. The process 
involves the introduction of antisense RNA, such as small interfering RNA (siRNA). 
Once introduced in a cell siRNA binds to and cleaves specific mRNAs and decreasing its 
activity. RNA interference was used in order to silence the NLRC5, NLRP1, NLRP3 
genes.  
A psh7SK vector (from Invitrogen) was used to generate different pshRNA clones. Most 
efficient was against the sequence: for NLRP3   GGAAGTGGACTGCGAGAAGTT, for 
NLRC5, GAACCTGTGGAGCTGTCTTGT and GCAACAGCATCTGCGTGTCAA.  
For NLRP1, GAAGGAGGAGCTGAAGGAGTT and 
GGCCTGATTATGTGGAGGAGA. 
 
The entire method takes 5 days to complete. Following is a exhaustive protocol of the 
procedure for transfection. 
2.10.2.1 Transfection Procedures 
To begin with a selection medium is made using the following: 200ml of (DMEM), 
containing GlutaMAX, 10% heat-inactivated Foetal Calf Serum (FCS), and 1% non-
essential amino acids (Invitrogen (UK), 1 ml Kanamycin (0.1mg.ml), 1ml Neomycin (0.1 
mg/ml). The medium is made in a sterile bottle in sterile conditions.  
3, 25 cm2 Nuclon® TM Surface flasks were chosen with BES cells growing in them with 
30-40% confluency. Supernatant was removed and the cell monolayer was washed with 
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2mls of Opti-MEM® I Reduced Serum Media. Then 1ml of the same medium was added 
to each flask and set aside.  
7 sterile eppendorgs was taken out of which 3 of them was grouped into ‘set A’ and 
another 3 was grouped into ‘setB’. The last eppendorf had 1 ml of OPTI-MEM and set 
aside.  
35 μl of OPTI-MEM  and 15μl of  DNA sample was added to each tubes of ‘setA’.  Tthe 
mixture was gently flicked and set aside for 5 minutes. To the tubes labelled ‘set B’, the 
following was added to each tube; 10μl Lipofectamine2000 and 40μl OPTI-MEM and set 
aside for 5 minutes.  
Contents of each corresponding tubes from ‘setA’ was mixed with tubes of ‘set B’and 
then incubated for 20 minutes at 37oC. The contents of the tubes were transferred to the 
3 flasks prepared before and incubated overnight at 37oC. As a negative control tube 
containing only OPTIMEM was transferred to a flask containing BES cells.  
The next day, the medium was aspirated from the flasks and 5ml of the selection medium 
containing the antibiotics was added to each flask. The flasks were again left overnight 
in the incubator at 37oC.  
At this point if the transfection is successful, the cells in the flask labelled ‘negative 
control’ will die due to the presence of antibiotic in the selection medium. Transfected 
cells will however thrive well due to the presence of antibiotic resistance gene in the 
transfected plasmid.  
Once the flasks are confluent in the next 2-3 days, they were fixed using 4%PFA, washed 
in X1 PBS and then treated with appropriate antibodies to confirm whether a protein of 
interest i.e NLRP3, NLRC5 was silenced, using flow cytometry.  
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2.11 Cytometric Bead Array        
To quantify the inflammatory response of the cells in response to different stimuli the 
released cytokines were measured. Cytokines are the messengers that co-ordinate 
inflammation and give a direct representation of cellular response. 
In this study the Human Inflammation BD™ Cytometric Bead Array (CBA {BD 
Biosciences}) kit was used to measure cytokine concentrations 
 
The Human TH1/TH2 CBA kit is capable of detecting six cytokines that play important 
roles in the human inflammatory response. These are Interleukin-4 (IL-4), Interferon 
-6 (IL-6), Interleukin-10 (IL-10), Tumor Necrosis Factor 
(TNF) and Interleukin-2 (IL-2). CBA analysis allows the fast and highly sensitive 
quantification of an array of cytokines in any one sample. 
In order to bind cytokines in a sample the beads are coated with capture antibodies 
specific for a particular cytokine. In the Human Inflammation BD™ CBA kit there are 
six bead populations with different fluorescent intensities specific for IL-4, IFN-β, IL-6, 
IL-10, TNF and IL-2. Once the beads have bound to the cytokines a phycoerythrin (PE)-
conjugated detection antibody mix is added, this is a mixture of PE-conjugated antibodies 
specific for each bead. 
2.11.1 Assay Procedure  
The standards and detection reagents were prepared according to the BD CBA Human 
Soluble Protein Master Buffer Kit manual. 50μl of the tissue culture supernatant prepared 
previously was added to flow tubes, followed by the addition of 50μl of the IFN-β beads, 
mixed, and incubated for 1 hour at RT. 50μl of the PE detection reagent was then added 
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and mixed, followed by a further 2 hour incubation at RT in the dark. 1ml of Wash Buffer 
was added to each tube, centrifuged at 200g for 5 minutes, and then the supernatant was 
carefully aspirated off and discarded. The bead pellets were resuspended in 300μl of Wash 
Buffer, and the samples were analysed using flow cytometry, with the data acquired being 
analysed using the FCAP Array software (Becton Dickinson). 
 
2.12 Statistical Analysis 
Statistical analysis – Data were evaluated by analysis of variance and the Dunnett 
multiple-comparison test using the InStat program (GraphPad Prism Software, San 
Diego, CA).  Where appropriate (comparison of two groups only), two-tailed t tests were 
also performed.  Statistical differences were considered significant at the level of p < 0.05. 
Experiments were performed using triplicate samples and were performed twice or more 
to verify the results.  
 
 
 
 
 
 
 
 
 
 
 
 [81] 
 
 
 
 
 
 
 
 
 
 
CHAPTER 3: 
Innate Immune Response to 
 Human Rhinoviruses (HRV5, HRV14, HRV58) 
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3.1 Introduction     
Human rhinoviruses, the common cold pathogens, are small, non-enveloped single 
stranded RNA viruses, which affect a significant number of humans during the winter 
months. Human infection causes severe inflammation mainly in the upper but also lower 
respiratory system, causing nasal secretions and cough. Although rhinovirus infections 
are not life-threatening, epidemiological studies have documented their involvement in 
acute respiratory illness, wheezing and asthma exacerbations in various human 
populations (Seemungal et al. 2001)(Cox and Le Souef 2014). The role of respiratory 
infections in asthma has always been of clinical interest and importance, but their overall 
contribution to this disease has, until recently, been underappreciated. With the use of 
highly sensitive and specific molecular diagnostic and detection methods, the 
identification of infectious organisms has increased, and with these findings has come a 
greater and clearer understanding of the contributions of specific respiratory infections to 
asthma. From a wide variety of studies, HRVs, have emerged as key and perhaps central 
microorganisms in many aspects of asthma. For example, studies have pointed to the 
importance and relevance of symptomatic infections with rhinovirus early in life as a 
major factor in recurrent wheezing and asthma. Studies by Johnston et al suggests that 
80-85% of children (9-11 years of age) who suffer from asthma also suffered from HRV 
infections. Similar studies show that adults suffer from asthma exacerbations due the 
HRV infection (Johnston et al. 1995).  
Rhinovirus infection induces inflammation and release of cytokines from the respiratory 
tract thereby attracting inflammatory cells to the airways. Inflammation is the process 
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aimed at restoring homeostasis after an infection and can be more damaging than the 
infection itself if uncontrolled, excessive or prolonged.  
Our body’s innate immune system recognises HRV through a plethora of germ-line 
encoded PRRs such as the TLRs and RLRs. Antiviral innate immune recognition is 
mostly sequestered by the active functioning of TLR3,TLR7 and TLR8 (Kawai and Akira 
2006, Xagorari and Chlichlia 2008). Also very important are the RLRS called RIG-I and 
MDA-5 (Slater et al. 2010) which have been shown to play a role in rhinovirus innate 
recognition.  
The aim of this study was to investigate the innate immune responses to Rhinoviral 
infection and whether different HRV strains contribute differently to the inflammatory 
response of the host.  
 
3.2 Results    
The body’s innate immune system responds to RNA virus infection and triggers an anti-
viral response which results in the production of type I interferons (IFNs). TLRs and 
RLRs are the two primary pattern recognition receptors that are responsible for the 
detection of RNA viruses. The RLH (RIG Like Helicase) pathway is very important in 
the detection of RNA virus invasion in most cell types apart from plasmacytoid dendritic 
cells. HRV strains are genomically classified in three groups HRV-A, HRV-B and HRV-
C (Spyridon Megremis 2012). In this study used HRV-A group strains (HRV5and 58) as 
well as HRV-B (HRV14) have been used in order to elucidate the mechanisms of anti-
viral innate immune response to HRV infection.  
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3.2.1 PRR expression Levels 
Measuring levels of PRR after infecting cells with a pathogen gives a direct understanding 
of the possible intracellular pathways that might be activated. It also helps us to elucidate 
what cellular stress responses might be occurring such as interferon and cytokine 
production, and whether at all these would result in inflammation and necrosis. Here we 
have measured activation of PRRs such as RIG-I and MDA5 (known to recognise RNA 
ligands) and also TLRs with special interest to TLR7 and TLR8 which are known to 
recognise RNA viruses such as HRVs (and viral ssRNA) , and trigger an innate immune 
response.  
3.2.1 .1 PRR expression of A549 cells upon HRV14 infection 
Lung Epithelial cells (A549) which are susceptible to HRV infection were infected with 
HRV14 (100PFU) in order to determine the upregulation of  MDA5 and RIG-I and were 
monitored at different time points (1h,2h, 4h, 6h, 12hrs). The viral infectious cycle is 6 
hours long which is why this is the maximum length of time the cells are left with the 
virus and an added 6 hours to notice differences in protein expression levels. 
Unstimulated cells were checked for receptor expression levels at 0hr. Detection of the 
expression levels were determined by using indirect Immunofluorescence and measuring 
the Fluorescence intensity (Fig. 3.1). Significant increase in the expression levels of RIG-
I and MDA5 were observed when stimulated with the virus showing slight preference for 
MDA5 expression over RIG-I. 
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Figure 3.1 (a) PRR expression levels in cells stimulated with HRV14. A549 Lung 
Epithelium Cells were infected with 100 PFU viral stock (HRV14). Following infection 
PRR expression was tested at different time points using the appropriate primary antibody 
followed by a secondary conjugated to FITC. Receptor expression was determine as the 
Geo.Mean of Fluorescent intensity. Fluorescence was detected using a FACSCalibur 
(BectonDickinson) The data represent the mean of three independent experiments.  
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Figure 3.1 (b) PRR expression levels in cells stimulated with HRV14. A549 Lung 
Epithelium Cells were infected with 100 PFU viral stock (HRV14). Following infection 
PRR expression was tested at different time points using the appropriate primary antibody 
followed by a secondary conjugated to FITC. Receptor expression was determine as the 
Geo.Mean of Fluorescent intensity. Fluorescence was detected using a FACS Calibur 
(BectonDickinson) counting 10,000 cells not gated. Isotype controls were performed, 
with values similar to unstimulated samples. The data represent the mean SD of 3 
independent experiment, indicating statistically significant (P < .05) increase in 
expression compared with corresponding unstimulated controls. 
 
As expected since HRV14 is a positive sense RNA virus and MDA5 has been shown to 
recognize RNA from positive sense RNA viruses, higher levels of MDA5 were observed 
as compared to RIG-I.  
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3.2.1.2  PRR expression of A549 cells upon HRV58 infection   
Expression levels of PRRs such as the RLR (RIG-I and MDA5) were measured post viral 
infection of A549 lung epithelial cells by HRV58 (100PFU).  
 
 
Figure 3.2 (a) PRR expression levels in cells stimulated with HRV58. A549 Lung 
Epithelium Cells were infected with 100 PFU viral stock (HRV58). Following infection 
PRR expression was tested at different time points using the appropriate primary antibody 
followed by a secondary conjugated to FITC. Receptor expression was determine as the 
Geo.Mean of Fluorescent intensity. Fluorescence was detected using a FACSCalibur 
(BectonDickinson). The data represent the mean of three independent experiments 
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Figure 3.2 (b) PRR expression levels in cells stimulated with HRV58. A549 Lung 
Epithelium Cells were infected with 100 PFU viral stock (HRV58). Following infection 
PRR expression was tested at different time points using the appropriate primary antibody 
followed by a secondary conjugated to FITC. Receptor expression was determine as the 
Geo.Mean of Fluorescent intensity. Fluorescence was detected using a FACSCalibur 
(BectonDickinson) counting 10,000 cells not gated. Isotype controls were performed, 
with values similar to unstimulated samples. The data represent the mean SD of 3 
independent experiment, indicating statistically significant (P < .05) increase in 
expression compared with corresponding unstimulated controls. 
 
We observe that when A549 cells were infected with HRV58, MDA5 recognises the viral 
pathogen and is upregulated however RIG-I also detects the virus but to a lesser extent. 
We suspect from this observation that the RLH pathway is activated. As a result of which 
we proceeded to investigate signalling pathways to verify RLR involvement.  . It was 
initially believed that RLRs would recognise only one ligand which is dsRNA but studies 
have shown that RIG-I and MDA5 recognise different viral RNAs from viruses (Kato et 
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al., 2006; Loo et al., 2008). RIG-I recognises single-stranded RNA (ssRNA) containing 
a terminal 5’-triphosphate (ppp) (Pichlmair et al., 2006), as well as linear dsRNA no 
longer than 23 nucleotides in length (Kato et al., 2008). MDA5 recognises long strands 
of dsRNA, but the mechanism by which this occurs is less clear (Kato et al., 2008).  
 RIG-I recognises negative sense ssRNA viruses, including influenza virus, Newcastle 
disease virus, Sendai virus, and Hepatitis C virus, whilst positive sense ssRNA viruses, 
such as picornaviruses, and more specifically encephalomyocarditis virus and 
Coxsackievirus B3, have been shown to activate MDA5 (Kato et al., 2006; Loo et al., 
2008; Wang et al., 2010).  
Since HRV is a positive sense ssRNA virus, MDA5 recognition over RIG-I is expected 
and supported by other studies.  
3.2.2 Signalling Detection Upon Infection With HRV  
 
RIG-I and MDA5 are activated by an RNA ligand. A downstream signalling is induced 
as a result of interaction of IPS-1 via a CARD-CARD interaction. Downstream signalling 
molecules are recruited and IκB is released from the NF-κB complex and gets 
phosphorylated. This phosphorylated  IκB is ubiquitinated and sent to the proteosome for 
degradation. NF-κB and IRF3 acts as transcription factors that translocate to the nucleus 
and upregulate type I IFNs and an eventual innate immune response. In the following 
experiments the detection of phospho-IκB correlates to the activation of NF-κB.  
 
3.2.2 .1  Signalling detection in HRV5 infected cells 
A549 cells were infected with 100 PFU viral stock (HRV5) for 1hr, 2hr, 4hr and 6hr or 
left unstimulated (Uns). Cell lysates were collected and analysed for Phospho-IκB and 
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IRF3 using SDS-PAGE gel electrophoresis and western blot. Primary antibodies specific 
for IRF3 or phospho-IκB were used followed by the appropriate secondary antibodies 
conjugated to HRP. The bands were visualised using the ECL procedure.  
A slow and gradual increase in the activation of phospho-IκB is observed with the most 
amounts present after 6 hours of stimulations (fig 3.4). A similar result is noticed in IRF3 
production. The commonly known activated IRF3 dimer is seen to form at 2hr and 
onwards.  
  
Figure 3.3 Phospho-IκB and IRF3 detection. A549 Lung Epithelium Cells were 
infected with 100 PFU viral stock (HRV5) or left unstimulated (Uns) for 1hr, 2hr, 4hr and 
6hr. Cell lysates were collected and analysed for Phospho-IκB and IRF3 using SDS-
PAGE gel electrophoresis and western blot. Primary antibodies specific for IRF3 or 
phospho-IκB  were used  followed by the appropriate secondary antibodies conjugated to 
HRP. Loading controls for β-actin are also depicted. The bottom panel shows a 
quantitative analysis (by densitometry) of Phospho-IκB and IRF3. The bands were 
visualised using the ECL procedure. Data are representative of experiments done three 
times. 
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3.2.2 .2 Signalling detection in HRV14 infected cells 
 
A549 cells were infected with 100 PFU viral stock (HRV14) for 1hr, 2hr, 4hr, 6hr and 12 
hrs. Cell lysates were collected and analysed for Phospho-IκB and IRF3. A gradual 
increase in Phospho-IκB production is seen from 1hr through to 12 hrs stimulations (fig. 
3.5). IRF3 activation is upregulated at 2hrs, 4hrs and 6rs and seems to dimerise at these 
timepoints.  
Figure 3.4  Phospho-IκB and IRF3 detection A549 cells were infected with 100 PFU 
viral stock (HRV14) or left unstimulated (Uns) for 1hr, 2hr, 4hr, 6hr and 12 hrs. Cell 
lysates were collected and analysed for Phospho-IκB and IRF3 using SDS-PAGE gel 
electrophoresis and western blot. Primary antibodies specific for IRF3 or phospho-IκB  
were used  followed by the appropriate secondary antibodies conjugated to HRP. Loading 
controls for β-actin are also depicted. The bottom panel shows a quantitative analysis (by 
densitometry) of Phospho-IκB and IRF3. The bands were visualised using the ECL 
procedure. Data are representative of experiments done three times.  
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3.2.2 .3 Signalling detection in HRV58 infected cells 
A549 cells were infected with 100 PFU viral stock (HRV58) for 1hr, 2hr, 4hr, 6hr and 12 
hrs or left unstimulated (Uns). Cell lysates were collected and analysed for Phospho-IκB 
and IRF3.  
Upregulation of Phospho-IκB is observed along with IRF3 and a heightened level is 
maintained from 1hr through to 12 hrs (Fig 3.6). Dimerisation of IRF3 is also clearly 
visible through the two bands forming. 
 
Figure 3.5 Phospho-IκB and IRF3 detection. A549 Lung Epithelium Cells were 
infected with 100 PFU viral stock (HRV58) or left unstimulated (Uns) for 1hr, 2hr, 4hr, 
6hr and 12 hrs. Cell lysates were collected and analysed for Phospho-IκB and IRF3 using 
SDS-PAGE gel electrophoresis and western blot. Primary antibodies specific for IRF3 or 
phospho-IκB were used followed by the appropriate secondary antibodies conjugated to 
HRP. Loading controls for β-actin are also depicted. The bottom panel shows a 
quantitative analysis (by densitometry) of Phospho-IκB and IRF3. The bands were 
visualised using the ECL procedure. Data are representative of experiments done three 
times. 
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Phospho-IκB detection corresponds with NF-κB activation, which, coupled with IRF3 
detection, gives an indication of MDA5 and RIG-I activity in response to different 
stimulations. This is true for all the three strains of HRV used; HRV5, HRV14 and 
HRV58.  
 
 
3.2.3 IFN-β and IL1β Production of HRV infected Cells  
    
A549 Lung Epithelial cells were infected with 100PFU of  HRV14 and left to incubate  
1, 2, 4, 6 and 12 hours and then supernatants were collected. The supernatants added to 
HEK IFNβ or HEK IL1β reporter cells and incubated for 24 hours. Quanti-Blue was 
added and the levels of SEAP  measured using a spectrophotometer at 630nm. The SEAP 
levels correspond to the expression levels of IFNβ/ IL1β. The same was repeated with 
HRV58.  
IFN-β is a type I IFN, which signals through the IFN-α/β receptor and the Jak-STAT 
pathway to drive interferon stimulated gene (ISG) expression and an innate immune 
response.  
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Figure 3.6 – IFNβ/ IL1β response in HRV14 infections. Supernatant from A549 cell 
Infections with  100PFU of  HRV14 for 1, 2, 4, 6 and 12 hours was added to HEK IFNβ/ 
HEK IL1β  reporter cells and incubated for 24 hours. Quanti-Blue was added and the 
levels of SEAP  measured using a spectrophotometer at 630nm. The SEAP levels 
correspond to the expression levels of IFNβ/ IL1β.  
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Figure 3.7 – IFNβ/ IL1β response in HRV58 infections. Supernatant from A549 cell 
infections with  100PFU of  HRV58 for 1, 2, 4, 6 and 12 hours was added to HEK IFNβ/ 
HEK IL1β  reporter cells and incubated for 24 hours. Quanti-Blue was added and the 
levels of SEAP was measured  using a spectrophotometer at 630nm. The SEAP levels 
correspond to the expression levels of IFNα/β. 
In both the stimulations with HRV14 and HRV58, a sharp rise in IL-1β is seen. This 
suggests that inflammation might occur as a result of HRV infections in lung cells. It 
could also correspond to the higher level of NLRP3 and whether or not this is a result of 
an activated NLRP3 inflammasome pathway, will be studied in the following chapter.  
However it becomes more apparent that as a result of the RLRs recognising viral invasion 
eventually stimulates the ISG resulting in the secretion of higher levels of IFN-β.  
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3.2.4 HRV5 ssRNA stimulations  
Picornaviruses are positive-sense ssRNA viruses and have a common replication pathway 
for all viruses in the family. During the viral replication cycle transcription of the viral 
genome into complementary RNA (negative strand) occurs. This template is used to form 
new strands of RNA which are double stranded (dsRNA). Other forms of RNA are also 
formed such as the replicative intermediate form (RF), a partially double stranded for (RI) 
etc. So, during viral replication a plethora of foreign RNA will be found in the host cell 
during an infection. These are known to be recognised by RLRs during an infection.  
In this study however we have isolated genomic ssRNA from HRV5 and used it to infect 
lung epithelial cells (A549) to determine which TLRs and RLRs recognise ssRNA and 
initiates an innate immune response.  
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3.2.4.1 Isolating ssRNA     
In order to determine the immunostimulatory effect of viral genomic ssRNA. The viral 
ssRNA was isolated from purified viral stocks and analysed by agarose gel 
electrophoresis (Fig 3.8).  
 
Figure 3.8 Agarose Gel Electrophoresis of isolated ssRNA from HRV5. HRV5 RNA 
was visualized in GelRed-stained gels using a standard UV transilluminator with an 
ethidium bromide filter. Data are representative of experiments done three times 
 
3.2.4.2  ssRNA stimulations and PRR expression levels 
Viral RNA mixed with lipofectamine for cell uptake was used to stimulate lung epithelial 
cells at different time points. The expression level of Pattern recognition receptors that 
recognize viral RNA such as TLR7, TLR8, MDA5 and RIG-I was determined by 
Immunofluorescence.(Fig 3.10).  A549 cells were stimulated with 20µg of purified 
ssRNA.  
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Figure 3.9 (a) PRR expression levels in cells stimulated with ssRNA. Following 
stimulation with ssRNA, PRR expression was examined at different time points using the 
appropriate primary antibody followed by a secondary conjugated to FITC. Receptor 
expression was determine as the Geo.Mean of Fluorescent intensity. Fluorescence was 
detected using a FACSCalibur (BectonDickinson) 
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Figure 3.9 (b) PRR expression levels in cells stimulated with ssRNA. Following 
stimulation with ssRNA, PRR expression was examined at different time points using the 
appropriate primary antibody followed by a secondary conjugated to FITC. Receptor 
expression was determine as the Geo.Mean of Fluorescent intensity. Fluorescence was 
detected using a FACSCalibur (BectonDickinson) counting 10,000 cells not gated. 
Isotype controls were performed, with values similar to unstimulated samples. The data 
represent the mean SD of 3 independent experiment, indicating statistically significant (P 
< .05) increase in expression compared with corresponding unstimulated controls. 
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88From these results we observed upregulation of TLR7 and TLR8 possibly due to the 
detection of the viral ssRNA genome in the endosomal compartments of the cells by the 
resident TLR7 and TLR8. These TLRs are seen to be upregulated after stimulating the 
cells which suggests that they act as host sensors for the HRV5 genome . Both RLHs 
appear to be upregulated  and more specifically MDA5, which is expected since it has 
been shown to be involved in Picornaviridae recognition.  
 
3.2.4.2  RLH Downstream Signalling  and IRF3 
As a response to viral infection mammalian cells elicits both the innate and the adaptive 
immune system. One of the most efficient antiviral response of the innate immune system    
is triggered through the production of interferons through IRF3 and IRF7 activation 
(Kawai et al., 2005).  RLHs signalling works through CARD-CARD interactions between 
the RLH and Interferon Promotor Stimulator 1 (IPS-1) also known as MAVS, Cardif and 
VISA. IPS-1 contains an N-terminal CARD domain and a C-terminal transmembrane 
(TM) domain. The TM domain is required for localisation to the mitochondria and allows 
association and activation of TRAF3. TRAF3 acts as a link between IPS-1 and 
TBK1/IKKi with TRAF Family Member-Associated NF-κB (TANK) family proteins 
(TANK, NAP1 and SINTBAD) acting as scaffold proteins. IKKi and TBK1 
phosphorylate and activate IRF3 and IRF7 which promote Type IFN production(Kawai 
T et al., 2005; Kumar H et al., 2006).  
In order to confirm the involvement of PRR in HRV5 detection and cytokine release the 
presence of IRF3 upon stimulation with virus or ssRNA was investigated. The cells were 
stimulated for different time points and analyzed by SDS-PAGE electrophoresis and 
western blotting. From the results we observed the presence of IRF3 in lung epithelial 
cells (A549) when stimulated with live virus and viral ssRNA (3.11). 
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Figure 3.10 Detection of IRF3 in cells stimulated with HRV5 or ssRNA. 
Western blot of IRF3 from lysates of unstimulated A549 cells and those cells after 1, 2, 
4, 6hr stimulation with HRV5 (A) or ssRNA (B). Lysates were separated by sodium 
dodecyl sulphate polyacrylamide gel electrophoresis and transferred on a nitrocellulose 
membrane. The membrane was probed for IRF3 specific mAb followed by the 
appropriate secondary antibody conjugated to HRP and imaged via enhanced 
chemiluminescence. The bottom panel shows a quantitative analysis (by densitometry) of 
IRF3. The data represent the mean of three independent experiments 
 
 
3.2.4.3 Cytokine secretions  
As mentioned before, TLRs and RLRs engage themselves after recognising virus or viral 
components in releasing inflammatory cytokines. In this study lung epithelial cells were 
stimulated with both live virus and viral ssRNA and the inflammatory response produced 
was measured by investigating cytokine secretion. We observe the secretion of IFNγ and 
IL6 in both stimulations with HRV5 and ssRNA. (Fig 3.12 and Fig3.13)  IL6 being more 
predominant in the ssRNA stimulations. 
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Figure 3.11  Levels of Cytokine secretions in A549 cells stimulated with 100PFU of 
live virus (HRV5). Cells were stimulated at different time points. The supernatants were 
harvested and assayed for cytokine secretion using the Th1/Th2 CBA kit (Becton 
Dickinson). Fluorescence was detected using a FACSCalibur (BectonDickinson 
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Figure 3.12  Levels of Cytokine secretions in A549 cells stimulated with 20μg of viral 
ssRNA Cells were stimulated at different time points. The supernatants were harvested 
and assayed for cytokine secretion using the Th1/Th2  CBA kit  (Becton Dickinson). 
Fluorescence was detected using a FACSCalibur (BectonDickinson). 
 
 
Secretion of IFNβ and IL-1β was also measured after infecting A549 cells with  100PFU 
of  HRV5 or 20μg of viral ssRNA,  for 1, 2, 4, 6 and 12 hours and supernatant was added 
to HEK IFNβ/ HEK IL1β  reporter cells and incubated for 24 hours. We observe high 
levels of IFNβ production for both the stimulations (with live virus and ssRNA), although 
the response to ssRNA  is milder than live virus (fig 3.13). This suggests that although 
ssRNA has the capability of inducing an acute interferon response, the live virus induces 
a stronger signal. This might be because of viral proteins that may independently 
contribute towards signalling for interferon production.  
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Figure 3.13  IFNβ response in HRV5 or HRV5 ssRNA infections. Supernatant from 
A549 cell infections with  100PFU of  HRV5 or 20μg of viral ssRNA,  for 1, 2, 4, 6 and 
12 hours was added to HEK IFNβ/ HEK IL1β  reporter cells and incubated for 24 hours. 
Quanti-Blue was added and the levels of SEAP was measured  using a spectrophotometer 
at 630nm. The SEAP levels correspond to the expression levels of IFNβ.  
 
A similar response in observed with IL-Iβ production where the live virus stimulations 
tend to produce more cytokine than the ssRNA itself (Fig 3.14). In the following chapter 
we describe how HRV has components (viral proteins/ viroporin) has the capacity to 
independently trigger an inflammatory response.  
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Figure 3.14  IL1β response in HRV5 or HRV5 ssRNA infections. Supernatant from 
A549 cell infections with  100PFU of  HRV5 or 20μg of viral ssRNA,  for 1, 2, 4, 6 and 
12 hours was added to HEK IFNβ/ HEK IL1β  reporter cells and incubated for 24 hours. 
Quanti-Blue was added and the levels of SEAP was measured  using a spectrophotometer 
at 630nm. The SEAP levels correspond to the expression levels of IL1β. 
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3.2.5 RLR Dimerization 
 
 RLRs have been shown to recognise viral RNA and stimulate an antiviral response with 
MAVs which is another RNA helicase used as an adaptor to initiate IFN signalling via 
phosphorylation of IRF3 and IRF7(Kawai et al., 2005) . It has been shown that activation 
of RIG-I or MDA5 leads to MAVs dimerisation which is essential for the downstream 
signal transduction. Since MAVS seems to dimerise upon activation (Yoneyama et al., 
2005) we decided to determine whether RIG-I or MDA5 could also dimerise once 
activated by their viral ligand. As stated in the methods the objective of these experiments 
was to determine whether these RLRs self dimerise or heterodimerise. RIG-I is 110KDa, 
MDA5 is 117KDa, while LGP2 is smaller and is around 60KDa. Thus a dimer of RIG-I 
should be roughly 200KDa, as should an MDA5 dimer, while a RIG-I/MDA5 with LGP2 
dimer should be around 170KDa. 
 
 
Human lung epithelial cells were stimulated with either HRV5 for 1, 2, 4 or 6 hours. 
Following stimulation with the virus for the different time points, the cells were lysed in 
lysis buffer (0.5% NP40, 1% CHAPS, 15 mM Nacl, 2mM PMSF, 1mM MgCl2) for at 
least an hour or overnight. The cell lysates were pre-cleared with Protein-A Sepharose 
beads prior to immunoprecipitations using specific antibodies against MDA5, RIG-I or 
LGP2. Once the specific antibodies had bound to their cellular target, the complex was 
precipitated using Protein A Sepharose beads, which have an affinity for the Fc region of 
the antibody. The pellets were either incubated in SDS-PAGE non-reducing buffer (0.5% 
SDS, 20% glycerol, 10mM TrisHCl) and incubated at room temperature or incubated in 
reducing buffer (1.4 M mercaptoethanol, 1% SDS, 20% glycerol, 10mM TrisHCl)  and 
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boiled prior to SDS-PAGE electrophoresis. It was expected that incubation with non-
reducing SDS-PAGE buffer at room temperature will retain any associations that might 
exist between homo and heterodimers. 
3.2.5.1 MDA5 and LGP-2 dimerisation 
Cell lysates were pre-cleared and LGP2 was precipitated using LGP2 Goat pAb and PAS 
beads and analysed by SDS-PAGE electrophoresis. Western blotting was performed 
using a MDA5 Rabbit pAb followed by a polyclonal Swine anti-Rabbit Ig HRP (Figure 
3.15). Dark higher bands approximately 170 kDa can be seen, possibly suggesting the 
presence of a MDA5- LGP2 dimer. A less strong band of ~110 kDa was also seen, which 
is most likely the MDA5 monomers. 
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Figure 3.15  LGP2 and MDA5 heterotypic association. A549 cells were stimulated 
with HRV5 for 1, 2, 4, or 6 hours, or left unstimulated. The cell lysates were precleared 
with PAS beads 2 times. LGP2 was precipitated out of the lysate using LGP2 Goat pAb 
and PAS beads. Pellets were washed in lysis buffer and analysed using SDS-PAGE (X2 
SDS-PAGE  Non-Reducing Sample Buffer) and western blotting with MDA5 Rabbit pAb 
(primary) and followed by polyclonal Swine anti-Rabbit Ig HRP. To visualise the protein 
bands ECL was performed. Data are representative of experiments done twice 
 
The results showed that there were two bands for each time point, one at around 170KDa 
which is most likely an LGP2 heterodimer with MDA5. We also notice MDA5 monomers 
at about 110kDa.   
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3.2.5.2 MDA5 homotypic associations 
To determine MDA5 homotypic interactions, cells were stimulated with HRV5 for 1, 2, 
4, or 6 hours, or left unstimulated, and an MDA5 Goat pAb was used to precipitate MDA5 
out of the cell lysate and analysed by SDS-PAGE electrophoresis. Western blotting was 
performed using an  MDA5 Rabbit pAb and detected using polyclonal Swine anti-Rabbit 
Ig HRP are shown in Figure  
 
Initially we investigated MDA5 homo-dimerisation from cell lysates of unstimulated cells 
as well as cells stimulated with HRV5 at different time points were precipitated with an 
antibody specific for MDA5. Once the antibody was allowed to bind to its cellular target, 
the complex was precipitated with Protein A Sepharose beads and analysed by non-
reducing SDS-PAGE. It was shown that MDA5 existed as an equilibrium between 
monomers and dimers 1 and 2 hr post infection, whereas after 4 and 6 hr of infection the 
whole of the MDA5 cellular pool shifted into homodimers (Fig 3.16). 
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Figure 3.16  Homotypic associations of MDA5. The cell lysates (unstimulated and 
stimulated with HRV5 at different time points) were pre-cleared with Protein-A 
Sepharose beads prior to immunoprecipitations. Then a specific antibody against MDA5 
was used. Once the MDA5 antibody had bound to its cellular target, the complex was 
precipitated using Protein A Sepharose beads, which have an affinity for the Fc region of 
the antibody. The pellets were incubated in SDS-PAGE non-reducing buffer and analysed 
via SDS-PAGE electrophoresis. Western blotting was performed using an MDA5 specific 
antibody followed by the appropriate secondary conjugated to HPR.The proteins were 
imaged via enhanced chemiluminescence. Data are representative of experiments done 
twice.  
 
 
The MDA5 immunoprecipitations show bands that around 200kDa for all the time points 
suggesting that MDA5 does indeed form a dimer. There are also bands at around 110KDa 
which is most likely MDA5 as a monomer. Firstly the heaviest band, at around 200kDa 
is only present in the later time points, not in the unstimulated. The 120kDa band appears 
at the unstimulated 1hr and 2 hr time point. This could suggest MDA5 is a monomer in 
its natural state, but upon infection MDA5 dimerises with itself and thus becomes active.  
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3.2.5.3 RIG-I and LGP-2 dimerisation 
To determine RIG-I  and LGP2 interactions A549 cells were stimulated with HRV5 for 
different time points, or left unstimulated. LGP2 was precipitated out of the lysate using 
LGP2 Goat pAb and PAS beads and analysed by non-reducing SDS-PAGE 
electrophoresis. Western blotting with RIG-I antibody  was used to determine 
interactions. The association between LGP2 and RIG-I can be seen in (Figure 3.17).   
 
Figure 3.17  LGP2 and RIG-I heterotypic association. A549 cells were stimulated with 
HRV5 for 1, 2, 4, or 6 hours, or left unstimulated. The cell lysates were precleasred with 
PAS beads 2 times. LGP2 was precipitated out of the lysate using LGP2 Goat pAb and 
PAS beads. Pellets were washed in lysis buffer and analysed using SDS-PAGE (X2 SDS-
PAGE  Non-Reducing Sample Buffer) and western blotting with RIG-I Rabbit pAb 
(primary) and followed by polyclonal Swine anti-Rabbit Ig HRP. To visualise the protein 
bands ECL was performed. Data are representative of experiments done twice. 
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3.2.5.4  LGP2  homotypic associations 
In order to determine whether LGP2 also homodimerises, A549 were stimulated with 
HRV5 for 1, 2, 4, or 6 hours, or left unstimulated, and an LGP2 Goat pAb was used to 
precipitate LGP2 out of the cell lysate. The western blot results after incubating with 
LGP2 Rabbit pAb and detecting using polyclonal Swine anti-Rabbit Ig HRP can be seen 
in Figure 3.18. 
 
Figure 3.18  Homotypic associations of LGP2. The cell lysates (unstimulated and 
stimulated with HRV5 at different time points) were pre-cleared with Protein-A 
Sepharose beads prior to immunoprecipitations. Then a specific antibody against LGP2 
was used. Once the LGP2 antibody had bound to its cellular target, the complex was 
precipitated using Protein A Sepharose beads, which have an affinity for the Fc region of 
the antibody. The pellets were incubated in SDS-PAGE non-reducing buffer and analysed 
via SDS-PAGE electrophoresis. Western blotting was performed using an LGP2 specific 
antibody followed by the appropriate secondary conjugated to HPR. The proteins were 
imaged via enhanced chemiluminescence. Data are representative of experiments done 
twice.  
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The bands seen above is around 60KDa showing LGP2 monomers at all time-points. It 
should be noted that while LGP2 appears to dimerise with RIG-I and MDA5 it clearly 
does not under these conditions homodimerise.  
3.2.5.5 RIG-I homotypic associations  
To determine RIG I  homotypic interactions, cells  were stimulated with HRV5 for 1, 2, 
4, or 6 hours, or left unstimulated, and an RIG-I Goat pAb was used to precipitate RIG-I 
out of the cell lysate and analysed by non reducing SDS-PAGE electrophoresis. Western 
blotting was performed using a  RIG-I Rabbit pAb and detected using polyclonal Swine 
anti-Rabbit Ig HRP are shown in (Figure 3.19).  
 
 
Figure  3.19  Homotypic associations of RIG-I. The cell lysates (unstimulated and 
stimulated with HRV5 at different time points) were pre-cleared with Protein-A 
Sepharose beads prior to immunoprecipitations. Then a goat anti RIG-I antibody was 
used. Once the RIG-I antibody had bound to its cellular target, the complex was 
precipitated using Protein A Sepharose beads, which have an affinity for the Fc region of 
the antibody. The pellets were incubated in SDS-PAGE non-reducing buffer and analysed 
via SDS-PAGE electrophoresis. Western blotting was performed using a rabbit anti  RIG-
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I specific antibody followed by swine anti rabbit Ig secondary conjugated to HPR The 
proteins were imaged via enhanced chemiluminescence. 
The RIG-I immunoprecipitations shows bands at around 190kDa, suggesting the presence 
of a RIG-I dimer, a band at around 110kDa showing that RIG-I exists as a monomer as 
well. The monomer exists in the unstimulated state and then upon stimulation with HRV5 
dimerises.  
3.2.5.6 RIG-I and MDA5 under reducing conditions 
In order to determine whether the presence of the dimers was specific. The 
immunoprecipitations were repeated and incubated in reducing buffer and boiled prior to 
SDS-PAGE electrophoresis to see whether the dimers were specific and  whether they 
could be disrupted (Fig.3.20)  
 
Figure 3.20  Immunoprecipitation of RIG-I and MDA5 under reducing conditions. 
The cell lysates (unstimulated and stimulated with HRV5 at different time points) were 
pre-cleared with Protein-A Sepharose beads prior to immunoprecipitations. Then a 
specific antibody against MDA5 (A) or RIG-I (B) was used. Once the RIG-I antibody had 
bound to its cellular target, the complex was precipitated using Protein A Sepharose 
beads, which have an affinity for the Fc region of the antibody. The pellets were  
incubated in SDS-PAGE -reducing buffer  and boiled then analysed via SDS-PAGE 
electrophoresis. Western blotting was performed using an MDA5 (A) or RIG-I (B) 
 [115] 
 
specific antibody followed by the appropriate secondary conjugated to HPR The proteins 
were imaged via enhanced chemiluminescence. 
 
The data showed that the dimers were disrupted, thus the high molecular weight proteins 
disappeared and only monomers were present after boiling the samples and treating them 
with reducing agents. 
 
 
3.3 Conclusion 
PRR have been shown to be key components of the innate immune system, creating a 
hostile environment for viral pathogens by triggering a cytokine and IFN immune 
response. TLRs as well as RIG-I and MDA5 have been shown to recognise different 
viruses and target specific viral PAMPs. TLR7 and TLR8 (Triantafilou et al., 2005) as 
well as MDA5 has been shown to recognize  members of the Picornavirus family (Kato 
H et al., 2006) (Wang, et. al, 2010). Thus it would seem likely that HRV could be 
recognized by more than one PRR.  
From this study, we can see cytokine secretion as well as IRF3 activation verifying the 
involvement of PRR in HRV5, 14 and 58 detection. The increased expression of TLR7 
and TLR8 when lung cells were stimulated with HRV5 or ssRNA are implicating these 
TLRs in HRV5 ssRNA detection. Furthermore MDA5 is also shown as up-regulated upon 
viral infection and IFN secretion is triggered once the virus infects the cells.  In addition 
to identifying the PRR involved in the innate immune response to HRV, RLR 
dimerisation was also investigated. It has been shown that different PRR can 
homodimerise upon activation to augment signalling like MAVs the adaptor molecule for 
RLR signalling or TLR8 which recognizes ss RNA and initiate innate immune responses. 
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It was shown that upon ligand stimulation, there was a formation of an TLR8 dimer, 
which enables downstream signalling processes (Tanji et al. 2013).  
Therefore it is possible that RLRs could also dimerise. From the immunoprecipitation 
experiments performed it was evident that like TLR8 and MAVs LGP2, RIG-I and MDA5 
exist as monomers in the cell cytoplasm but once activated they form homodimers upon 
infection, possibly to augment the IFN activation. However it appears that in an 
uninfected cell both RIG-I and MDA5 forms heterodimers with LGP2, maybe to prevent 
signalling activities without the presence of a pathogen. HoweverLGP2 exists as a 
monomer and does not form a homodimer at any point, before or after stimulation. The 
mechanism by which LGP2 works is very unclear still. These studies have shown that 
LGP2 seems to form heterodimers with both RIG-I and MDA-5.  
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Chapter 4 
 
Inflammasome activation in HRV infection 
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4.1 Introduction  
Human Rhinoviruses have been linked with underlying lung disorders such as asthma and 
chronic obstructive pulmonary disease in children and adults. 
However rhinovirus innate recognition has not been fully elucidated. A study by Stokes 
et. al. shows that epithelial cell responses to rhinovirus are modulated by IL-1β signalling 
via MyD88 (Stokes et al. 2011). Furthermore there is evidence supporting Rhinoviral 
infection as a trigger of acute inflammatory exacerbations in patients with underlying 
airway disease showing that IL-1β levels are enhanced (Hakonarson et al. 1999) within 
the airways of patients with Chronic obstructive pulmonary disease (COPD) or asthma 
(de Kluijver et al. 2003, Stokes et al. 2011, Terajima et al. 1997) which can aggravate 
symptoms. A new study by Dolinay et al. using a mouse model shows that 
inflammasome-regulated cytokines IL18 and IL-1β are critical mediators of acute lung 
injury. Their secretion was elevated in the plasma of patients with acute respiratory 
distress syndrome (ARDS) and served as a novel biomarker of intensive care unit 
morbidity and mortality (Dolinay et al. 2012). These studies implicate the inflammasome 
pathway and its downstream cytokines to play critical roles in respiratory inflammation. 
 
Maturation and secretion of interleukins IL-1β and IL-18 is controlled by NOD-like 
receptors (NLRs) which can be activated by physical damage to the plasma membrane 
caused by bacterial products and viruses as well as host-derived danger signals (danger 
associated molecular patterns, DAMPs) and assemble into high-molecular weight, 
caspase-1-activating platforms called ‘‘inflammasomes’’. These Inflammasomes play a 
key role in host defence against bacteria and viruses (Martinon et al. 2002, Yazdi et al. 
2010).  
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This study investigated the contribution of NLR inflammasomes and IL1β secretion in 
rhinovirus pathogenesis, and the mechanism of inflammasome activation in response to 
rhinovirus infection. 
4.2 Results 
4.2.1 HRV infection induces inflammasome activation 
A wide variety of danger signals activate inflammasomes. These include pathogen-
associated molecular patterns and host-derived molecules that are indicative of cellular 
damage (danger-associated molecular patterns). In order to determine if HRVs are 
detected by the inflammasome we infected bronchial cells. The experiments showed that 
HRV infection induced IL-1β secretion (Fig. 4.1a A) and Caspase-1 cleavage (Fig. 4.1a 
B).  
 
To define the NLR involvement we knocked down NLRP3, NLRP1, NLRC4 or NLRC5 
using shRNA and infected the cells with different HRV strains (HRV14, HRV5, HRV6, 
HRV58) (shRNA controls in lentivirus constructs were also used) our results were the 
same for all rhinovirus strains used and showed that the shRNA controls had no effect but 
IL1β production was impaired when NLRP3 or NLRC5 were knocked down while 
silencing of NLRP1 or NLRC4 had no effect in IL1β production (Fig. 4.1C). By knocking 
down both NLRP3 and NLRC5 we completely abrogated IL1β secretion.  
IL6 secretion was measured as a control since it is independent of inflammasome 
activation but is a known marker for NF-κB activation. HRV infected cells with knocked 
down NLRP3, NLRP1, NLRC4 or NLRC5 had a robust IL6 response (Fig. 4.1D). These 
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findings suggest that rhinovirus infection activates the NLRP3 and NLRC5 dependent 
inflammasome. 
 
 
Figure 4.1 (a) HRV infection activates the NLRP3 and NLRC5 inflammasome. 
Bronchial epithelial cells (106) were infected with 100PFU of HRV14, HRV5, HRV6 and 
HRV58. Supernatant was collected at 12hr post infection and analysed for IL1β (A) using 
the CBA bead array system on a FACSCalibur (Becton Dickinson) Cells extracts from 
infected bronchial epithelial cells were analysed for the presence of caspase p10 by 
western blotting (B). The data represent the mean of three independent experiments. 
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Figure 4.1(b) HRV infection activates the NLRP3 and NLRC5 inflammasome. 
Bronchial epithelial cells (106) were infected with 100PFU of HRV14, HRV5, HRV6 and 
HRV58. Supernatant was collected at 12hr post infection and analysed for IL1β NLRP3, 
NLRP1, NLRC5 or NLRC4 expression was knocked down by siRNA and the cells were 
again infected with 5moi of HRV14 HRV5, HRV6 and HRV58. Supernatant was 
collected at 12hr post infection and analysed for IL1β (C) and IL6 using the CBA system 
(D). The data represent the mean of three independent experiments. 
 
 
 
 
 [122] 
 
4.2.2 2B ion channel protein triggers inflammasome activation 
To investigate how rhinoviruses stimulate inflammasome activation we looked at 
rhinovirus proteins that might enhance membrane permeability since it has been shown 
that membrane perturbations causing potassium efflux by microbial toxins such as 
aerolysin and nigericin have been shown to activate the NLRP3 inflammmasome 
(Mariathasan et al. 2006). Furthermore the influenza virus M2 proton channel activates 
the NLRP3 inflammasome pathway by modulating the intracellular K+ concentration 
(Ichinohe et al. 2010).  
Enteroviruses encode a cytotoxic pore forming protein 2B which changes intracellular 
Ca2+ homeostasis and interferes with protein trafficking through the secretory pathway(de 
Jong et al. 2003, van Kuppeveld et al. 1997). Therefore cells were transfected with a 
plasmid expressing  myc-tagged rhinovirus 2B as well as an empty plasmid pEF-myc 
with a myc tag as a negative control and inflammasome activation was determined by 
measuring IL1β secretion (Fig. 4.2A) as well as detecting the presence of caspase 1 via 
western blotting (Fig. 4.2B). The results showed that 2B expression was sufficient to 
stimulate inflammasome activation.   
NLRP3, NLRC4, NLRP1, NLRC5 or NLRP3 and NLRP5 simultaneously were knocked 
down using siRNA in bronchial cells and cells were transfected with p2B-myc. When 
IL1β secretion as well as caspase 1 expression was examined the data showed a 
significant reduction in IL1βsecretion (Fig 4.2C) as well as a reduction in caspase 1 
expression when NLRP3 or NLRC5 were knocked down while there was no significant 
change in neither IL1β or caspase 1 when NLRP1 or NLRC4 were knocked down. When 
both NLRC5 and NLRP3 were silenced IL1β was completely inhibited (Fig. 4.2 b).  
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Figure 4.2 (a)   HRV 2B activates inflammasome. Bronchial epithelial cells were 
transfected with either 10 µg p2B-myc or 10 µg pEF-myc an empty plasmid expressing 
myc as a negative control. Supernatants were collected and tested for IL1β secretion using 
the CBA bead array system (BectonDickinson) (A). Cells extracts from mock 
untransfected and also transfected bronchial cells were analysed for the presence of 
Caspase p10 by western blotting (B). NLRP3, NLRP1, NLRC4, NLRC5 or NLRP3 and 
NLRC5 expression was knocked down by psiRNA and the cells were again transfected 
with p2B-myc and examined for IL1βsecretion secretion (C). The data represent the mean 
of three independent experiments. 
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Figure 4.2 (b)   HRV 2B activates inflammasome Bronchial epithelial cells were 
transfected with either 10 µg p2B-myc or 10 µg pEF-myc an empty plasmid expressing 
myc as a negative control. Cells extracts from mock untransfected and also transfected 
bronchial cells were analysed for the presence of Caspase p10 by western blotting. 
NLRP3, NLRP1, NLRC4, NLRC5 or NLRP3 and NLRC5 expression was knocked down 
by psiRNA and the cells were again transfected with p2B-myc and examined for the 
presence of Caspase p10 by western blotting (D). The data represent the mean of three 
independent experiments. 
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4.2.3 2B protein changes the calcium homeostasis in the cell 
Three mechanisms leading to inflammasome activation had been proposed and studied. 
Extracellular ATP triggers K+ efflux  (Kanneganti et al. 2007) and induces NLRP3 
recruitment, release of lysosomal contents caused by lysosome disruption (Halle et al. 
2008, Hornung et al. 2008) or production of ROS (Dostert et al. 2008). Furthermore 
Murakami et al. also shows that Ca2+ mobilization could be another mechanism of 
inflammasome activation (Murakami et al. 2012). 
Since several studies have identified Ca2+ signalling as a key cellular target for viral 
infection (Chami et al. 2006)we investigated whether HRV 2B also alters intracellular 
calcium fluxes, which could trigger NLRP3 and NLRC5 activation.  
Bronchial cells were transfected with p2B-myc. Cells transfected with empty plasmid 
pEF-myc were also used as a control. The Ca2+ sensitive dye FLUO3-AM was used to 
stain cells for the determination of cytosolic Ca2+ by flow cytometry. Expression of 2B 
resulted in a significant increase in cytosolic Ca2+ (Fig. 4.3). 
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Fig. 4.3 Cytosolic Ca2+ measurements 
Bronchial cells were transfected with 10 µg  of p2B-myc and the calcium-sensitive dye 
FLUO3-AM was used to measure the cytosolic calcium level by flow cytometry (white 
histogram) mock untreated cells are also depicted (grey histogram). This is a 
representative of four independent experiments 
 
 
4.2.4 Calcium inhibitors block rhinovirus induced inflammasome activation  
To investigate whether we could inhibit rhinovirus induced inflammasome activation, we 
used a permeant Ca2+ chelator, BAPTA-AM as well as ion channel inhibitors: 5-(N-ethyl-
N-isopropyl) amiloride (EIPA) and benzamil, which block Na+/H+ ion channels, and 
verapamil, which blocks Ca+ channels (Stuart and Brown 2006). Human bronchial 
epithelial cells were seeded onto 6-well plates. The following day, cells were infected 
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with HRV5, HRV6, HRV14 or HRV58 (100PFU) in medium containing the different 
concentrations of each drug for 60 min (the best working concentration was for BAPTA 
15 µM, EIPA 25µM, Benzamil 50µM, Verapamil 50 µM).  
Supernatant containing virus was removed and the cells were washed. Fresh medium 
containing the drugs was added and the cells were incubated a total of 12 h. (Viability of 
cells was determined by using 0.2% trypan blue and examining cells under a microscope). 
Cell-free supernatant was collected at 12hr post-infection and analyzed by CBA bead 
array (BD) for IL-1β as well as IL6 as a control since it is a cytokine induced in viral 
infection but not triggered by inflammasome activation. In some cases, supernatants and 
cell extracts were collected for Western blot analysis.  
To exclude the possibility that the drugs mentioned above affected rhinovirus replication, 
cells were treated with the optimal concentration of drugs or not treated with drugs and 
then infected with different strains of rhinoviruses and plaque assay titration was carried 
out. The results showed that BAPTA-AM, EIPA, benzamil, and verapamil had no effect 
on viral replication (data not shown). 
Our data showed that BAPTA-AM as well as verapamil although to a less degree were 
able to inhibit IL1β production as well as caspase 1 activation (Fig. 4.4). EIPA or 
benzamil had no effect in IL1β production and caspase 1 activation. Thus indicating that 
calcium chelators or calcium inhibitors could be used in the future to control exacerbated 
IL1βproduction which is often found in viral inflammatory airway disease. 
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Figure 4.4 (a)Calcium inhibitors block rhinovirus induced inflammasome activation  
Bronchial cells were infected with HRV14 and cultured in the presence or absence of 
BAPTA-AM, EIPA, or benzamil or verapamil for 12 hrs. Supernatants were collected 
and tested for IL1β and IL6 secretion using the CBA bead array system 
(BectonDickinson) (A). The data presented is the mean of three independent experiments. 
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Figure 4.4 (b)Calcium inhibitors block rhinovirus induced inflammasome activation 
Bronchial cells were infected with HRV14 and cultured in the presence or absence of 
BAPTA-AM, EIPA, or benzamil or verapamil for 12 hrs. Cell lysate was collected and 
caspase1 expression was investigated by western blotting as well as β-actin as a control 
(B). The data presented is the mean of three independent experiments. 
 
 
4.2.5 2B localises with NLRC5 and NLRP3 in the golgi 
To elucidate the intracellular interactions of NLRP3 and NLRC5 inflammasome we 
looked at 2B trafficking in the cell. Previous studies have shown that 2B accumulation 
occurs at the ER and Golgi (de Jong et al. 2008). 
Bronchial cells were transfected with p2B-myc incubated for 24hr and then permeabilised 
with 0.02% saponin. An anti myc antibody previously conjugated to FITC was used for 
2B labelling.  
The 2B protein mainly localised at the Golgi complex membranes, whereas NLRP3 and 
NLRC5 were distributed in the cytoplasm in unstimulated cells. However after 2B 
transfection there was a percentage of NLRP3 and NLRC5 as well as ASC, which is a 
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key adaptor to caspase-1 activation (Mariathasan et al. 2004), that partially translocated 
from the cytoplasm to the Golgi (Fig. 4.5). 
In order to investigate the role of the Golgi apparatus in inflammasome activation we 
utilized Brefeldin A (BFA). The fungal metabolite BFA has been known to induce rapid 
and reversible disassembly of the Golgi stack into tubules and vesicles, resulting in the 
redistribution of Golgi-resident enzymes and accumulation of proteins in the ER in a 
reversible manner (Lippincott-Schwartz et al. 1989, Misumi et al. 1986). 
Treatment with BFA disassembled the Golgi and resulted in 2B redistribution (Fig. 4.6) 
which blocked inflammasome activation by rhinovirus since there was no IL1β 
production in the supernatant of cells treated with BFA. In order to show that the absence 
of IL-1β in the supernatant is not due to a transport defect, cells were stimulated with LPS 
plus ATP and treated with BFA (Fig. 4.6C). The results showed that in these cells 
inflammasome activation was not blocked by BFA. Thus indicating that localisation of 
2B in the Golgi is essential for triggering inflammasome activation. 
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Figure 4.5 Localisation of 2B, NLRP3 and NLRC5 in the Golgi. Cells were rinsed 
twice in PBS/0.02% BSA, prior to fixation with 4% formaldehyde for 15 min. Followed 
by permeabilisation using PBS/0.02% BSA/0.02% Saponin. and then stained with 
GM130 mAb followed by Alexa 546-Fab mouse specific Ig to label the golgi system. 
Anti NLRC5 specific antibody conjugated to Alexa 633 and anti NLRP3 antibody 
conjugated directly to Alexa 488 were used (A).  
Bronchial epithelial cells were transfected with p2B-myc at 24 h post transfection cells 
were fixed and permeabilised. An anti myc antibody conjugated to FITC was used to label 
the 2B  protein. The golgi sytem was stained with an anti GM130 mAb followed by Alexa 
546-Fab mouse specific Ig. Anti NLRP3 antibody conjugated directly to Alexa 633 (B) 
or anti NLRC5 antibody conjugated to Alexa 633 (C)) were used. Cells were imaged 
using a Zeiss 510 confocal microscope. Bars 10 µm. The data presented is the mean of 
four independent experiments. The merged images show no apparent localization 
between NLRP3 and golgi before the presence of 2B, whereas there is extensive 
colocalisation between NLR3, NLRC5 or ASC and the Golgi when 2B is present. 
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Figure 4.6 (a) Redistribution of 2B. NLRP3 and NLRC5 prior to Brefeldin A 
treatment. Bronchial cells transfected with p2B-myc at 24 h post transfection were used. 
Golgi was stained with GM130 mAb followed by Alexa 546-Fab mouse specific Ig. An 
anti myc antibody conjugated to FITC was used to label the 2B  protein. Cells were 
stained for NLRP3 using a rabbit anti NLRP3 Fab conjugated to Alexa 633 or a goat anti 
NLRC5 conjugated to Alexa 647. The distribution of NLRP3 (A) and NLRC5 (B) in cells 
transfected with 2B is depicted.  
 
 [134] 
 
 
Figure 4.6 (b)Redistribution of 2B. NLRP3 and NLRC5 post Brefeldin A treatment. 
Bronchial cells transfected with p2B-myc at 24 h post transfection cells were treated with 
10µg/ml Brefeldin A. Golgi was stained with GM130 mAb followed by Alexa 546-Fab 
mouse specific Ig. An anti myc antibody conjugated to FITC was used to label the 2B  
protein. Cells were stained for NLRP3 using a rabbit anti NLRP3 Fab conjugated to Alexa 
633 or a goat anti NLRC5 conjugated to Alexa 647. The distribution of NLRP3 (A) and 
NLRC5 (B) in cells transfected with 2B is depicted (4.6 A).  Following treatment with 
BFA the distribution of NLRP3 and NLRC5 is shown in panel C and D respectively (The 
merged images show a reduced degree of colocalisation between 2B and the Golgi). 
Supernatants were also collected and tested for IL1β secretion using the CBA bead array 
system (BectonDickinson) from unstimulated (mock) or transfected with 2B (E). The data 
presented is the mean of three independent experiments. 
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4.3 Discussion 
Respiratory viral infections, especially HRV, a member of the Picornaviridae family are 
a major cause of asthma and COPD, being associated with over 50% of COPD 
exacerbations (Johnston et al. 1995, Seemungal et al. 2001). The presence of an upper 
respiratory tract infection leads to a more severe exacerbation and a longer recovery time. 
Exacerbations are associated with increased airway inflammation and increased IL6 and 
TNFα production in addition IL-1β levels are enhanced within the airways of patients 
with COPD or asthma, with further increases detected during acute exacerbations (de 
Kluijver et al. 2003, Fleming et al. 1999, Terajima et al. 1997). Furthermore, epithelial 
and monocytic cells (PBMCs and alveolar macrophages) taken from such patients 
respond to inflammatory stimuli with greater IL-1β production (Hallsworth et al. 1994). 
IL-1β is an important proinflammatory mediator that is generated at sites of injury or 
immunological challenge to coordinate programs such as cellular recruitment to a site of 
infection or injury. Proinflammatory stimuli induce expression of the inactive IL-1β 
precursor but cytokine maturation and release are controlled by inflammasomes.  
Several multimolecular proteins complexes comprised of members of the nucleotide 
binding domain leucine-rich repeat containing (NLR) family referred to as 
inflammasomes, have been identified as caspase-1 activators. These molecules activate 
caspase 1 and thus control the second, required step of IL- 1β cytokine activation 
(Martinon et al. 2002). 
In this study we investigated the involvement of inflammasome and IL1β release in 
human rhinoviruses infection in Primary bronchial cells which is a clinically relevant cell 
type, for viral respiratory infection. There is an increasing number of studies linking 
asthma and COPD exacerbations with viral respiratory infections, especially rhinovirus 
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infections and only by understanding the mechanisms for the persistence of inflammation 
may lead to new therapeutic approaches. 
By silencing different NLRs we discovered that rhinovirus infection activates NLRP3 and 
NLRC5 which leads to caspase 1 activation and IL1β production. To investigate how 
rhinoviruses stimulate inflammasome activation we looked at rhinovirus proteins that 
might enhance membrane permeability  since it has been shown that the NLRP3 
inflammasome can be activated by pore-forming toxins secreted by bacteria (Koizumi et 
al. 2012). The rhinovirus 2B protein, one of the nonstructural proteins involved in viral 
RNA replication, was a possible candidate for inflammasome activation since it has been 
shown that the 2B protein from Coxsackievirus another member of the Picornaviridae 
family forms membrane-integral pores, thereby increasing the efflux of Ca2+from the 
stores (van Kuppeveld et al. 1997).  
Therefore we transfected a plasmid expressing rhinovirus 2B protein p2B-myc into 
Primary bronchial cells. Our results showed that 2B protein activates inflammasomes and 
more specifically NLRP3 and NLRC5. NLRP3 has been shown to recognize a variety of 
ligands, however NLRC5 role in innate and adaptive immune responses remains 
controversial. NLRC5 has been implicated in regulating inflammasome signalling (Davis 
et al. 2011) either as a positive (Neerincx et al. 2010) or negative regulator (Benko et al. 
2010). Here we see that NLRC5 like NLRP3 can recognize rhinovirus 2B protein 
independently and trigger IL1β secretion. To discover the mechanism of inflammasome 
activation by 2B we looked at Ca2+levels using Fluo3-AM. The data revealed an increase 
in cytosolic Ca2+ when 2B was transfected.  
Tracking rhinovirus 2B protein intracellularly showed that it localised partially in the ER 
but mainly in the Golgi with NLRP3 and NLRC5. When the Golgi was disrupted using 
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BFA, caspase 1 activation and IL1β secretion was disrupted verifying that localisation to 
the Golgi is a prerequisite for inflammasome activation. Furthermore by using 2B ER and 
Golgi specific targeted constructs we confirmed that Golgi complex localisation of 
picornavirus 2B but not endoplasmic reticulum localization is a pre-requisite for NLR 
activation. 
The ability of 2B viroporin to localise to the Golgi complex suggests that the NLRP3 and 
NLRC5 inflammasomes mechanism of activation in rhinovirus infection is by sensing the 
imbalances in Ca2+ intracellular homeostasis.  
When Ca2+ inhibitors and chelators were used to inhibit inflammasome activation, it was 
shown that BAPTA-AM and verapamil were able to inhibit IL1β secretion induced by 
HRV infection thus indicating that calcium inhibitors could be used in the future to 
control exacerbated IL1β production which is often found in viral inflammatory airway 
disease. 
NLRs have been shown to have different roles in separate cell types (Ting et al. 2010).  
There is emerging evidence which suggests that during bacterial infections, multiple NLR 
inflammasomes have the potential to become activated. For example Candida albicans 
leads to up-regulation of NLRP3 and NLRC4 inflammasome in the oral mucosa (Tomalka 
et al. 2011).  The mechanisms that govern pathogen-induced inflammasome activation 
remain poorly characterized, and the contribution of individual NLRs has not been fully 
elucidated. Here we show that infection of primary bronchial cells with HRV leads to 
NLRP3 and NLRC5 activation and IL1β secretion. The overlapping biologic functions 
and pathogen specificity of NLRC5 with NLRP3 suggests that these proteins might act 
in a cooperative manner during the inflammasome assembly.  
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NLRP3 expression is inducible following several infections of bacteria or viruses 
(Kanneganti 2010, Kanneganti et al. 2006).  
 However there could be a tissue specific role for the NLRC5 inflammasome in host 
sensing and immune defence thus explaining why viral respiratory infections lead to 
greater airway inflammation and more severe exacerbations since rhinovirus respiratory 
infections can be detected by both NLRP3 and NLRC5.  
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Chapter 5 
Human respiratory syncytial virus viroporin SH signals inflammasome activation 
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5.1 Introduction 
Respiratory syncytial virus (RSV) remains the leading cause of serious viral bronchiolitis 
and pneumonia in infants and young children throughout the world. The burden of disease 
is significant, with 70% of all infants being infected with RSV within the first year of 
their life (Hall 1999). It is the most common cause of hospitalisation in infants and of 
acute respiratory failure in paediatric intensive care units. 40% of those children 
discharged from hospital have recurrent, repeated respiratory symptoms and wheezing 
for at least 10 years (Simoes 1999). The infection is also important in the elderly and 
immunocompromised individuals. The pathology of the virus is associated with innate 
immunity and skewed immune responses towards a Th2 phenotype (Becker 2006, Pinto 
et al. 2006).   
One cytokine that is associated with RSV infection is IL-1β. Although this cytokine has 
been shown to be secreted by RSV-infected airway cells (Schmitz et al. 2005), the 
question that remains is what the mechanism of inflammasome activation is? It is now 
emerging that Inflammasomes are multiprotein complexes that act as a platform for the 
activation of caspase 1 which in turn cleaves pro-IL1β and pro-IL18 resulting into their 
secretion (Martinon et al. 2009). 
Since inflammasomes have been shown to be triggered by diverse ligands, it has been 
suggested that two or potentially more signals are required for full activation. The first or 
priming signal can by triggered from a transcriptionally active PRR or cytokine receptor, 
this leads to transcriptional activation of the genes encoding pro-IL1β and pro-IL18 
(Bauernfeind et al. 2009). The second signal is triggered in response to various stress 
signals associated with damaged self (Martinon et al. 2009).  
The question that arises is how is IL-1𝛽 triggered in response to RSV infection and which 
is the “priming” step that leads to IL-1β secretion. A recent study by Segovia et al has 
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shown that RSV triggers NLRP3 activation via ROS production. Although this study has 
provided some clues, it hasn’t revealed which part of the virus triggers this inflammation 
and the mechanism of NLRP3 activation remains unknown.  
In the current study we have attempted to shed more light into the mechanisms of RSV-
induced inflammasome activation. 
5.2 Results  
5.2.1 RSV infection activates the NLRP3 inflammasome 
In order to determine if RSV is detected by the inflammasome, we investigated 
inflammasome activation by measuring IL1β secretion from primary RSV infected lung 
epithelial cells. RNA viruses such as vesicular stomatitis virus (VSV), and 
encephalomyocarditis virus EMCV as well as a DNA virus Herpes simplex virus (HSV1) 
were also compared to RSV  
The data showed that RSV infection resulted in IL1β secretion within 6hr (Figure 5.1a A) 
IL1β secretion was not observed in infections with the other viruses. To verify if IL1β 
secretion was NLRP3 specific, NLRP3 expression was knocked down by psiRNA which 
resulted in a reduction in IL1β secretion (Figure 5.1a B) thus verifying that RSV is 
detected by the NLRP3 inflammasome. IL-6 secretion was measured as a control for the 
psiRNA effect since it is independent of inflammasome activation but is a known marker 
for NF-kB activation. All of the tested viruses triggered IL-6 secretion, but only RSV was 
detected by the inflammasome in these unprimed cells. 
5.2.1.1 RSV triggers pro-IL1β secretion 
IL1β secretion requires two signals: transcription of pro-IL1β (signal 1) and processing 
by caspase 1 (signal 2). To examine whether RSV infection provides the transcriptional 
signal, we infected cells with RSV and examined the pro-IL1β response via western 
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blotting. RSV infection induced a pro-IL1β response while infection by the other viruses 
did not (Figure 5.1b C). 
 
Figure 5.1 (a) RSV infection activates the NLRP3 inflammasome. Lung epithelial 
cells were infected with 100PFU of RSV or ECMV or VSV or HSV1 viruses. Supernatant 
was collected at 12hr post infection and analysed for IL1β and IL6 using the CBA bead 
array system on a FACSCalibur (Becton Dickinson) (A). 
NLRP3 expression was knocked down by psiRNA and the cells were again infected with 
5moi of RSV or ECMV or VSV or HSV1 viruses. Supernatant was collected at 12hr post 
infection and analysed for IL1β and IL6 using the CBA system (B) 
 
 
 
 
 
 [143] 
 
 
 
Figure 5.1(b) RSV infection activates the NLRP3 inflammasome. Lung epithelial cells 
were infected with 100PFU of RSV or ECMV or VSV or HSV1 viruses.  
Cells extracts from infected lung epithelial cells were analysed for the presence of pro- 
IL1β by western blotting and loading controls for β-actin are also depicted (C). The data 
represent the mean of three independent experiments. 
5.2.1.2 TLR signalling is required for inflammasome activation. 
RSV is detected by different PRRs such as TLR4 (Kurt-Jones et al. 2000), TLR7 
(Davidson et al. 2011), TLR3 and RIG-I (Liu et al. 2007). To determine if they also play 
a role in inflammasome activation we individually knocked down RIG-I, TLR3, TLR4, 
TLR7 or TLR8 in RSV-infected cells as well as TLR2 (Figure 5.2). Only the knocking 
down of TLR4 resulted in a reduction in expression of pro-IL1β and IL1β. IFNβ secretion 
was not reduced by knocking down any of these molecules, showing that the IL1β 
reduction was specific. TLR4 therefore appears to be required for signal 1, the 
transcription of pro-ILβ that results in the subsequent release of mature IL1β by RSV 
infection.  
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However some IL1β was still produced leading us to believe that in addition to the 
established TLR sensors there could yet exist an additional mechanism for triggering IL1β 
production.  
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Figure 5.2 (a) TLR4 provides the first or priming signal of activation. 
Lung epithelial cells were infected with 100PFU of RSV and the presence of pro- IL1β 
by western blotting was examined as well as the secretion of IL1β and IFNβ using the 
CBA system. RIG-I expression was knocked down by psiRNA and the cells were again 
infected and examined for pro- IL1β as well as IL1β and IFNβ secretion (A).TLR3 
expression was knocked down by psiRNA and the cells were again infected and tested 
for pro- IL1β as well as IL1β and IFNβ secretion (B). TLR7 expression was knocked 
down by psiRNA and the cells were again infected and tested for pro- IL1β as well as 
IL1β and IFNβ secretion(C). TLR4 expression was knocked down by psiRNA and the 
cells were again infected and tested for pro- IL1β as well as IL1β and IFNβ secretion (D). 
The data represent the mean of three independent experiments. 
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Figure 5.2 (b) TLR4 provides the first or priming signal of activation. 
Lung epithelial cells were infected with 100PFU of RSV and the presence of pro- IL1β 
by western blotting was examined as well as the secretion of IL1β and IFNβ using the 
CBA system. TLR8 expression was knocked down by psiRNA and the cells were again 
infected and tested for pro- IL1β as well as IL1β and IFNβ secretion (E). TLR2 expression 
was knocked down by psiRNA and the cells were again infected and tested for pro- IL1β 
as well as IL1β and IFNβ secretion (F). The data represent the mean of three independent 
experiments.  
 
 
 
 
5.2.1.3 SH mediated mechanism of inflammasome activation 
To discover how RSV infection triggers signal 2 we looked at RSV viral proteins which 
enhance membrane permeability since It has been shown that the influenza M2 ion 
channel induces inflammasome activation, by modulating the intracellular K+ 
concentration (Ichinohe et al. 2010).  
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The RSV small hydrophobic protein (SH) has been classified as a viroporin. It alters 
membrane permeability displaying properties of a cation selective ion channel (Gan et al. 
2012, Kochva et al. 2003). SH is not essential for viral replication in vitro (Bukreyev et 
al. 1997). However, deletion of the SH gene leads to attenuation in mouse and chimpanzee 
models, suggesting it is important for infectivity in vivo (Bukreyev et al. 1997; Whitehead 
et al. 1999).   
To test the role of SH in inflammasome activation an SH deletion mutant RSV rgRSV-
GF (ΔSHRSV)  (Techaarpornkul et al. 2001)  was used. The ΔSHRSV mutant has been 
shown in previous studies to grow and replicate efficiently in cell culture (Bukreyev et al. 
1997). The infection with rgRSV-GF failed to induce caspase activation and release of 
IL1β (Figure 5.3A). However rgRSV-GF infected cells released IL6 a non-inflammasome 
cytokine, IFNβ and pro-IL1β. RSV infection induced caspase 1 production while rgRSV-
GF infection did not. Together these results indicate that SH plays an essential role in 
triggering signal 2 leading to caspase 1 production and inflammasome activation (Figure 
5.3).  
To investigate the mechanism of SH induced inflammasome activation   (Techaarpornkul 
et al. 2001) we infected cells with RSV or with rgRSV-GF and used drugs that block the 
ion channel of several other viroporins, such as Amantadine, Rimantadine which block 
the influenza M2 channel and hexamethylene amiloride (HMA) which blocks the HIV 
Vpu channel as well as the p7 channel of Hepatitis C virus to obtain further understanding 
of the channel properties of SH protein (Figure 5.4)  
HMA was successful in inhibiting IL1β secretion upon RSV infection. However there 
was no downregulation when amantadine or rimantadine were used. Having observed the 
effect of HMA, we then examined the effect of other ion channel inhibitors: 5-(N-ethyl-
N-isopropyl)amiloride (EIPA) and benzamil, which also block Na+/H+ ion channels, and 
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verapamil, which blocks Ca+ channels. Verapamil had no effect on IL1β secretion 
whereas HMA, EIPA and benzamil reduced IL1β secretion in RSV infection. These 
results suggest that SH displays is selective for monovalent cations (Na+ and K+) similar 
to the HCV p7 protein (Figure 5.4).  
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Figure 5.3 (a) RSV and ΔSHRSV mediated mechanism of inflammasome activation. 
Lung epithelial cells were either infected with RSV or ΔSHRSV. Cell supernatant was 
collected and tested for IL1β, IL6 and IFNβ secretion. The data presented are the mean 
of three independent experiments. 
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Figure 5.3 (b) RSV and ΔSHRSV mediated mechanism of inflammasome activation. 
Cells extracts from infected lung epithelial cells were analysed for the presence of pro-
IL1β and Caspase p10 by western blotting. The data presented are the mean of three 
independent experiments. 
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Figure 5.4 (a) Effects of ion channel inhibitors on inflammasome activation. 
Lung epithelial cells with infected with RSV and cultured in the presence or absence of 
HMA or amantadine for 12 hrs. Supernatants were collected and tested for IL1β and IL6 
secretion using the CBA bead array system (BectonDickinson). Fluorescence was 
detected using a FACSCalibur(BectonDickinson) The data presented are the mean of 
three independent experiments. 
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Figure 5.4 (b) Effects of ion channel inhibitors on inflammasome activation. 
Lung epithelial cells with infected with RSV and cultured in the presence or absence of 
Rimantadine or EIPA, or benzamil or verapamil for 12 hrs. Supernatants were collected 
and tested for IL1β and IL6 secretion using the CBA bead array system 
(BectonDickinson). Fluorescence was detected using a FACSCalibur(BectonDickinson) 
The data presented are the mean of three independent experiments. 
 
5.2.2 SH interactions 
To elucidate the intracellular mechanism by which SH activates NLRP3 inflammasome 
we examined SH trafficking in the cell. Previous studies have shown that RSV assembly 
and SH accumulation occurs within lipid raft structures on the cell surface and into lipid 
raft domains in the Golgi network(Rixon et al. 2004). 
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Lung cells were infected with RSV fixed and permebealised with 0.2% saponin. An anti-
SH antibody previously described was used for SH labelling. The SH protein localised at 
the endoplasmic reticulum and Golgi complex membranes. Whereas NLRP3 was 
distributed in the cytoplasm and after RSV infection much of the NLRP3 as well as ASC 
was found in the Golgi (Figure 5.5).  
To analyse the role of lipid raft membranes within the Golgi complex in SH induced 
inflammasome activation, cells infected with RSV were treated with nystatin which 
disrupts lipid rafts. The cells were imaged and the images showed that NLRP3 and ASC 
re-distribution followed nystatin treatment of infected cells, thus showing that lipid raft 
disruption inhibited inflammasome activation since the re-distribution of NLRP3 and 
ASC will inhibit their interactions and formation of inflammasome (Figure 5.6A, B). 
Furthermore, IL1β production in RSV-infected cells was dramatically reduced after 
nystatin treatment (Figure 5.6D). 
To verify the importance of Golgi co-localisation in inflammasome activation we utilized 
Brefeldin A (BFA). The fungal metabolite BFA has been known to induce rapid and 
reversible disassembly of the Golgi stack into tubules and vesicles (Lippincott-Schwartz 
et al. 1989, Misumi et al. 1986).  
Treatment with BFA disassembled the Golgi and resulted in NLRP3 and ASC 
redistribution (Fig. 5.6C) which blocked inflammasome activation by RSV since there 
was no IL1β production in the supernatant of cells treated with BFA(Fig. 5.6D). 
 
 
 
 [154] 
 
 
Figure 5.5 (a) Localisation of SH in the Golgi. Lung epithelial cells were stimulated 
with RSV for 6hr and then stained with GM130 mAb followed by Alexa 488-Fab mouse 
specific Ig to label the Golgi system. An anti SH antibody was used to label the SH RSV 
protein followed by Alexa 546-Fab mouse specific Ig. The nucleus was labelled using the 
nuclear stain Topro-3 (A) 
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Figure 5.5 (b) Localisation of SH, NLRP3 and ASC in the Golgi. Lung epithelial cells 
were stimulated with RSV for 6hr and then stained with GM130 mAb followed by Alexa 
488-Fab mouse specific Ig to label the Golgi system. Ustimulated cells (B, C) or cells 
stimulated with RSV for 6hrs (D, E) were stained for NLRP3 using a rabbit anti NLRP3 
Fab conjugated to Alexa 546 or a goat anti ASC Fab conjugated to Alexa 546. The nucleus 
was labelled using the nuclear stain Topro-3. Yellow regions indicate localisation of 
receptors. Cells were imaged using a Zeiss 510 confocal microscope. Bars 10 µm. The 
data are a representative of four independent experiments. 
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Figure 5.6 (a)  NLRP3, ASC redistribution by nystatin and BFA treatment. Lung 
epithelial cells were stimulated with RSV and then either left untreated (A) or cultured 
with 25 µM nystatin (B) or 10 µM BFA (C). Golgi was stained with GM130 mAb 
followed by Alexa 488-Fab mouse specific Ig. Cells were stained for NLRP3 using a 
rabbit anti NLRP3 Fab conjugated to Alexa 546 and a goat anti ASC Fab conjugated to 
Alexa 647. Cells were imaged using a Zeiss 510 confocal microscope. Bars 10 µm. The 
data presented are the mean of four independent experiments. 
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Figure 5.6 (b) Supernatants were collected from lung epithelial cells stimulated with 
RSV (or left unstimulated) and cultured in the absence or presence of 25 µM nystatin or 
10 µM BFA  and tested for IL1β secretion using the CBA bead array system (Becton 
Dickinson). The data presented are the mean of four independent experiments. 
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5.3 Discussion 
In this study it was shown that RSV is capable of triggering NLRP3 activation. This is in 
agreement with the recent study by (Segovia et al. 2012). The data clearly demonstrates 
that RSV is able to trigger NLRP3 inflammasome activation on its own, without the need 
for priming the cells with another PAMP as it has previously been proven necessary for 
other viruses, such as encephalomyocarditis virus and vesicular stomatitis virus (Rajan et 
al. 2011). RSV appears to be able on its own to provide both signal 1 and signal 2 for 
inflammasome activation. The question that remains is how are signal 1 and 2 triggered?  
 
In order to answer this question, the induction of signal 1 in RSV infection was 
investigated. There are many potential PRRs that might trigger signal 1 in the case of 
RSV, such as TLR4 (Kurt-Jones et al. 2000), TLR7 (Davidson et al. 2011), TLR3 and 
RIG-I (Liu et al. 2007). In order to investigate whether one or more of these PRRs trigger 
signal 1, siRNA was used to knock down their expression and the secretion of IL1β was 
monitored. Reduction in transcription of IL1β secretion was seen only when TLR4 was 
knocked down, suggesting that TLR4 is solely responsible for triggering signal 1 of RSV-
induced inflammasome activation.  
TLR2 knock down had no effect in IL1β secretion. These findings are contrary to those 
by Segovia et al, who have reported that TLR2 triggers these responses.  The differences 
observed in the two studies, might be due to the different cell types used. The study of 
Segovia et al. was mainly performed on mouse knockout cells. This study was performed 
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in human lung epithelial cells. These cells are the main target of human RSV in vivo. In 
a mouse model, RSV might be detected by different PRRs.  
 Once it was demonstrated that signal 1 is triggered by TLR4, the mechanism of 
the induction of signal 2 was also investigated. Three models have been proposed. One 
model supports that extracellular ATP triggers K+ efflux (Kanneganti et al. 2007)   and 
induces NLRP3 recruitment, another the release of lysosomal contents caused by 
lysosome disruption (Halle et al. 2008, Hornung et al. 2008) and NLRP3 activation due 
to production of ROS (Dostert et al. 2008).  
RSV viral proteins that might enhance membrane permeability were also examined since 
it has been shown that the influenza M2 ion channel induces inflammasome activation, 
by modulating the intracellular K+ concentration (Ichinohe et al. 2010). The RSV SH 
protein has been classified as a viroporin. During the infection of cells by the virus, 
membrane permeability is modified by the use of viroporins which facilitate virus entry. 
The main activity of viroporins is to create pores at biological membranes to permit the 
passage of ions and small molecules, this is useful both in the entry as well as the exit 
mechanism of the virus.  
In order to determine whether RSV SH protein contributes to NLRP3 activation 
RSV mutants lacking the viroporin SH were used. These mutants have been shown in 
previous studies to grow and replicate efficiently in cell culture (Bukreyev et al. 1997). 
The results demonstrated that the RSV mutants lacking the viroporin SH are unable to 
trigger inflammasome activation, thus suggesting that signal 2 is triggered from the SH 
protein, possibly by the formation of a pore or channel on the plasma membrane. RSV 
SH protein joins an increasing list of viral proteins that have been shown to form ion 
channels in lipid bilayers, including  Picornavirus 2B, (Agirre et al. 2002, van Kuppeveld 
et al. 1997) HIV-1 Vpu (Cohen et al. 1988, Sakai et al. 2003) and HCV p7 which are 
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permeable to both Na+ and K+ ions, and display relatively low ion selectivity 
(Premkumar et al. 2004), as well as M2 influenza viroporin which exhibits proton 
conductance and has been shown to activate the NLRP3 inflammasome (Ichinohe et al. 
2010). 
The use of drugs which block viral ion channels were shown to be able to inhibit IL1β 
secretion induced by RSV infection suggesting that SH functions similarly to HCV p7 
which is selective for monovalent cations (Na+ and K+). 
It has previously been shown that SH associates with lipid rafts on the cell surface, but 
after internalisation it accumulates in the Golgi complex within membrane structures that 
are enriched with the lipid raft marker, GM1(Rixon et al. 2004). Our studies confirmed 
that SH was indeed localised intracellularly in the Golgi membranes. Interestingly, 
NALP3 was also shown to accumulate in the Golgi apparatus upon RSV infection. 
Lipid rafts are specialized membrane microdomains which provide a favourable 
environment for intra-molecular cross talk but also aid to expedite signal transduction. 
Several new studies have found accumulation of ion channels and their modulators in 
lipid rafts (Dart 2010, Martens et al. 2004), which is in agreement with our findings. Lipid 
rafts are not only on the plasma membrane, but have been shown to accumulate in the 
Golgi network as well. Their function there is believed to be the sorting of secretory cargo 
and in the case of RSV, it might be taking advantage of that for its exit mechanism. 
The data from this study show that upon infection with RSV, the SH protein is targeted 
to the Golgi where it must function as an ion channel. In addition, there is trafficking of 
NLRP3 from the cytoplasm to the Golgi where it localises within lipid rafts structures 
there. These intracellular raft structures seem to be crucial for the accumulation of ion 
channels and their modulators. Sensing of cellular stress imposed by imbalances in ionic 
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concentrations in intracellular vesicles could be a general viral recognition pathway that 
can be utilised by the infected host cell to signal the activation of NLR inflammasomes. 
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CHAPTER 6 
INNATE IMMUNE RESPONSE TO INFLUENZA A VIRUS (H3N2) 
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6.1 Introduction          
The Influenza virus (IAV) is a seasonal infection associated with significant morbidity 
and mortality. IAV causes annual epidemics that affect approximately 5 million people 
worldwide. It is a negative stranded RNA virus causing severe illness in humans and 
animals. Until recently, cellular recognition of IAV was thought to be mediated by  
(TLRs) 3, 7/8, which recognize dsRNA and , ssRNA (Kawai and Akira 2006) and RIG-I 
(Pichlmair et al. 2006). 
More recently, several groups have demonstrated an important role for the 
inflammasome, in particular NLRP3, in the cellular recognition of IAV and the release of 
IL1β (Allen et al. 2009, Ichinohe 2009). The activation of the NLRP3 inflammasome and 
production of IL-1β usually requires two signals (Schroder and Tschopp 2010) . In the 
case of IAV, viral RNA is a trigger and Toll-like receptor 7 (TLR7) signalling is required 
for the transcription of pro-IL-1β, while the IAV  M2 channel was shown to trigger signal 
2 for the activation of NLRP3 inflammasome (Ichinohe et al. 2010). The M2 channel is 
a viroporin involved in viral genome replication as well as virus particle entry into and 
release from infected cells 
 
  Upon IAV infection, NLRP3 traffics to the Golgi apparatus in primed dendritic cells and 
macrophages (Ichinohe et al. 2010). Acidification of the Golgi apparatus was essential 
for influenza-induced activation of inflammasomes, thus showing the importance of 
intracellular pH in inflammasome activation. 
However most of these studies are performed on dendritic cells or mouse models and 
there is not a lot of information on whether IAV triggers inflammasome assembly in the 
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lung or respiratory tract. Thus by using a tissue tropic IAV strain I investigated 
inflammasome activation in human bronchial cells infected by IAV.  
 
 
6.2.1 PRR Expression Levels in IAV infection   
Bronchial Epithelial Cells (BES) were infected with H3N2 (100PFU) in order to 
determine the regulation of PRRs such as RIG-I, MDA-5  and were monitored at different 
time points (1h,2h, 4h, 6h,12h). Unstimulated cells were checked for receptor expression 
levels at 0hr. Detection of the expression levels were determined by using indirect 
Immunofluorescence and measuring the Fluorescence intensity (Fig. 6.1). Significant 
increase in the expression levels of RIG-I and MDA5 were observed when stimulated 
with the virus showing slight preference for RIG-I expression over MDA5. We also 
observe slight upregulation of NLRP3.  
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Figure 6.1 (a)  PRR expression levels in cells stimulated with H3N2. BES were infected 
with 100 PFU viral stock (H3N2). Following infection PRR expression was tested at 
different time points using the appropriate primary antibody followed by a secondary 
conjugated to FITC. Receptor expression was determine as the Geo.Mean of Fluorescent 
intensity. Fluorescence was detected using a FACSCalibur (BectonDickinson) The data 
represent the mean of three independent experiments. 
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Figure 6.1 (b)  PRR expression levels in cells stimulated with H3N2. BES were infected 
with 100 PFU viral stock (H3N2). Following infection PRR expression was tested at 
different time points using the appropriate primary antibody followed by a secondary 
conjugated to FITC. Receptor expression was determine as the Geo.Mean of Fluorescent 
intensity. Fluorescence intensity was detected using a FACSCalibur (Becton Dickinson, 
Oxford, UK) counting 10,000 cells not gated. Isotype controls were performed, with 
values similar to unstimulated samples. The data represent the mean SD of 3 independent 
experiment, indicating statistically significant (P < .05) increase in expression compared 
with corresponding unstimulated controls. 
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6.2.2 Innate immune responses to IAV   
To determine whether IAV triggers innate immune responses in the bronchi, BES were 
infected with 100 PFU viral stock (H3N2) for 1hr, 2hr, 4hr, 6hr and 12 hrs. Cell lysates 
were collected and analysed for Phospho-IκB and IRF3. A gradual increase in Phospho-
IκB production is seen from 1hr through to 12 hrs stimulations (fig 6.2). IRF3 
dimerisation is also observed at these timepoints. 
  
Figure 6.2    IRF3 and Phospho-IκB detection. BES were infected with 100 PFU viral 
stock (H3N2) for 1hr, 2hr, 4hr, 6hr and 12 hrs or left unstimulated (Uns).Cell lysates were 
collected and analysed for Phospho-IκB and IRF3 using SDS-PAGE gel electrophoresis 
and western blot. Primary antibodies specific for IRF3 or phospho-IκB were used  
followed by the appropriate secondary antibodies conjugated to HRP. Loading controls 
for β-actin are also depicted. The bottom panel shows a quantitative analysis (by 
densitometry) of IRF3 and Phospho-IκB.  The bands were visualised using the ECL 
procedure. The data is a representative of two independent experiments.    
 
6.2.3 IFN-β and IL1β  Production 
Since there was NFkB signalling induced by IAV, I also investigated IFN-β and IL1β 
secretion since both RIG-I and NLRP3 have been shown to be involved in IAV detection 
by the host. Thus BES cells were infected with 100PFU of  H2N2 and left to incubate  1, 
2, 4, 6 and 12 hours and then supernatants were collected. The supernatants added to HEK 
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IFNβ or HEK IL1β reporter cells and incubated for 24 hours. Quanti-Blue was added and 
the levels of SEAP measured using a spectrophotometer at 630nm. The SEAP levels 
correspond to the expression levels of IFNβ/ IL1β.  
IFN-β is a type I IFN, which signals through the IFN-α/β receptor and the Jak-STAT 
pathway to drive interferon stimulated gene (ISG) expression and an innate immune 
response. 
 
Figure 6.3 – IFNβ/ IL1β response in H3N2 infections of Bronchial cells. Supernatant 
from BES cell infections with 100PFU of H3N2 for 1, 2, 4, 6 and 12 hours was added to 
HEK IFNβ/ HEK IL1β reporter cells and incubated for 24 hours. Quanti-Blue was added 
and the levels of SEAP measured using a spectrophotometer at 630nm. The SEAP levels 
correspond to the expression levels of IFNβ/ IL1β. 
An elevated level of IL-1β and IFN-β production is observed. This suggests that 
inflammation occurs as a result of IAV infections of the lung cells. From the IFNβ 
response, it seems that RLRs recognise viral invasion as well and stimulate the ISG 
resulting in the secretion of IFN-β. 
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6.2.4  H3N2 activates the Inflammasome     
 
NLRP3 forms a multiprotein complex with the adaptor protein ASC (pycard) and 
caspase-1, which leads to the catalytic cleavage of the immature (‘pro’) forms of 
interleukin 1β (IL-1β), IL-18 and IL-33. Inflammasome-mediated cytokine release via 
NLRP3 requires caspase 1 activation) (Ichinohe et al. 2010). Thus the presence of p10 
the active component of caspase 1 was determined in infected cell lysate. The data showed 
a gradual increase in Caspase-1 p10 production from 1hr through to 12hr timepoints post 
viral infection. The absence of Caspase-1 p10 in unstimulated cells verifies that viral 
stimulation is indeed required for inflammasome activation.   
 
 
 
Figure 6.4 Caspase-1 (p10).  Bronchial Cells (BES) were infected with 100 PFU viral 
stock (H3N2) for 1hr, 2hr, 4hr, 6hr and 12 hrs or left unstimulated (Uns). Cell lysates 
were collected and analysed for Caspase 1 (p10) using SDS-PAGE gel electrophoresis 
and western blot. Primary antibodies specific for Caspase-1(p10) or ASC were used 
followed by the appropriate secondary antibodies conjugated to HRP. Loading controls 
for β-actin are also depicted. The bottom panel shows a quantitative analysis (by 
densitometry) of Caspase-1 (p10). The bands were visualised using the ECL procedure. 
This data is a representative of two independent experiments.  
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6.2.4 .1 NLRP3 inflammasome activation 
In order to determine  which NLR  is activated , Different NLRs (NLRP3, NLRC5 and 
NALP1) were silenced using shRNA . The silenced cells were then infected with H3N2 
(100PFU). Th  the presence of Caspase-1 in the transfected cells was investigated via 
western blotting(figure 6.5).  
 
 
Figure 6.5 Bronchial epithelial cells were transfected with shRNA to knock down 
the levels of NLRC5, NLRP3 and NALP1. The transfected cells were then infected with 
H2N2.  The cells were analysed for the presence of Caspase-1(p10) by western blotting. 
Primary antibodies specific for Caspase 1 (p10) were used followed by the appropriate 
secondary antibodies conjugated to HRP. The bands were visualised using the ECL 
procedure. This data is a representative of two independent experiments 
It is observed that silencing NLRP1 and NLRC5 did not abrogate Caspase-1p10 
production. Hence NLRC5 and NLRP1 are not involved in IAV detection. However on 
the contrary knocking down NLRP3 had a dramatic effect on Caspase-1 p10 production 
by completely abrogating it. Since Caspase-1 production directly correlates with 
inflammasome activation, NLRP3 inflammasome is the main sensor of IAV in BES cells 
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6.2.5 Effects of different Inhibitors in IAV infection 
In order to determine the mechanism of NLRP3 activation, different ion channel 
inhibitors were used since it has been shown that M2 plays a role in inflammasome 
recruitment.  BES cells were treated with Adamantanes which are a class of known 
antiviral drugs that has been used in the past and still currently in use, to treat Influenza 
virus A infections (Jing et al. 2008). Adamantanes have two derivatives: Rimantadine and 
Amantadine which in this experiment has been used to treat bronchial cells post infection 
with H3N2.  
ROS inhibitor N-acetyl-L-cysteine was also used (Halasi et al. 2013) in order to study the 
effect it might cause on inflammasome production. A calcium inhibitor such as Verapamil 
was also used.  
The best working concentrations for the drugs were ROS inhibitor N-acetyl-L-cysteine 
(10μM), Verapamil (50μM), Rimantadine (10μM) and Amantadine (10μM).  
Supernatants containing the virus was removed and the cells were washed. The drugs 
were added along with fresh medium and incubated for 12 hours. Viability assays prior 
to infection were performed to verify that the drugs had no lethal effect on the cells. 
The supernatant was collected for cytokine analysis. The cells were lysed and analysed 
for the presence of Caspase 1 (p10) via Western Blotting. 
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Figure 6.6 Effects of drugs on H3N2 induced Inflammasome activation. BES cells 
were first infected with H3N2 for 12 hours and then treated with different inhibitors and 
left to incubate for a further of 12 hours. As controls cells were either left unstimulated 
or treated with virus but no inhibitors. All cells were lysed in X2 reducing buffer and 
analysed for the presence of Caspase-1 (p10). Primary antibodies specific for Caspase-
1(p10) were used followed by the appropriate secondary antibodies conjugated to HRP. 
The bottom panel shows a quantitative analysis (by densitometry) of Caspase-1 (p10). 
The bands were visualised using the ECL procedure.  
 
 
 
 
The data showed that in the unstimulated cell there is no production of Caspase-1 p10 
whereas in the Virus Only stimulation, there is considerable amount of Caspase-1 p10 
present. Cells treated with drugs Verapamil and ROS inhibitor has no effect on Caspase-
1 p10. However cells treated with Amantadine and Rimantadine has a reduction in 
Caspase-1 p10 suggesting that by blocking K+ channels there is a direct effect on 
inflammasome activation (Leonov et al. 2011). The anti-flu amino adamantyls 
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(Amantadine and Rimantadine) are known to block the influenza M2 channel, they 
specifically inhibit the H+ of the Influenza M2. The positive charge of the amino group 
in the adamantyls cause an electrostatic hindrance to the M2 H+ (Leonov et al. 2011). 
Functional studies indicate that amantadine binds to the pore of the IAV M2 proton-
selective ion channel (Jing et al. 2008). Unwarranted NLRP3 inflammasome activation 
causes inflammatory disease and it is vastly demonstrated that potassium efflux could 
lead to engaging this inflammasome (Kanneganti and Lamkanfi 2013) (Munoz-Planillo 
et al. 2013). Blocking K+ channels through the use of adamantyls can prevent the 
assembly of the NLRP3 inflammasome and the resultant Caspase-1 secretion. 
6.3 Discussion 
It has been previously demonstrated that IAV initiates an innate immune response through 
the recognition of viral RNA that results in the activation of the NLRP3 inflammasome, 
in vivo (Allen et al. 2009). A plethora of PRRs such as the RLHs, TLRs and NLRs have 
been identified and shown to be activated in response to IAV in dendritic cells, 
macrophages and also demonstrated in vivo. Also the Influenza viral ion channel protein 
M2 is involved in inflammasome activation in dendritic cells and macrophages (Ichinohe 
et al. 2010). In this study we demonstrate that infection of bronchial cells can elicit an 
innate immune response and viral invasion is recognised by RIG-I and MDA-5, the latter 
being less expressed in the infected cells. NLRP3 also senses IAV infection of BES and 
triggers the assembly of the NLRP3 inflammasome and cause the release of IL-1β. Using 
drugs such and Amantadine and Rimantadine which are K+ channel blockers we propose 
that the M2 ion channel is involved the NLRP3 inflammasome activation in bronchial 
cells.   
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CHAPTER 7 
DISCUSSION 
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The cells and organs of the human body require a constant stream of oxygen to stay alive. 
The respiratory system provides oxygen to the body’s cells while removing carbon 
dioxide, a waste product that can be lethal if allowed to accumulate. Like other organs, 
such as the skin and gastrointestinal tract, the respiratory tract is constantly exposed to 
microbes and particles by inhalation. It contains both mechanical (ie, ciliated epithelial 
movement and mucus production) and biochemical (ie, antimicrobial enzymes/ peptides) 
barriers that inhibit colonization of the lungs by most microorganisms. However, many 
respiratory pathogens, including viruses, have evolved to successfully colonize and 
replicate on or within the lung epithelial cells, occasionally causing life-threatening 
diseases. Viral infections of the respiratory tract are the most common triggers of 
bronchiolitis, wheezing and acute asthma exacerbations. Previous studies have shown that 
respiratory syncytial virus (RSV), human rhinovirus (HRV), (Johnston et al. 1995, 
Seemungal et al. 2001) human influenza virus (IAV), and human parainfluenza virus 
(HPIV) are detected in the acute exacerbation of asthma and chronic obstructive 
pulmonary disease (COPD), leading to rapid decline in lung function and increased 
mortality (Kurai et al. 2013). However, the relationships between viral infections, host 
immune response, and host factors in the pathophysiology of chronic bronchitis, chronic 
obstructive pulmonary disease, and bronchial asthma remains unclear.   
 
The increased airway inflammation is caused by the excessive production of cytokines 
such as Il-6 and TNFα. In this study we have also noticed an over-secretion of IL-1β in 
respiratory viral infections which causes inflammation of the lung tissue. The 
conglomeration of all these cytokines leads to COPD and asthma. A further increment of 
these pro-inflammatory cytokines are observed in acute exacerbations (de Kluijver et al. 
2003, Fleming et al. 1999, Terajima et al. 1997). Epithelial cells and monocytes (PBMCs 
and alveolar macrophages) collected from COPD and asthma patients secrete greater 
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amounts of IL-1β, responding vigorously to inflammatory stimulus (Hallsworth et al. 
1994). 
IL-1β is an important pro-inflammatory mediator and is generally produced at a site of 
injury/ damage or a site of infections (or immunological challenge). This happens, in 
order to recruit cells (immune cells/ immune receptors) to the site of damage to combat 
pathogen entry. Pathogen induced stimulus prompts the production of inactive IL-1β 
which is converted to the active form my multi-molecular protein complexes termed as 
inflammasomes. Mature cytokines are then released from the cells onto the site of 
infection causing inflammation and tissue damage. Inflammasomes contain members of 
the nucleotide binding domain leucine-rich repeat containing (NLR) family. These are 
identified as caspase-1 activators and thus controlling the second step required for the 
maturation and release of IL-1β.  
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Figure 7.1 NLRP3 Inflammasome activation. Three major models are proposed for the 
inflammasome activation which makes the signal 2 for activation. 1.) ATP acts an an 
NLRP3 agonist resulting in its activation and inflammasome assemblage 2.) Crystal and 
particles acts as an NLRP3 agonist, which are engulfed and results in lysosomal rupture 
3.) DAMPs or Danger Associate Molecular Patters and also PAMPs trigger the formation 
of ROS (Reactive Oxygen Species). A ROS dependent pathway triggers the 
inflammasome activation after engaging NLRP3. Diagram modified from (Tschopp et al. 
2003).  
In this study IL-1β production was investigated in response to inflammasome activation 
induced by various respiratory viruses such as RSV, HRVs and IAV in primary bronchial 
epithelial cells which is a clinically relevant cell type for viral respiratory infections. 
Silencing different NLRs allowed us to discover their involvement in inflammasome 
activation. These experiments confirmed that NLRP3 plays a major role in RSV, HRV 
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and IAV infections in addition NLRC5 inflammasomes was also involved in Caspase-1 
activation and the subsequent production of IL-1β in HRV infections. NLRs have been 
shown to have different roles in separate cell types (Ting et al. 2010).  
There is emerging evidence which suggests that during bacterial infections, multiple NLR 
inflammasomes have the potential to become activated. For example Candida albicans 
leads to up-regulation of NLRP3 and NLRC4 inflammasome in the oral mucosa (Tomalka 
et al. 2011)  Here we show that infection of primary bronchial cells with HRV leads to 
NLRP3 and NLRC5 activation and IL1β secretion. The overlapping biologic functions 
and pathogen specificity of NLRC5 with NLRP3 suggests that these proteins might act 
in a cooperative manner during inflammasome assembly and that the host immune 
response  has evolved to use both NLRC5 and NLRP3 in case one of them stops 
functioning the other can compensate. 
 
To determine the mechanism of  inflammasome activation by these viruses  we studied 
viral proteins  that  affect ion homeostasis in the cell since inflammasome has been shown 
to be triggered by K+/Na+ fluxes as well as Ca2+ imbalances(Chami et al. 2006). The 2B 
protein encoded by the Rhinovirus genome is a non-structural protein which also 
enhances membrane permeability. 2B protein forms integral pores in the membranes 
which could be a mechanism of inflammasome activation since bacterial  pore forming 
toxins activate the NLRP3 inflammasome  (Koizumi et al. 2012) . These pores allow 
Calcium ion efflux (van Kuppeveld et al. 1997).  
Tracking 2B protein intracellularly via confocal microscopy and the use of calcium 
inhibitors revealed that 2B viroporin localises to the Golgi complex and reduces ER and 
Golgi Ca2+ levels thus triggering NLRP3 and NLRC5 inflammasome activation. 
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For RSV our experiments showed that the small hydrophobic (SH) viroporin, which 
forms channels in the plasma membrane, is essential in triggering the NLRP3 
inflammasome in RSV infections of lung epithelial cells. Furthermore, RSV mutants 
lacking the viroporin SH were unable to trigger inflammasome activation and IL-1β 
secretion. Pharmacological treatment of RSV-infected cells with drugs that inhibited viral 
ion channels blocked inflammasome activation. Upon RSV infection, the RSV SH 
viroporin accumulates in the Golgi within lipid raft structures which are specialised 
membrane microdomain which form favourable conditions for intra-molecular cross-
talks and also facilitate signal transduction. Recent studies have reported that several ion 
channels as well as their modulators accumulate in lipid rafts (Dart 2010, Martens et al. 
2004). Lipid rafts are found in the Golgi network as well as the plasma membrane. They 
are positioned at the Golgi network possibly for sorting secretory cargo (Klemm et al. 
2009). In the case of RSV, the virus might be using lipid rafts as its exit mechanism by 
forming ion channels selective for monovalent cations (Na+ and K+), RSV triggers the 
translocation of NLRP3 from the cytoplasm to the Golgi and its activation. 
 
 
 
 
 
In conclusion our data reveals that during an RSV infection, its SH protein localises at 
the Golgi network and there it acts as an ion channel protein causing ionic flux across 
internal vesicular membranes. NLRP3 is observed to translocate from the cytosol of the 
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cell to the Golgi and localise with the lipid raft structures present there. These intracellular 
raft structures are crucial for ion channel accumulation. When cells are imposed with 
stress caused by viral invasion, ionic concentration imbalance occurs within intracellular 
vesicles and the cytosol mediated by viral pore forming proteins such as the SH protein. 
This could be a possible mechanism of viral recognition and an induction of an innate 
immune response through the activation of the NLR inflammasomes.  
Influenza virus like the other respiratory viruses discussed above has the same delirious 
effect on the human body and cause annual epidemics and more than ~5 million people 
suffer from it every year. Although a great deal of study has been made on trying to 
elucidate how the Influenza virus works there are still unknown areas in human 
knowledge regarding its exact function during infection. The scope of this study was to 
provide a glimpse into how the body innate immunity detects the invading pathogen and 
triggers an inflammatory response in order to combat the situation. Bronchial epithelial 
cells which are a suitable candidate for such viral infections were used and we infer from 
this study that PRRs such as the RIG-I and MDA-5 play a key role in recognising the 
invading pathogen and trigger the first line of defence. The NLRs such and the NLRP3 
in particular engages itself in forming a very typical macromolecular complex triggered 
by K+ imbalances caused by IAV, which lead to NLRP3 inflammasome activation and  
the production of inflammatory cytokines. Thus we propose that using ion channel 
inhibitors such as Adamantyls will help prevent inflammatory signals and greatly reduce 
the production of IL1β from lung cells. These data demonstrate that the Influenza M2 ion 
channel in highly involved in the NLRP3 assemblage and using K+ channel blockers can 
reduce the production of IL-1β. Ichinohe et al has demonstrated similar findings but in 
dendritic cells and macrophages. Our data is in agreement with Ichinohe et. al. however 
they are based on  lung tissue, which is more relevant to IAV infections. 
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In conclusion it is observed that most respiratory viruses encode ion channel proteins 
called viroporins including HRV, RSV and IAV. These small ion channel proteins change 
intracellular ion homeostasis which triggers the innate immune system and one of the 
main responses is the activation of the inflammasome. A disruption of the permeability 
barrier is observed in most respiratory viral infections across intracellular compartments 
(For example the Golgi and the trans-Golgi network) and also the plasma membrane. 
Viroporins trigger ion flux across these cellular compartments/membranes (such as 
Na+/K+ and Ca2+) and this ionic imbalance across the membranes causes the 
inflammasome activation and IL-1β secretion. This is the body’s natural defence against 
combating invading pathogens however repeated infections can cause damage to the lung 
tissues and cytokine secretion seems to do more harm than just controlling pathogen 
invasion. Therefore by blocking the ion channels could prove therapeutically beneficial 
in antiviral therapy.  
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